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An Introduction to Compulsory
Treatment for Drug Abuse:
Clinical Practice and Research
Carl G. Leukefeld and Frank M. Tims
INTRODUCTlON
Civil commitment as a form of compulsory treatment for the treat-
ment of drug abusers has been legally possible in the United States
in the last 25 years (California Civil Addict Program, New York State
Civil Commitment, and the Federal Narcotic Addict Rehabilitation Act
(NARA)). The focus of civil commitment procedures has been on the
compulsive drug abusers, especially antisocial addicts responsible for
committing large numbers of criminal acts. Today the concept has
been suggested, by individuals in both the drug abuse and criminal
justice fields, for users of intravenous drugs, who are at risk for
contracting and transmitting the acquired immunodeficiency syndrome
(AIDS) virus and who are unwilling to enter treatment voluntarily.
The concept of compulsory treatment as a mechanism for reducing
the prevalence of drug abuse and the consequences of that abuse, for
both those individuals and U.S. society at large, is not new.
Compulsory treatment may be defined as activities that increase the
likelihood that drug abusers will enter and remain in treatment,
change their behavior in a socially desirable way, and sustain that
change. While the implementation and outcomes of the above civil
commitment programs differ to some extent, their intent and enabling
legislation were quite similar, as were their commitment procedures.
Their purpose was to control and rehabilitate the compulsive drug
abuser by providing drug abuse treatment, monitoring drug use, and
providing reasonable sanctions for program infractions.
Although the Federal and State civil commitment programs were only
in full operation for about a decade, 1965 to 1975, and were replaced
by a system of community drug treatment programs, the desire for
community programs to induce larger numbers of addicts into
1
treatment and the high number of prisoners with addiction histories
suggest that civil commitment be reexamined. Concern about the
spread of AIDS among intravenous drug abusers and from intravenous
drug abusers to their sexual partners and children has given renewed
impetus to such reexamination.
The relationship between heroin addiction and crime is well estab-
lished (Anglin, this volume; Nurco 1986). Likewise, the relationship
of intravenous drug use and AIDS is well established, with 25 percent
of all AIDS cases related to intravenous drug use. This review
presents the convergence of knowledge regarding drug abuse treat-
ment effectiveness with the emergence of the current AIDS problem
among intravenous drug abusers. AIDS is spreading among intra-
venous drug abusers through sharing of needles contaminated with the
human immunodeficiency virus (HIV). Through this sharing of
needles, it is believed that the vast majority of needle-using addicts
are at risk for contracting AIDS.
AIDS AND INTRAVENOUS DRUG USE
Currently, AIDS among intravenous drug abusers is largely confined
to the New York City/northern New Jersey metropolitan area, with
lesser concentrations in California, Florida, and Texas. The current
concentration of AIDS appears to be a temporal phenomenon—rates
are highest in those communities where AIDS was first detected.
Once introduced among intravenous drug abusers in a community,
infection spreads very rapidly. For example, the AIDS virus has been
detected in stored sera. First recognized among intravenous drug
abusers in New York City in 1978, infection rates were established at
40 percent in 1980 from stored blood and 60 percent in the latter
part of 1986. Rates of infection appear to be low in most of the
country, yet significant rates of infection are beginning to emerge in
some areas. With time, AIDS prevalence among intravenous drug
abusers is expected to increase rapidly in cities across the United
States.
The Public Health Service and the National Institute on Drug Abuse
(NIDA) have identified intravenous drug abusers as a major source for
the spread of AIDS to the heterosexual population. While data on
heterosexual AIDS transmission is incomplete, there is some indication
that transmission may occur fairly readily, at least among regular
sexual partners of persons with AIDS. Since many intravenous drug
abusers are sexually active, and since many female abusers resort to
prostitution to support their drug habits, the potential for the spread
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of AIDS from intravenous drug abusers to the general population is
considerable, especially as HIV infection becomes more widespread
among intravenous drug abusers. This potential is of serious concern
for health-care delivery and drug abuse treatment programs, and for
the criminal justice system as well.
TREATMENT EFFECTIVENESS FOR INTRAVENOUS DRUG USERS
NIDA has sponsored research that suggests that treatment for drug
abuse is effective (Tims 1981; Tims and Ludford 1984). Clients
entering drug-free outpatient (counseling) programs, drug-free
residential (therapeutic community) treatment, and methadone
maintenance treatment generally experience dramatic reductions in
drug use and associated criminality. Many studies also show improve-
ment in employment status and other behavioral outcomes among
treated drug abusers, The question of which treatment is superior
becomes clouded by the prevailing pattern for clients who have
multiple treatment experiences, often in more than one type of
program, before becoming abstinent from their principal drug of
abuse. This pattern of multiple treatments is reflected in a study by
Simpson and Sells (1982), in which opioid addicts were followed over
a 6-year period after admission to treatment. By the sixth year, 61
percent of these addicts were opioid abstinent and had been so for at
least 1 year. Treatment figured prominently in the attainment of
stable abstinence patterns, with about 80 percent of those abstinent
having achieved this status directly in connection with a treatment
episode. In addition to the 61 percent who were abstinent, 18
percent had given up daily opioid use but had other problems such as
occasional opioid use, heavy use of nonopioids or alcohol, or long-
term incarceration. Thus, even though a significant number of clients
had other problems, only one-fifth of those treated continued their
pretreatment levels of opioid use at 6 years after leaving treatment.
Relapse prevention is an important component of treatment program-
ming, and is the subject of ongoing research (Marlatt and George
1984; Tims and Leukefeld 1986). The greatest risk of relapse after
leaving treatment occurs during the first 90 days, at a time when
clients are exposed to drug-related stimuli, without the support of a
structured program to help resolve their conflicts. For this reason,
aftercare programs have been developed to follow up individuals in
the community, and to provide a resource to assist in maintaining the
client’s commitment to abstinence. Aftercare models include self-help
groups, such as Narcotics Anonymous, and approaches that stress the
development of coping skills through professionally guided self-help
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training groups. Also, cognitive-behavioral models such as those
developed by Brownell et al. (1986) include coping strategies and
development of more effective perspectives on drug use “slips” and
relapse. Civil commitment programs also include a lengthy aftercare
component.
THE ROLE OF CIVIL COMMITMENT IN TREATMENT AND AIDS
CONTAINMENT
Recognizing that about 25 States have an existing civil commitment
statute, a panel of drug abuse treatment researchers met in January
1987 to examine the demand-reduction potential, clinical and thera-
peutic value, as well as costs/benefits associated with civil commit-
ment for drug abusers from a public health perspective. The review
was to be the first meeting. After identifying the scientific base
during this meeting, additional efforts might focus on the pre- and
postadjudicatory mechanisms for mandatory treatment as well as on
national policy implications of compulsory treatment and civil
commitment.
The initial review was organized into five parts. Dr. Douglas Anglin
reviews data from several evaluations he completed on the California
Civil Addict Program. Dr. James Maddux, a former medical officer in
charge of the U.S. Public Health Service Fort Worth Narcotic
Hospital, reviews followup studies that compare compulsory followup
treatment and voluntary treatment of addicts released from the Public
Health Service hospitals in Fort Worth, TX and Lexington, KY. It
was suggested that emphasis be placed on what has been learned from
existing studies. Three major issues suggested for inclusion were:
(1) When is legal coercion therapeutically useful?
(2) What is legal coercion’s value in reducing the “contagious”
aspects of the drug-using lifestyle?
(3) Where and how has compulsory treatment and civil
commitment/legal coercion been used in the past?
It was also suggested that emphasis be placed on background,
overview, settings, and specific methodologies that are available for
better understanding compulsory treatment and civil commitment.
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The first section, or group of papers, sets the stage with an overview
of compulsory treatment, civil commitment, court referral, and other
forms of legal coercion for drug abuse treatment.
The second section reviews long-term treatment evaluation studies by
focusing on the influence of judicial status—including probation,
parole, and mandatory release—on drug abuse, criminal behavior, and
related outcomes during and after treatment. Presentations included
longitudinal study results pertinent to compulsory treatment. A
description of the rationale, strengths, limitations, and generalizability
of findings is also incorporated. Dr. Robert Hubbard provides an
examination of clients involved in the Treatment Outcome Prospective
Study (TOPS), which confirms previous studies related to retention in
treatment and motivation by clients referred from the criminal justice
system and, more specifically, by Treatment Alternatives to Street
Crime (TASC). Dr. D. Dwayne Simpson reports on the influence of
pretreatment legal status 12 years after treatment for a group of
male addicts.
The third section reviews efficacy studies that focus on civil commit-
ment, legal coercion, and court referral and highlights research
results and findings. The impact of civil commitment on treatment
outcomes and retention in treatment is stressed. Ms. Beth Weinman
describes TASC and discusses several evaluations of TASC.
Dr. Herman Joseph presents an historical perspective which focuses
on probation activities and diversion programs in New York City.
Dr. James lnciardi recalls his personal experiences as a staff member
in the New York Narcotics Addiction Control Commission, which had
responsibility for implementing the New York State Civil Commitment
Program. Dr. Eric Wish describes four approaches for identifying
drug abuse in the criminal justice system. Dr. George De Leon
reports on the linkage of therapeutic communities with the criminal
justice system and reviews data related to the effectiveness of
therapeutic communities. Dr. John Ball completes the presentations in
this group of papers by providing information from his study of
methadone maintenance programs.
The fourth section focuses on the costs and potential benefits from
civil commitment studies and related research. Dr. Barry Brown
examines civil commitment from the international perspective and
reports that little is known about costs and related benefits for civil
commitment internationally. He reviews the status of civil commit-
ment in 43 countries. Dr. Henrick Harwood presents cost-benefit
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information focused on TASC and other criminal justice system
programs.
Finally, the last section includes consensus statements of current
knowledge. In addition, the final section includes areas for future
research, which were developed during the consensus process.
Consensus development used the following issues as a frame of
reference:
Based upon the literature, how can the civil commitment process
be improved? Are there viable alternative models to civil
commitment which might be more productive/efficient from a
clinical/public health perspective?
What major research questions, strategies, and design features
should be incorporated into evaluative studies of compulsory
treatment and, more specifically, civil commitment?
What is the potential of compulsory treatment and civil
commitment for curbing the spread of AIDS?
REFERENCES
Brownell, K.D.; Marlatt, G.A.; Lichtenstein, E.; and Wilson, G.T.
Understanding and preventing relapse. Am Psychol 42:765-782,
1986.
Marlatt, G.A., and George, W.M. Relapse prevention: Introduction
and overview of the model. Br J Addict 79:261-273, 1984.
Nurco, D. Drug addiction and crime: A complicated issue. Br J
Addict 82:7-9, 1986.
Simpson, D.D., and Sells, S.B. Effectiveness of treatment for drug
abuse: An overview of the DARP research program. Adv Alcohol
Subst Abuse 2(1):7-29, 1982.
Tims, F.M. Effectiveness of Drug Abuse Treatment Programs.
National Institute on Drug Abuse Treatment Research Report.
DHHS Pub. No. (ADM) 84-1143. Washington, DC: Supt. of Docs.,
U.S. Govt. Print. Off., 1981. 181 pp.
Tims, F.M., and Leukefeld, C.G., eds. Relapse and Recovery in Drug
Abuse. National Institute on Drug Abuse Research Monograph 72.
DHHS Pub. No. (ADM) 86-1473. Washington, DC: U.S. Govt. Print.
Off., 1986. 197 pp.
6
Tims, F.M., and Ludford, J. Drug Abuse Treatment Evaluation:
Strategies, Progress, and Prospects. National Institute on Drug
Abuse Research Monograph 51. DHHS Pub. No. (ADM) 84-1329.
Washington, DC: U.S. Govt. Print. Off., 1984. 180 pp.
AUTHORS
Carl G. Leukefeld, D.S.W.
Frank M. Tims, Ph.D.
National Institute on Drug Abuse
National Institutes of Health
Parklawn Building, Room 10-A-38
5600 Fishers Lane
Rockville, MD 20857
7
The Efficacy of Civil Commitment
in Treating Narcotic Addiction
M. Douglas Anglin
INTRODUCTION
Civil commitment approaches to the control of narcotics addiction are
not new. The United States Public Health Service (USPHS) hospitals
in Fort Worth and Lexington represented an early attempt at
enforced treatment. Findings from the USPHS efforts in this respect
are reviewed by Maddux in this volume.
Before renewed consideration can be given to the compulsory commit-
ment of drug addicts for treatment, it is crucial to determine whether
such treatment can be effective in reducing addiction, or at least in
minimizing the adverse social consequences of addiction. There have
been only a few studies that have addressed this question, and the
empirical evidence derived from most of them has been equivocal.
Most commitment programs implemented over the last 20 years were
based more on the hope that treatment would be effective than on
consistent and objective demonstration of efficacy.
In order to demonstrate conclusively whether enforced, or compul-
sory, treatment is effective, William H. McGlothlin and I conducted
an evaluation of the California Civil Addict Program (CAP), the first
true civil commitment program implemented in the United States
(McGlothlin et al. 1977).
BACKGROUND
The initial study was performed during 1974, 1975, and 1976. Nearly
1,000 individuals admitted to the California CAP from 1962 to 1964
for a 7-year period of commitment were selected for followup. For a
full description of the California CAP, see McGlothlin et al. 1977.
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For other research results, see Anglin and McGlothlin 1984 and
Anglin, in press. Subsequently, in 1978, the combined effects of civil
commitment and methadone maintenance on another sample of
approximately 300 CAP admissions were studied (Anglin et al. 1981).
The first CAP study took advantage of a natural experiment that was
inadvertently created during the initial years of the program. The
laws creating the CAP were passed in 1961, and the program actually
began late in 1962. However, judges and other officials involved in
the initial implementation of the program were not very clear about
commitment procedures and thus made many procedural mistakes. In
the first 18 months of the program, therefore, nearly half the
individuals admitted were released on a writ of habeas corpus after
minimal exposure to the inpatient component.
This group thus encompassed people who were eligible for the
program and who had the same characteristics as others admitted to
the program, but who, because of what was apparently a semi-
random process, were released after only a short time because of
procedural errors.
To take advantage of these circumstances, a treatment sample of
individuals was selected. These individuals had stayed in the program
for at least one inpatient stay and a subsequent release to supervised
community release, or outpatient status (OPS), and were matched with
individuals from among the group who had writted out. A time series
approach was used to study the data obtained from following up these
two groups.
OVERALL OUTCOMES OF CML COMMITMENT
Figure 1 is a time series graph from the original study. The
dependent variable was the percentage of time during each year that
narcotics were used on a daily basis. The solid line represents the
group that was admitted to the California Rehabilitation Center,
which is the inpatient facility for the CAP. The treatment sample
consisted of those who achieved at least one outpatient release.
Many of these, in fact, remained in the program for the full term.
The broken line represents those admissions who writted out after
minimal exposure to the program. They comprised the comparison
group. The break in the lines corresponds to the admission date to
the CAP. Eight years of preadmission data and 11 to 13 years of
postadmission data were obtained during the followup interviews.
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FIGURE 1. Percent of nonincarcerated time using narcotics daily: CAP treatment and comparison samples
For part of the preadmission period, the treatment group reported
somewhat less daily narcotic use than did the comparison group. On
the whole, members of the treatment group spent an average of a
little over 40 percent of their time using narcotics daily before the 2
years immediately preceding commitment, compared to an average of
slightly less than 50 percent for the comparison group. For the 2
years before admission to the CAP, however, addiction levels for both
groups were “out of control,” and there was a sharp and converging
rise in the daily use of narcotics.
In the first year after release from treatment (either by writ or by
release to OPS), there was a sharp separation between the two
groups, with the comparison group using narcotics daily at a much
higher rate. Among the treatment group, an immediate and dramatic
drop occurred in daily narcotic use, which was sustained over the 5-
year period when most of the group were under supervision in the
CAP. After year 5, a time-related attenuation was evident, which
was associated with other social interventions and with maturing out
(Winick 1962). The comparison group showed a time-related attenua-
tion over the entire postadmission period, eventually converging
toward the treatment group level by year 5.
Years 6, 7, and 8 show increased daily use levels by both groups.
Chronologically, that period occurred during a heroin epidemic in the
United States in the early 1970s. This concomitant increase in levels
of daily use by both CAP groups provides strong evidence that
consumption of heroin is directly related to availability of the drug.
Based on this time series data, it is clear that civil commitment has
an important and dramatic effect on suppressing daily heroin use by
narcotics addicts. However, the program was not just concerned with
narcotic use per se; it was also intended to affect addiction-related
behaviors, particularly those with adverse social consequences.
Figure 2 is a graph showing the reported percentage of time each
group engaged in property crime activities. Prior to admission, both
groups spent comparable amounts of time involved in the commission
of property crime. As before, a sharp and sustained reduction was
observed after admission for the treatment group, whereas the
comparison group shows only a time-related attenuation.
The differences observed in figures 1 and 2 must be considered as
minimal measures of the effects of civil commitment. In many
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FIGURE 2. Percent of nonincarcerated time involved in property crime; CAP treatment and comparison samples
cases, individuals in the comparison group were not totally free of
legal supervision. Some were on parole or probation or were subject
to other types of supervision that also suppressed their narcotic use
and criminal behavior. Had this not been the case, their use levels
and crime rate would undoubtedly have been higher. Thus, the
difference between the curves gives only a minimum estimate of the
effectiveness of civil commitment.
Table 1 presents a complete set of dependent variables for both
groups, including employment, time spent dealing drugs, and so forth.
All these measures show similar effects to those observed in figures 1
and 2 for daily narcotics use and for property crime involvement.
However, as the behavior or measure becomes more prosocial, the
effect becomes less dramatic. Statistically significant increases in
employment were observed, for example, but the change was not
nearly as large as were reductions in antisocial behavior.
Table 1 shows the difference between the precommitment to postcom-
mitment change in status and behavior for the treatment group and
the corresponding change for the comparison group. These data take
into account the initial precommitment levels of the variables and
determine the net difference in change scores for the two samples,
i.e., [comparison group postcommitment minus comparison group
precommitment] minus [treatment group postcommitment minus
treatment group precommitment].
Three periods are considered. Period I is the interval from time of
first narcotic use (N1) to civil commitment admission (A). Period II
is the 7 years after commitment, A to (A + 7), corresponding to the
full commitment term. Period Ill is the interval from A + 7 to the
interview (I), when, except for extended commitments, most of the
treatment group had been discharged from the CAP.
It must be noted that period II is defined on a purely chronological
basis, so that it represents the intended period of legal commitment.
Such a definition again gives a minimal estimate of the efficacy of
civil commitment, because a large minority of the treatment group
was released from CAP supervision before the imposed commitment
period expired. Reasons for early release included a determination as
unfit for treatment, incarceration for criminal offenses, and, less
often, graduation in good standing.
To test the sample differences for statistical significance, the data
are expressed in terms of the means of the individual measures. The
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TABLE 1. Summary of mean precommitment and postcommitment status and behavior for comparison (C) and
treatment (T) samples
TABLE 1. (Continued)
1Data on arrests, self-reported crimes, and income from crime are rates per nonincarcerated person-year. Crime income does not include
drug dealing, gambling. etc.
2Heavy alcohol use is defined as drinking a six-pack of beer, or a bottle of wine, or seven drinks of liquor over a 6-hour period two or
more times per week.
NOTE: Period I=First narcotic use (N1) to civil commitment (A); Period II=A to (A + 7 years). the legislated period of commitment; Period
Ill=(A + 7 years) to time of interview (I). The percentages in this table are the mean of individual percentages for the
respective periods. not the percentage of the overall parson-months.
SOURCE: McGlothlin et al. 1977.
right half table 1 shows the difference between the change scores
and the corresponding t-ratio. For example, the difference between
drug arrest change scores between periods I and II is:
(TII-TI)-(CII-CI)=(.53-0.83)(-0.95-1.06)=-0.19.
Thus, the decrease in the drug arrest rate from preadmission, period
I, to postadmission, period II, for the treatment group was about 19
percent more than the corresponding change for the comparison
group. There was also a 40 percent greater reduction in nondrug
arrests. There was, however, an expected increase in parole viola-
tions (34 percent larger), because members of the treatment group
were on a lengthy supervised outpatient status and so were at risk
for administrative violation more often than the comparison group. It
should be noted that the violation increase did not even reach the
level of decrease in nondrug arrests, and certainly not the decrease
in the nondrug and drug arrests combined. Clearly, the CAP
benefited other agencies in the CJS by reducing criminal activity and
by handling individuals under civil commitment authority internally
rather than by instituting new and costly legal proceedings.
In general, members of the treatment group spent about 2 percent
more time incarcerated during the aftercare period, a negligible
difference. They spent 29 percent more time under legal supervision,
an expected difference because supervised community aftercare is a
strong component of the CAP. Their daily narcotic use was down 15
percent more. Their criminal activities were down by 12 percent
more if percent of time involved in property crime was the measure,
but were down 36 percent more when the number of crimes com-
mitted was the measure, and down 32 percent more when mean
income from crime was the measure. Their dealing was down 5
percent more, their employment was up by 7 percent more, and their
alcohol abuse was down 3 percent more (not statistically significant).
For a composite score—the percentage of time alive, not incarcerated,
and not using drugs daily—the change in the treatment group was 7
percent higher than the comparison group. Except for the daily
narcotic use and crime reductions, these changes were moderate for
the most part.
EFFECTIVE ELEMENTS OF CIVIL COMMITMENT
What is the component of civil commitment that produces the
greatest effect? While some period of inpatient care may be
necessary in the majority of cases, it is apparently the close
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community supervision, with objective narcotics testing, that is most
important. To test the assumption that the level of legal super-
vision makes a critical difference in daily narcotic use, the data was
aggregated into periods when the subjects were under different types
of supervision. Figure 3 presents the results for daily narcotic use.
Before 1960, only data for no supervision and various legal super-
visions (e.g., probation or parole) without drug testing was available
for our subjects. The graphs for these two conditions are very
similar. After 1960, sufficient data were available to construct
graphs for legal supervision with testing and for abscondence from
supervised conditions. After 1964, OPS data became available. OPS
differed from other legal supervisions with testing because of
specially trained parole officers, smaller case loads, and more
frequent drug testing.
It is clear that the level of supervision exemplified by OPS produced
the best results in reducing daily narcotic use for each of the 2-year
intervals for which data were available. The next most effective
approach over all the periods, although it fluctuated somewhat more,
was legal supervision with testing. The least effective, as might be
expected, was absconded status. In this condition, individuals under
supervision either rejected the degree of control exercised by their
parole officers, or got out of control in their drug use or other
behavior, and fled rather than wait for violation to occur.
Data from absconded periods are important because addicts in
abscondence represent a failure of the CJS to maintain control.
Absconding also becomes more common as controls become stricter.
Thus, it is necessary to balance the level of constraint that super-
vision places on addicts against the likelihood that they will abscond
if the control becomes too severe.
In its initial 6 to 8 years, the CAP was a very stringent program.
Addicts spent an average of 18 months incarcerated in the inpatient
phase. They were then released to the aftercare, or outpatient,
phase where they were closely and severely monitored to induce them
to remain drug free. The popular expression of parole agents was
“You use, you lose.” Outpatients who were detected in any narcotic
use violations were usually returned to the institution for another
incarceration period.
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FIGURE 3. Percent of nonincarcerated time using narcotics daily as a function of legal supervisory status; total
CAP sample
In the 1970s, the program became more liberal, in both its inpatient
and outpatient requirements. The initial inpatient stays became
shorter and addicts who used drugs or otherwise violated parole
conditions were reincarcerated for a limited placement of 36 to 60
days. In the OPS phase, some infrequent drug use was tolerated if
the overall behavioral pattern of the addict was acceptable.
Although not presented here, our research findings for a 1970 CAP
treatment sample showed poorer outcomes resulting from these policy
changes (McGlothlin et al. 1977). Nevertheless, after the increasing
popularity of methadone maintenance (MM) in the 1970s, this later
CAP treatment sample performed as well as the earlier CAP treatment
group because a substantial minority entered MM.
While the more frequent and consistent OPS monitoring of the earlier
period was also more effective, for both program periods it was clear
that rigid application of policies that routinely returned individuals to
inpatient care could result in poorer outcomes for some (Jamison and
McGlothlin, in press). The best approach appeared to be a flexible
relationship between the parole officer and the parolee, in which the
parole officer had some sort of leverage to “bargain” for better
behavior. It became something of a therapeutic conspiracy between
some parole officers and their wards, “Well, you’ve been dirty once.
Now if you don’t give me another dirty, I won’t report it to my
superiors.” Some parole supervisors would accept this arrangement
and would tolerate occasional narcotic use as long as agents were
effective in preventing rearrest or a relapse to addiction. This sort
of bargaining seemed to work better than the parole officer who said,
“lf I find you dirty once, you’re going back in. If you hang around
with some of your old friends, you’re going back in.” That sort of
rigid application of policy often resulted in parolees absconding and
subsequently relapsing to high levels of addiction, dealing, and crime.
SUMMARY OF FINDINGS
Based on the data presented here and on other data, the most
effective civil commitment approach for narcotic addicts is to place
them on long-term parole, 5 to 10 years, so that their drug use and
other behavior can be closely monitored. While an inpatient period
may often be required initially, a few months should suffice to
stabilize the addict; inpatient time should be protracted only if the
addict needs vocational or educational training or for other reasons
unrelated to their addiction.
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Once released to the community, frequent and careful monitoring is
required, using urine assays or other objective tests. lf relapse to
narcotic use, property crime, or dealing becomes apparent, only a
short return to the inpatient facility, at most 30 to 90 days, is
required to detoxify addicts and ready them for release again.
It is important to remember that the measure of recidivism often
used by the CJS for evaluation is not a particularly useful one in
assessing treatment outcomes for narcotic addicts. When dealing with
something of such a chronic relapsing nature as addiction, different
measures are more appropriate. The same perspective should be
applied to narcotic addiction control as many mental health profes-
sionals take toward intervention with the chronically mentally ill:
such intervention requires a lengthy, if not lifetime, management
program. lt is unrealistic to expect a cure, e.g., successfully
maintained abstinence, in the majority of addicts who frequently come
into contact with the CJS (Anglin and McGlothlin 1985). Instead, to
evaluate interventions properly, it is important to use such measures
as how much less time is spent incarcerated, how many fewer
relapses occur, and how much less time after the intervention is
spent using at an addicted level.
It would appear that an assessment of the CAP treatment and
comparison groups for recidivism or relapse rate alone would have
shown few differences between them. Nearly everyone in each group
became readdicted at some point after intervention, but the treatment
group had fewer such multiple instances, and when they did occur,
they were of shorter duration. There were also longer nonaddicted
periods of controlled use, or even abstinent periods, separating their
relapses.
Such realistic expectations should structure the major goals of civil
commitment. Although a small number of addicts do mature out of
their addiction every year, social policy efforts must be directed
toward long-term management programs using the CJS and treatment
to effectively minimize the adverse individual and social consequences
of addiction.
MM AND CIVIL COMMITMENT
Because long-term followup information was obtained on the addiction
career, the study was able to examine the effects of MM for some
who had been civilly committed. As noted earlier, the CAP program
began in 1962. MM did not become generally available in California
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until after 1970. Subjects were interviewed in 1974 and 1975, about 3
years of followup data were available for those among the civil addict
sample who subsequently entered MM.
For analysis purposes, MM participation included any MM program
that our subjects encountered, however administered in their local
area. Subjects were divided into three groups depending on their
narcotic use and treatment status during the 3 years before the
interview. The “inactive” group included subjects who had shown
minimal daily (addicted) narcotic use in the 3 years before the
interview and were not in treatment. The “active” group comprised
subjects who showed considerable daily narcotic use in the 3 years
before the interview but had not entered treatment. The “methadone”
group had entered treatment at some time during the 3-year period.
The activities of each group were traced backwards using the actual
MM admission date as a reference point for the methadone group.
The median admission date for the methadone group was used as the
reference point for the inactive and active groups. The results for
daily use of narcotics are shown in figure 4. (The reference point is
indicated by an “M” on the abscissa).
Ten years before the MM admission date, just before most of the
subjects entered the CAP, there was little difference among the
groups. The CAP period started about years 8 and 9 before admission
and continued until about year 4. Over this 5- to 6-year period,
there is a dramatic separation in the level of daily narcotic use for
the groups. Those designated as active reduced their daily narcotics
use only minimally over the period of CAP supervision. (This period
of supervision is marked by dashes along the abscissa.) As soon as
supervision ended, there was a “bounce-back” effect in which actives
actually exceeded their precommitment daily narcotics use. Part of
this increase, however, was due to a heroin epidemic in the United
States (marked by asterisks along the abscissa).
The methadone group apparently was comprised of subjects who
responded reasonably well to the CAP by decreasing their addicted
level of narcotic use, but who also rebounded on discharge to a level
similar to that observed for the pre-CAP period. After MM entry,
this group demonstrated a dramatic decrease in daily use that
continued during the 3 years of followup. The inactive group, which
apparently matured out of addiction over time, responded ideally to
the CAP intent. These civil commitments reduced their daily narcotic
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FIGURE 4. Percent of nonincarcerated time using narcotics daily; CAP inactive, active, and methadone
subsamples
use to a considerable degree over the prescribed commitment period.
By the time they were released, sufficient gains had been achieved
and stabilized so that these improvements could be independently
sustained in the community.
The important point these findings demonstrate for civil commitment
is that, no matter what the behavioral characteristics of the group or
their addiction career patterns, civil commitment produced desirable
effects to some degree for all types of admissions. Apparently, the
approach is a type of control that is differentially effective even on
the most recalcitrant of offenders.
Figure 5 is structured in the same manner as figure 4, only the
measure displayed is property crime involvement. The pattern of
change over the course of the CAP and MM is very similar to that
seen for daily narcotic use. For the same three groups, similar
suppression occurs during the CAP, with the same rebound effects for
the first two groups, after discharge, and the sustained low crimi-
nality for the inactive group. These results are further compelling
evidence that civil commitment and MM are generally efficacious
interventions and each has an appropriate application.
The findings presented above have occasionally been criticized on the
grounds that the data about the civil commitment program are
“contaminated” because some of the subjects have been on MM. That
is not the case, however.
First, the data points in the time series before 1971 are uncon-
taminated by MM, and one sees strong effects due solely to CAP
intervention (figures 1 and 2). Second, the addicts on MM were
segregated into a separate group in figures 4 and 5, and the effects
remain for the two groups that had never been involved with MM.
Despite the observed efficacy of the California CAP, these studies
have revealed several shortcomings that limited its overall utility.
Interviews with Hispanics in the program, for example, indicated that
they did not like the large group therapy format that required
discussion of personal thoughts, feelings, and behavior with others,
particularly with individuals of other ethnic groups. Therapy for
Hispanics might be more effective if they were assigned to a group
of their own, or if individual counseling were employed more often.
Such an approach could, however, lead to charges of racism, which
might dilute the comprehensive effectiveness of the program.
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FIGURE 5. Percent of nonincarcerated time involved in property crime: CAP inactive, active, and methadone
subsamples
Furthermore, since 1980, the length of the commitment period has
been shortened from 7 years to a much shorter period that is set by
the California determinant sentence law. Although there is no
explicit evidence about the effect of this change, previous research
and experience indicate that the success of treatment is directly
related to the length of participation in the program. Therefore,
shortening the total length of the treatment program has likely
reduced its effectiveness. Determining the effects of this change
would be an appropriate subject for future research.
OTHER CIVIL COMMITMENT EFFORTS
Three major civil commitment programs have been tried in the United
States; each is discussed in this volume. The first of these was the
California CAP. Because of its relative success, New York began a
civil commitment program (Inciardi, this volume), and the Federal
Government passed the Narcotics Addiction Rehabilitation Act (NARA)
(Maddux, this volume), which also created a civil commitment
program. On the whole, the laws creating the new programs were
not very different from the California law. In general, the same
procedures were mandated: a diversion during criminal adjudication
from incarceration in jail or prison to a narcotic treatment facility or
program. There was also provision for the involuntary commitment of
addicted individuals who did not have any criminal charges against
them. This provision, however, was used relatively infrequently in
the California program, and is not used at all today, except in rare
instances. Involuntary commitment without criminal charges was also
infrequently used in the New York and NARA programs.
The general consensus of several authors is that the New York
program was pretty much a failure. James lnciardi presents this
conclusion elsewhere in this volume. Also, Titles I and Ill of the
Federal NARA did not fare well upon evaluation (Lindblad and
Besteman, in press). But Title II, administered by the Federal Bureau
of Prisons, was more efficacious (Kitchener and Teitelbaum, in press).
Most researchers in the field agree that implementation strategies
produced the outcome differences for the various civil commitment
programs reviewed in this volume. While it is possible to develop
reasonable social intervention policies that achieve good behavioral
outcomes when properly applied, how the policies are implemented can
ensure or sabotage success.
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New York’s program was not particularly successful partly because it
was implemented through the State’s social welfare agency, rather
than through an established agency with experience in dealing with
addicts and addicted behavior. The Federal NARA program had
minimal results for Title I and Ill commitments for similar reasons.
In contrast, California’s and NARA’s Title II programs were imple-
mented through the CJS, specifically the California Department of
Corrections and the Federal Bureau of Prisons, and both worked
reasonably well, or as well as any other type of intervention has
worked for the narcotic addict.
BEYOND CIVIL COMMITMENT
Many of the basic drug treatment programs now in the community did
not become established nationwide until after the NARA was passed;
in fact, NARA funding provided seed money for getting many
community programs started. It was not until the mid-1970s that a
broadly based infrastructure for community treatment was developed.
In the ensuing years, a “shotgun” marriage occurred between the
treatment community and the CJS, with many individuals referred to
drug treatment by the courts, probation, or parole. In essence, there
has developed a kind of de facto coercive structure in court,
probation, and parole referrals to drug treatment that is similar to
compulsory treatment efforts, albeit somewhat more haphazard and
less coordinated. Because of this development, some recent research
conducted at UCLA has not involved civil commitment per se, but
instead has studied CJS referrals to treatment in California.
LEGAL COERCION INTO COMMUNITY TREATMENT
Subjects from two studies of MM clients were asked why they had
entered MM or therapeutic community treatment programs. Two
cohorts were established: a Southern California cohort of 1971 to
1973 admissions to MM and a 1976 to 1978 cross-section cohort of
clients in MM treatment (Anglin and McGlothlin 1985; Anglin et al.,
in press). For each cohort, the total number of treatment entries for
MM and therapeutic communities and the self-reported reasons for
entry were determined. The results are shown in table 2.
In the admission cohort, 46 percent of those entering MM gave a
legal reason that motivated their entry. These reasons could be
subdivided into pressure from police, pressure from probation or
parole, pressure from the courts, and indirect pressure (“The cop on
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TABLE 2. Major self-reported reasons for treatment entries for southern California programs (percent)
NOTE: MM=Methadone Maintenance: TC=Therapeutic Commmunity; P.O.=Probation or Parole officer.
the beat said he would bust me if I didn’t get some help,” or “I was
so well-known in the community that it was just a matter of time..”).
All of these situations represented some level of legal coercion into
treatment.
Among those from the admissions cohort who entered therapeutic
communities (which represent a less desirable situation for the addicts
because they are, in effect, restricted to a residential facility for a
period of time), 73 percent reported legal coercion as the main
reason for their entry into the program. Simply put, the threshold
level of coercion for motivating someone to enter treatment is higher
for therapeutic communities than for MM programs.
The same pattern was observed for the cross-section sample and for
both sexes. In this cohort, for MM entries, 36 percent of the men
and 21 percent of the women reported legal coercion. For those
entering therapeutic communities, 66 percent of the men and 54
percent of the women reported legal coercion.
Other reasons for entering treatment were more indeterminate, and
some of the classifications represent our best coding of open-ended
types of answers. The answers may have been as vague as a desire
to use less heroin. As is clear from the table, after legal reasons,
the most important reasons are either attempts to lower heroin use
or they reflect “burn out” with the addict lifestyle.
EFFECTS OF LEGAL COERCION INTO TREATMENT
Because there is a common belief that people entering treatment
under legal coercion do not do as well as volunteer admissions, this
presumption was tested by subdividing the admissions cohort into
three smaller groups: those who came in under moderate legal
coercion, those who came in under high legal coercion, and those
who reported no legal coercion and thus entered for “more voluntary
reasons.” High legal coercion was defined as having an active legal
supervision, with urine monitoring at entry and/or a self-perceived
legal coercion. Moderate legal supervision did not require either the
testing condition or the self-perception of coercion. Approximately
half of these combined categories contained individuals under
supervision by the CAP.
Possible differences in performance among these groups during their
first MM treatment episode were examined. Table 3 presents
behavioral variables under the three levels of legal coercion. As can
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TABLE 3. During treatment behavior of MM admissions entering under no, moderate, and high legal coercion*
No Coercion Moderate Coercion High Coercion F-value
(n=84) (n=101) (n=111)
#Months MI-MD
CJS Legal Supervision
3 1
8 3
Criminal Activities
Property Crime
Number Crimes/Month
Crime Income/Month
Dealing
Dealing Income/Week
Drug Involvement
Daily Narcotic Use
lrregular Narcotic Use
No Use
Heavy Alcohol Use
Daily Marijuana Use
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5
15.76 18.40 16.64
2.59 3.71 2.69
151.72 360.39 205.29
25.93 23.13 26.48
50.93 52.13 40.37
11.36 14.96 14.20 0.01
40.91 37.42 36.76 0.16
47.71 47.61 47.02 0.01
39.27 40.61 41.08 0.04
14.66 7.10 12.66 1.63
27 0.42
67 331.21**
0.19
0.58
2.48
0.48
0.11
TABLE 3. (Continued)
No Coercion Moderate Coercion
(n=84) (n=101)
High Coercion
(n=111)
F-value
Social Activities
Working
Work Income/Week
Married
Common-Law Relationship
56.59 57.67 54.50 0.15
93.77 101.61 91.74 0.34
40.89 42.63 35.31 0.69
33.61 35.92 44.46 1.59
*Unless otherwise noted, all measures represent percent of nonincarcerated time in the indicated status.
**p<.001
Ml=Methadone Intake
MD=Methadone Discharge
be seen, no significant differences occur for the period after entry
into treatment and treatment discharge, other than for percent of
time under CJS supervision.
The difference with respect to supervision level is to be expected
because it is an artifact of the way we have defined legal coercion.
However, criminal activities, drug involvement, and social activities of
these groups are essentially the same. These groups cannot be
distinguished in terms of their behaviors.
Since these three groups cannot be differentiated other than on the
level of coercion used to bring them into treatment, the findings
have very important social policy implications. The results provide a
powerful argument for a general social policy of using CJS coercion
to bring into treatment as many people as possible by whatever legal
means available. After all, until addicts are exposed to an environ-
ment where intervention can occur and are retained for a sufficient
period to produce and maintain positive outcomes, change cannot be
expected.
The advent of AIDS, where treatment seems to act as a buffer
against the probability of infection, is an added incentive for
following this policy. Based on the cumulative findings presented
above, civil commitment and other forms of legal coercion, when
properly implemented, work and seem to work for a majority of
addicts. Such efforts should be considered for much stronger
implementation, both in isolation, for addict offenders reluctant to
enter community treatment programs, and in cooperation with
treatment, as in the Federal TASC program (Hubbard, this volume).
CONCLUSIONS
The general conclusion from studies of the California CAP is that
civil commitment and other drug treatment initiatives, particularly
MM, are effective ways to reduce narcotics addiction and to minimize
the adverse social effects associated with it. How an individual is
exposed to treatment seems to be irrelevant. What is important is
that the narcotics addict must be brought into an environment where
intervention can occur over time. Civil commitment and other legally
coercive measures are useful and proven strategies to get people into
a treatment program when they will not enter voluntarily. The use
of such measures, in a better coordinated and expanded fashion, could
produce significant individual and social benefits.
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While this conclusion is amply supported by research findings, given
the current state of treatment availability in the United States, it is
one that should not necessarily be immediately implemented until
other changes have been made in the treatment delivery system.
Funding for drug abuse treatment, particularly programs for narcotic
addiction, has been reduced during the last decade to a point where
relatively long waiting lists exist for most publicly funded programs.
Unless funding is provided to create new programs or to expand
existing ones, the coercion or commitment of individuals into drug
treatment will only exacerbate the current situation.
Further, little or no widespread outreach efforts exist to induce drug
abusers to enter treatment voluntarily. Such efforts would certainly
increase the population in treatment at a lesser implementation cost.
Without these two changes, civil commitment then would be ap-
propriate only for a limited number of addicts who are unlikely to
enter treatment otherwise, and who are sufficiently problematic in
their behavior to warrant commitment.
Several features characterize an effective civil commitment program.
Inpatient care should be an option, and close monitoring with regular
urine testing of parolees in the community is essential. Despite the
need for testing, supervision of parolees should not be so strict that
they abscond rather than remain in the program. Parole officers
should have the flexibility to allow parolees to remain on the streets
if they test positive in only a few instances, or at widely spaced
intervals. As a useful adjunct for the CJS effort, MM is an
extremely valuable tool for limiting narcotics use, and its availability
should be expanded.
The general processes related to the cessation of narcotics use, or
maturing out (Winick 1962; Anglin et al. 1966; and Brecht et al. 1987),
are probabilistic and time-related ones. A small but accumulating
percentage of identified addicts will stop using narcotics on an
addicted basis in each year after intervention. Some parameters that
differentially influence that percentage can be specified, but their
effect is not very large in the short term. The chronic relapsing
nature of narcotic addiction, requires a long-term monitoring effort
like civil commitment, in combination with community treatment, so
that the percentage ceasing addicted use in any year can be maxi-
mized, and the duration of individual addiction careers—and their
cost to society—can be minimized.
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Clinical Experience With Civil
Commitment
James F. Maddux
INTRODUCTlON
Unfortunately, many compulsive users of psychoactive substances
enter treatment only when under legal coercion. Even those who
enter voluntarily often do so under some form of social or pharma-
cological coercion, such as pressure from family or friends, perceived
imminent arrest, loss of regular drug seller, or inability to pay the
cost of an increasing daily dosage. With or without external
coercion, nearly all seem to have an ambivalent attitude toward their
substance dependence. They want to free themselves of the burden
and consequences of substance dependence, but they also want the
effects of the substance. In an individual at different times, one
desire or the other becomes dominant. Among contemporary opioid
users, two other personality attributes often adversely affect engage-
ment in treatment. The first, variously labeled psychopathy, psycho-
pathic deviance, sociopathy, antisocial behavior, or antisocial attitude,
has often been reported as a noteworthy personality feature of opioid
users. The other, variously labeled impulsivity, low frustration
tolerance, or inability to delay gratification, has also been frequently
reported among opioid users (Maddux et al. 1986). An ambivalent
attitude toward the drug dependence, together with an antisocial
attitude and a low tolerance for distress, create a conflicted and
unstable motivation for treatment. This unstable motivation has
represented a major problem in the treatment of opioid dependence.
In this chapter, clinical experience with opioid addicts in treatment
voluntarily under varied criminal law coercions and under civil com-
mitment is reviewed. Experience at the two former Public Health
Service (PHS) hospitals at Lexington, KY, and Fort Worth, TX, is
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described. The effect of varied treatment and correctional inter-
actions on long-term outcomes is estimated.
PREMATURE DEPARTURE OF VOLUNTARY PATIENTS
In 1936, the first annual report of the PHS hospital at Lexington
stated that treatment of voluntary patients had not been very
effective because most of them left before treatment was completed.
Although the Lexington PHS hospital and its sister hospital (opened
in 1938 at Fort Worth) were established primarily to care for nar-
cotics addicts convicted of Federal law violations, the two hospitals
were also authorized to admit and treat voluntary patients. Most
admissions to both hospitals were voluntary from 1935 until 1968,
when admission of voluntary patients ceased. Approximately 70
percent of the voluntary patients signed out against medical advice
before completing treatment (Rasor and Maddux 1966). Most of those
who remained to complete treatment had the legal pressure of pro-
bation from a State court (Levine and Monroe 1964).
The hospital programs were designed to treat not only withdrawal
illness but also the drug-using habit and associated mental and social
problemS as well. The treatment programs included four fairly
distinct elements: drug withdrawal, residence in a drug-free envi-
ronment, psychotherapy, and supervised activities (Kolb 1939; Kolb
and Himmelsbach 1938; Kolb and Ossenfort 1938). The recommended
duration of hospital treatment was 6 months, but this was later
reduced to 4 months. The supervised activities came to include work,
vocational training, remedial education, and recreational activities.
Medical care, dental care, social work service, and religious services
were provided.
Nearly all of the professional staff viewed drug withdrawal as a
preliminary or minor aspect of treatment, with the important thera-
peutic work to come later. Consequently, the departure of most
voluntary patients during or shortly after withdrawal became a source
of continuing frustration for the staff. Usually the voluntary
patients signed out silently, but some gave reasons for leaving, such
as: I came only to reduce my habit; I’m not getting enough metha-
done; I want to go to work; I need to take care of family problems
(Maddux et al. 1971). Whatever the reasons, most voluntary patients
would not or could not stay to complete the treatment program.
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In 1946, the “Blue Grass” admission was initiated at the Lexington
hospital to reduce premature departures (Kay 1974). The Common-
wealth of Kentucky made habitual narcotics use a misdemeanor, with
punishment of up to 1 year in jail. Patients who left against advice
were readmitted only if they pleaded guilty to narcotic use in a
Kentucky court. The consequent sentence was then suspended on
condition that the person stay at the Lexington hospital until
treatment was completed. If the patient attempted to leave pre-
maturely, the local sheriff was notified. The Blue Grass procedure
came into disfavor because patients were required to obtain a
criminal conviction as a condition of admission to the hospital, and
was discontinued about 1956. During the 1950s hospital staff
members recommended enactment of a Federal civil commitment law
for narcotic addicts, but legal counsel in the Department of Health,
Education, and Welfare considered such a law unconstitutional.
EARLY FOLLOWUP STUDIES
Several followup studies from 1943 into the 1960s indicated that
addicts treated under legal coercion had better outcomes than others.
Pescor’s (1943) followup study suggested that paroled prisoners and
probationers had better outcomes than voluntary patients (table 1).
However, prisoners without compulsory posthospital supervision did no
better than the voluntary patients. The Hunt and Odoroff study
(1962) showed that nonvoluntary patients did better than voluntary
TABLE 1. Percentage of opioid addicts continuously abstinent for 6
months or longer after discharge from Lexington PHS
hospital, by hospital status
Hospital Status Percentage Abstinent
Voluntary (n=1206) 13
Probation (n=491) 27
Paroled Prisoner (n=110) 31
Other Prisoner (n=2895) 10
SOURCE: Pescor 1943.
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TABLE 2. Percentage of opioid addicts found continuously abstinent 1
to 4 1/2 years after discharge from Lexington PHS
hospital, by hospital status
Hospital Status Percentage Abstinent
Voluntary (n=1503) 6
Nonvoluntary (n=378) 11
SOURCE: Hunt and Odoroff 1962.
patients (table 2). Duvall et al. (1963) reported, however, that
voluntary black males had better outcomes than black male prisoners
(table 3). All of these studies had methodological problems, and, in
the case of the Duvall study, the small number of prisoners creates a
problem in interpretation. An increase of one abstinent prisoner
would increase the percentage abstinent from 4 to 8 percent.
Vaillant’s (1966a; Vaillant 1966b) 12-year followup study tended to
confirm Pescor’s finding of two decades earlier with respect to the
importance of postinstitution parole. Table 4 shows that only 4
percent of voluntary hospitalizations, but 67 percent of prison/parole
combinations were followed by postinstitution abstinence for 1 year.
These data also present a problem in interpretation because only 100
subjects were followed, and what is included in the table are episodes
of institutionalization of subjects over a 12-year period. The
episodes are not mutually independent.
TABLE 3. Percentage of black male addicts abstinent 6 months after
discharge from Lexington PHS hospital, by hospital status
Hospital Status Percentage Abstinent
Voluntary (n=38) 11
Prisoner (n=24) 4
SOURCE: Duvall et al. 1963.
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TABLE 4. Percentage of institutionalizations followed by 1 year of
abstinence during 12-year followup
Type of Institutionalization Percentage Abstinent
Voluntary Hospitalization (n=270) 4
Prison<9 Months (n=279) 4
Prison>8 Months With No Significant
Parole (n=46) 13
Prison>8 Months With Parole>1 Year
(n=30) 67
SOURCE: Vaillant 1966b.
As I have noted, some “voluntary” patients were admitted to both the
Lexington and Fort Worth PHS hospitals under legal pressure of pro-
bation from a State court. A followup study in the 1960s at the Fort
Worth PHS hospital showed that voluntary patients with legal pres-
sure had better outcomes than those with no legal pressure (table 5)
(Maddux et al. 1971). Patients with legal pressure not only had
hospitalization with legal pressure, but they also had compulsory
posthospital supervision.
TABLE 5. Percentage of opioid addicts abstinent during 1 year after
discharge from Fort Worth PHS hospital, by hospital
status
Hospital Status Percentage Abstinent
Voluntary With Legal Pressure
(n=61) 20
Voluntary With No Legal Pressure
(n=120) 7
SOURCE: Maddux et al. 1971.
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While these studies generally found better outcomes of treatment with
legal coercion, the outcomes were not markedly better than those
after treatment with no legal coercion. With the exception of the
Vaillant (1966b) followup study, the studies found that only 4 to 31
percent of patients treated under legal coercion remained abstinent
for 6 months or longer after release from the institution. Even after
treatment with legal coercion, most patients resumed opioid use.
FEDERAL CIVIL COMMITMENT LAW
At the White House Conference on Narcotic and Drug Abuse, con-
vened by President Kennedy in 1962, one of the major topics was
treatment under civil commitment (White House Conference on
Narcotic and Drug Abuse 1963). Nearly all the speakers approved
civil commitment or some form of compulsory treatment, although
little clinical experience with civil commitment was described. At
that time, most States had laws that permitted civil commitment of
narcotic addicts, but those laws had been infrequently used (Harney
1962). California, in 1961, and New York, in 1962, enacted legislation
that provided for the development of large rehabilitation programs
based on civil commitment. Civil commitment was advocated as
having two main purposes: protection of society and rehabilitation of
the individual. Some cautionary comments were made about the
possibility of “commitment” becoming another name for incarceration.
Following the White House Conference, the President’s Advisory
Commission on Narcotic and Drug Abuse recommended that a civil
commitment statute be enacted to provide an alternative method of
handling the federally convicted offender who was a confirmed
narcotic or marijuana abuser (President’s Advisory Commission on
Narcotic and Drug Abuse 1963).
When Congress enacted the Narcotic Addict Rehabilitation Act
(NARA) (Public Law 69-793) in 1966, the statute provided not only
for civil commitment of convicted offenders as recommended by the
Advisory Commission but also of persons charged, but not convicted,
and of persons not charged with any offense. The act consisted of
four titles.
Title 1 authorized civil commitment for treatment of eligible addicts
charged with a Federal offense who chose to be committed instead of
prosecuted. After examination, addicts considered suitable for
rehabilitation could be committed to the Surgeon General for 36
months of institutional treatment and supervised aftercare.
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Title II authorized civil commitment of eligible addicts convicted of a
Federal offense. After examination, addicts considered suitable could
be committed to the Attorney General for a period not to exceed 10
years of institutional treatment and aftercare.
Title Ill authorized civil commitment of addicts not charged with any
criminal offense. Any addict or individual related to an addict could
petition the U.S. Attorney in the district in which he or she resided
for commitment to treatment. As under Title I and Title II, exam-
ination was required prior to commitment to determine if the person
was an addict who was likely to be rehabilitated. Addicts con-
sidered suitable could then be committed to treatment in a hospital
for a period not to exceed 6 months. Following hospital treatment,
the court could place the person under the custody of the Surgeon
General for posthospital treatment for 36 months. During this period
the person could be recommitted for another 6 months of hospital
care.
Title IV authorized financial assistance to States and localities for
treatment programs for narcotic addicts. Grants to States and com-
munities for drug abuse were later administered under amendments to
the Community Mental Health Centers Act until 1980, when drug
abuse, alcoholism, and mental health grants were consolidated into a
block grant. In 1986, the Anti-Drug Act (Public Law 99-570) pro-
vided for additional funds in the block grant for treatment and
prevention of drug abuse.
NARA PROGRAM
The NARA authorized the Surgeon General to enter into contracts
with any public or private agency to provide examination or treat-
ment of committed addicts; but, in order to develop the NARA
program quickly, it was decided to use the Lexington and Fort Worth
PHS hospitals for examination and institutional treatment. In 1967,
the PHS renamed the two hospitals “clinical research centers.”
However, under the NARA, their clinical missions continued, and they
are referred to as “hospitals” throughout this chapter.
Admission of NARA patients to the Lexington and Fort Worth
hospitals began in 1967. Admission of Federal prisoners ceased in
1967, and admission of voluntary patients ceased in 1988. From 1967
through 1973, 10,153 NARA patients were admitted to the two hospi-
tals. Five percent were admitted under Title I, 2 percent under Title
II, and 93 percent under Title Ill. In 1968, admission of Title II
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patients ceased because the Bureau of Prisons had developed rehabili-
tation programs for addicts and began to accept Title II patients.
Patients who entered hospitals with NARA commitment did not seem
to differ noticeably from those previously admitted with voluntary or
prisoner status. In 1962, 84 percent of admissions to the two centers
were men; from 1967 through 1973, 85 percent of the NARA admis-
sions were men. In 1962, admissions had the following ethnic
distribution: white, 48 percent; black, 36 percent; and Hispanic, 16
percent (Maddux 1965). During the years 1970 through 1973, 5,931
NARA admissions had the following ethnic distribution: white, 43
percent; black, 47 percent; and Hispanic, 10 percent. Clinically, the
NARA patients seemed to resemble their predecessors: most were
undereducated, most had erratic work histories, and all had become
handicapped by their drug dependence. Antisocial attitudes and low
tolerance for distress seemed prominent.
ATTRITION OF NARA PATIENTS
To the dismay of court officials, many of the NARA patients sent to
hospitals for examination were found not suitable for treatment.
Through 1968, the Fort Worth hospital found 38 percent of the NARA
admissions not suitable for treatment. Through 1971 the Lexington
hospital found 51 percent not suitable for admission. The patients
coming to the two hospitals may have differed in suitability, or the
professional staffs may have differed in their judgments of suitability.
Nearly all the “not suitable” patients were found to be narcotic
addicts, but they were considered too antagonistic, disruptive, or
dangerous to participate in the institution treatment program. Many
entered the NARA program under Title Ill as a condition of probation
after conviction in a State court. Having entered the NARA program,
patients had in many instances complied with the State court
requirement, and some acted to get themselves labeled unsuitable:
they refused to get out of bed; would not come to interviews;
remained silent in group therapy; refused to shower; and some
threatened violence against staff members or other patients. The
professional staff worked hard to draw these patients into therapeutic
interaction before they reported them as not suitable (Maddux 1978).
Some NARA patients expressed contradictory attitudes to court
officials and hospital staff. For example, a heroin user would apply
for commitment and tell the judge that he wanted treatment in the
NARA program; the judge would send him for examination to one of
the hospitals. There he would insist that he did not want treatment
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and intended to resume heroin use as soon as possible; for ap-
proximately 3 weeks he would refuse to take part in the treatment
program; when returned to the court as “not suitable,” he would tell
the judge that he did not understand why the hospital rejected him,
for he wanted treatment in the NARA program.
Thus, many NARA patients, who previously would have entered the
hospitals voluntarily and then signed out against advice, now entered
the examination phase of the NARA program but avoided commitment
by adverse conduct. Furthermore, some patients committed for 6
months of institutional care under Title Ill became so antagonistic
during hospitalization that they were discharged and the court
commitment terminated. Mandell and Amsell (1973) found that only
35 percent of 7,353 NARA patients admitted for examination were
discharged to aftercare. The attrition continued after discharge to
aftercare. Langenauer and Bowden (1971) reported that only 38
percent of 252 NARA patients released remained in aftercare 6
months after discharge. Patients were lost from aftercare by
recommitment for institutional care, conviction, incarceration, death,
and disappearance.
The NARA provided penalties for escape from institutional commit-
ment under Title Ill, but no one was prosecuted. Some judges
questioned the constitutionality of the law. Only a small number of
patients committed under Title Ill escaped from institutional custody.
Patients did not have to escape to get out: they could obtain their
release by adverse behavior.
Release from the hospitals for adverse behavior was not new under
the NARA. The two hospitals had always discharged patients
considered disruptive or dangerous in the hospital environment.
Disruptive prisoner patients were transferred to prisons, and disrup-
tive voluntary patients were discharged involuntarily. From 1938
through 1969, approximately 30 percent of prisoner addicts admitted
to the Fort Worth hospital were subsequently transferred to prisons
(Maddux, unpublished). These patients seemed to have intense
chronic anger, manifested by episodic outbursts of fury, or by
persisting antagonistic behavior. They probably used heroin as
attempted self-medication for their anger.
DEVELOPMENT OF HOSPITAL PROGRAMS
Although the NARA program required new and different procedures,
the fundamental treatment programs of hospitals did not change very
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much in direct response to the NARA. Evaluation reports had to be
prepared and sent to courts, patients had to be transported between
courts and the hospitals, and reports had to be sent to community
agencies providing posthospital service.
During the 1950s and 1960s, treatment programs changed in response
to changes in the theory and practice of American psychiatry. The
main changes consisted of (1) the advent of a psychoanalytic orien-
tation in diagnosis and psychotherapy: (2) introduction of group
therapy; and (3) development of sociotherapy (Lowry 1956; Lewis and
Osberg 1958; Maddux 1965).
While individual psychotherapy became psychoanalytically oriented,
only a small number of patients entered psychotherapy. Few staff
members were available, and few patients seemed ready to explore
their personal problems in individual psychotherapy sessions. Group
therapy seemed more suitable for most patients, and by the end of
the 1960s most patients were in some form of group therapy or group
counseling.
The recognition that the social milieu of the mental patient could be
either therapeutic or noxious became widespread in the United States
after World War II. The hospitals attempted to create a therapeutic
milieu. This effort was influenced initially by the therapeutic
community developed in England by Jones (1953) and later by the
Synanon treatment program (Yablonsky and Dederich 1965).
At the Fort Worth hospital during the years 1964 to 1966, Hughes et
al. (1970) attempted to develop a rehabilitation-oriented community of
addict patients by implementing intensive group work and by enlisting
patient collaboration in the treatment program. This unit was based
partly on the Synanon model. During the late 1960s, the Lexington
program was reorganized into five relatively autonomous treatment
units, each based on the therapeutic community concept and each
having about 100 patients (Conrad 1977). All units emphasized daily
therapeutic interaction among staff and patients using confrontation
as a major technique, with emphasis on current behavior. Emotional
disorders also received attention, especially the depression that often
emerged as a person became engaged in treatment.
One of the units, directed by ex-addicts, resembled Synanon more
than the other units. This unit was in operation for 2 years.
Toward the end of the second year the ex-addict leaders regrettably
began to behave in an irresponsible manner, which required
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termination of the unit. Partially self-governing units had existed at
the Lexington and Fort Worth hospitals in the years preceding NARA.
Most of these units eventually became corrupted by antisocial
behavior, with consequent disillusion and anger among staff. Synanon
itself degenerated in the 1970s (Deitch and Zweben 1981).
Grants to States and communities under Title IV of the NARA and
under other legislative authority led to closure of the Fort Worth and
Lexington hospitals in the early 1970s. The increasing local services
for drug abuse treatment led to decreasing Title Ill commitments.
Addicts could be committed legally under Title Ill only if appropriate
State or other facilities were not available. Consequently, the
hospitals lost their clinical mission, and their research mission was
terminated.
NARA FOLLOWUP STUDIES
Two followup studies of NARA patients were completed. Langenauer
and Bowden (1971) reported that 86 percent of 97 patients remaining
in aftercare in the sixth month had used an opioid drug at some time
during the 6 months. Stephens and Cottrell (1972) reported that 87
percent of 200 NARA patients used an opioid drug at some time
during the first 6 months after release from the hospital, but only 65
percent became readdicted. The two studies found that 13 to 14
percent remained abstinent for 6 months. Thus, with respect to
duration of abstinence, the NARA program seemed to lead to some-
what better results than did voluntary hospitalization. Moreover,
some of the previous studies may have overestimated abstinence. In
the NARA posthospital service, counselors observed subjects
repeatedly during the followup period, and regular urine testing was
done. In our study of the addiction careers of 246 opioid users, we
found that repeated observation tended to reveal more opioid use
(Desmond and Maddux 1977; Maddux and Desmond 1981).
Followup studies of voluntary, prisoner, and civil commitment patients
from the PHS hospitals gave an unduly pessimistic picture of treat-
ment outcomes. They emphasized a severe outcome measure of
success, namely, continuous abstinence during 6-month to 4 1/2-year
periods after discharge. Both the Drug Abuse Reporting Program
(DARP) and the Treatment Outcome Prospective Study (TOPS) used a
more advanced design to estimate treatment effectiveness, namely,
before and after measures (Simpson and Sells 1982; Hubbard et al.
1984). Since nearly all opioid users are using daily before entering
treatment, a before and after comparison will nearly always show
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improvement after treatment. The early followups concentrated on
opioid use, while the DARP and the TOPS followups measured not
only opiold use but also other substance use and other behaviors.
LEGAL COERCION AND LONG-TERM OUTCOMES
While short-term outcomes seem better with legal coercion during and
after institutional treatment, hardly any research exists on the
effects of coercion on long-term outcomes. Zahn and Ball (1972)
found that length of hospital stay was associated with 3-year cure
among Puerto Rican addicts who had been treated at the Lexington
hospital. Since those with a longer stay were predominately
prisoners, the findings point to a better outcome after nonvoluntary
treatment. However, the subjects had a mean age of only 33 at the
time of the followup interview.
In his 20-year followup of Lexington patients, Vaillant (1973) reported
that addicts who achieved stable abstinence of 3 years or longer
received more imprisonments with parole than did subjects who died.
His group would have had a mean age of 45 at the time of followup,
if all were alive. O’Donnell (1969) did not analyze the possible
different outcomes from voluntary and nonvoluntary hospitalization in
his long-term followup of Kentucky addicts. In their 12-year
followup study, Simpson et al. (1986) found that treatment patterns
over time were too varied and confounded with other influences to
permit comparisons for long-term outcomes. However, 57 percent of
the subjects abstinent in the 12th year reported that fear of being
jailed was a reason for quitting addiction.
In 1984, 18 years after our study of addiction careers began, 22 (9
percent) of the subjects were found in stable abstinence, that is, for
3 years or longer they had abstained from opioid drugs, they had not
been alcoholic, they had worked regularly, and they had no felony
arrests (Maddux and Desmond 1981). The treatment and correctional
experience of this group varied widely. One subject had one
voluntary hospitalization lasting 11 days and then entered stable
abstinence, which endured for 20 years (through 1984). Residence
relocation away from San Antonio and intense religious activity
probably facilitated his abstinence. Another subject voluntarily
entered methadone maintenance while he was on probation for 10
years after a criminal conviction. Treatment was not required as a
condition of probation. During 8 years on methadone, he repeatedly
expressed fear of prison. He had never been in prison, but he had
spent 2 months in jail. He withdrew from methadone and entered
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stable abstinence, which continued for 7 years (through 1986). His
enduring fear of prison probably facilitated his abstinence. Another
subject had seven treatment and correctional interactions before
entering stable abstinence. The last two immediately preceded his
abstinence. He was convicted of a drug law violation and placed on
probation, with the requirement that he apply for treatment under
the NARA. While in residential treatment under a Title Ill commit-
ment, he seemed to undergo marked changes in attitude. On comple-
tion of treatment, he was employed as a drug abuse counselor. His
stable abstinence continued for 12 years (through 1984). His employ-
ment as a drug abuse counselor probably facilitated his abstinence.
These three vignettes illustrate the variations in treatment modes, in
numbers of treatment and correctional interactions, and in legal
coercions, which can lead to stable abstinence. Although the treat-
ment and correctional interactions varied, 20 (92 percent) of the 22
subjects in stable abstinence had one or more treatment or correc-
tional interactions during the year preceding the onset of stable
abstinence. Thus, a treatment or correctional interaction may have
sewed as a critical experience that enabled the person to begin
stable abstinence. The vignettes also suggest the importance for
continued stable abstinence of the motivational state and of post-
treatment activities such as residence relocation, religious activity,
and employment in a drug abuse treatment agency.
The long-term pattern of treatment admissions and correctional
interactions of the 22 subjects in stable abstinence was compared
with that of 22 subjects who did not achieve stable abstinence by
1964. Each subject in stable abstinence was matched with a subject
not in stable abstinence, by age and calendar year of first opioid use.
Then, for each member of each pair, the number of voluntary
treatment admissions, nonvoluntary treatment admissions, and
correctional interactions was counted for the same period of time,
namely, the years from first use to onset of stable abstinence in the
member in stable abstinence of each pair. The mean age of first
opioid use of the subjects in stable abstinence was 18; as a conse-
quence of selection, the mean age of first opioid use was the same
for the comparison group. The mean number of years from first use
to onset of stable abstinence in the stably abstinent group was 18.
Table 6 shows a similar pattern of treatment admissions and correc-
tional interactions in both groups. None of the small differences
between groups were statistically significant. Nonvoluntary treatment
did not appear associated with achievement of stable abstinence.
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TABLE 6. Treatment admissions and correctional interactions during
mean period of 18 years of subjects in stable abstinence
and those not in stable abstinence
Stable
abstinence
(n=22)
Not in
Stable
abstinence
(n=22)
Mean Voluntary Treatment
Admissions 3.3 3.7
Mean Nonvoluntary Treatment
Admissionsa 2.4 2.1
Mean Correctional lnteractionsb 3.1 4.0
aNonvoluntary Treatment Admission=treatment while on probation or parole, awaiting
prosecution, in prisoner status, or under civil commitment.
bCorrectional Interaction=probation, prison, or jail 1 week or longer.
ILLICIT OPIOID USERS NOT IN TREATMENT
At a conference in 1969, a colleague assured this author that the
problem of heroin addiction in the United States would disappear
within 2 years, because all the heroin addicts would be maintained on
methadone. Since that time, many studies have demonstrated that
while patients remain in methadone maintenance treatment their
heroin use and criminal behavior diminish and their legitimate
employment increases (Cooper et al. 1983). A review of 113 studies
indicated that approximately 15 to 35 percent of methadone patients
dropped out during the first year of treatment (McLellan 1983). The
dropout rate for methadone maintenance seems much lower than that
for drug-free treatment in either voluntary status or Title Ill
commitment.
Since our study of addiction careers began before and continued after
methadone maintenance became available to large numbers of opioid
users in San Antonio in 1970, we can estimate how methadone
maintenance affected the study group. During the 16-year period
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from 1970 through 1986, 62 percent of the subjects alive in 1970
entered methadone maintenance; due to dropouts, much smaller
percentages were found on methadone in any specified year. In 1984,
only 12 percent were maintained on methadone during most of the
year (table 7). However, if we exclude deceased subjects and those
in prison or jail, thereby restricting the denominator to the 155
subjects alive and in the community, then 19 percent were maintained
on methadone. Only 10 percent were known to be using heroin. If,
as before, we restrict the denominator to those alive and in the
community, then 16 percent were using heroin. Some of the subjects
TABLE 7. Status of 248 San Antonio opioid users in 1984
Status Number Percent
Using Heroin Daily
Using Heroin Occasionally
Deceased
Jail or Prison
Maintained on Methadone
Social Recoverya
Partial Social Recovery
Abstinent From Opioids
Stableb
Not Stable
Alcoholic
Other
Partial Information Indicating
Abstinence
Partial Information Indicating
Substance Abuse or Other
Related Problems
Unknown
4
8
TOTAL 248 100
16 6
9 4
53 21
40 16
7
22
22 9
29 12
16 6
4
10
2 1
3
9
2
aSocial recovery=3 or more years continuous maintenance, not alcoholic, regular
work, negative urines, and no felony arrest.
bStable=3 or more years continuous abstinence, not alcoholic, regular work, and no
felony arrest.
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with unknown status were probably using heroin. lf all the unknowns
were using heroin, the total using heroin would be 19 percent, or 30
percent of those alive and in the community.
Although the problem of heroin addiction did not disappear, metha-
done maintenance has undoubtedly reduced the pool of illicit opioid
users in the community. Nonetheless, a noteworthy segment of our
study subjects, between 16 and 30 percent of those alive and in the
community, were using an illicit opioid drug in 1964. All of our
subjects were men, and 87 percent had a Mexican-American back-
ground. In these respects, they differed from the U.S. population of
illicit opioid users, but we have no reason to believe that they
differed in severity of opioid dependence. Our data suggest that
many chronic opioid users are not in treatment and are not incar-
cerated.
CIVIL COMMITMENT IN AN ARRAY OF COERCIONS
The unstable motivation for treatment described at the beginning of
this chapter varies among individuals and, with time, in a given
individual. Some opioid users enter and stay in treatment with a
minimum of external coercion, such as pressure from family members.
Some enter and stay in treatment in response to the threat of loss of
a job or loss of a license to practice a profession. Some stay in
treatment after civil commitment with no criminal coercion. Some
stay in treatment after criminal conviction and probation, as an
alternative preferred over prison; some stay in treatment only after
criminal conviction and sentencing to an institution having a treat-
ment program.
Within this array of pressures and coercions, civil commitment,
without criminal law coercion, can probably bring some opioid users
into treatment who would not enter voluntarily and who have not
incurred any criminal law coercion. Thereby, it would reduce
somewhat the pool of opioid users in the community who are not in
treatment. The experience of the PHS hospitals suggests that civil
commitment, without any Federal criminal law coercion (the Title Ill
commitment), will hold only about one-third of the admissions
through 8 months of institutional care. Some of these, as noted,
were under coercion of probation from a State court. None of the
Title Ill patients were prosecuted for escape from institutional
treatment. In general, law enforcement agencies do not seem to
pursue persons who escape from civil commitment, whether for
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substance abuse or other forms of mental illness, as vigorously as
they pursue persons who escape from criminal custody.
For persons with criminal convictions, civil commitment in lieu of
sentencing seems to have no special advantage if the correctional
system has treatment programs, or if community programs are avail-
able and can be utilized. The criminal conviction itself provides
strong coercion.
LIMITATIONS OF CIVIL COMMITMENT
Civil commitment has three serious limitations. First, civil commit-
ment cannot overcome deficits in services. Few States with civil
commitment laws for drug users appear to have treatment programs
for committed persons. Furthermore, in 1987, insufficient treatment
services, especially methadone maintenance, existed in the United
States for opioid users who voluntarily applied for treatment.
Second, coercion can bring a person into treatment, but it cannot
make him or her participate in the treatment. Until the 1950s, a
prisoner patient could serve his time quietly at one of the PHS
hospitals, without psychotherapy or counseling, and with minimum or
no participation in vocational training or remedial education. The
staff knew of these passive patients, but hoped that residence in a
drug-free environment would help to extinguish the drug-using habit.
After 1950, with the advent of group therapy and the therapeutic
community concept, it became increasingly difficult for patients to
remain aloof from psychosocial interaction with staff and other
patients. Even into the 1970s, however, some patients passively
participated in group therapy or other activities. Patients called this
“going along with the program.” Some Title Ill patients probably left
the program because of the discomfort created by confrontations from
staff and other patients. Most modem institutional treatment
programs are based on some form of the therapeutic community.
They cannot treat all the opioid users. Secure custodial care only is
required for some.
Third, civil commitment operates within constitutional guarantees of
individual liberty. This is a controversial area. Under what circum-
stances and to what extent should society curtail the liberty of a
compulsive drug user? Szasz (1972), a psychiatrist, developed the
argument that in a free society all drugs should be legalized. He
proposed that it should be none of the government’s business what
drug a man puts into his body. Newman (London 1972; Newman
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1974), director of the New York City methadone maintenance pro-
gram, vigorously opposed civil commitment. He was concerned about
curtailment of civil liberty but also about insufficient voluntary
treatment services, especially methadone maintenance.
The problem becomes further complicated because nonvoluntary
treatment, whether civil or criminal commitment, usually has dual
goals: first, to help the individuai; and second, to protect the
community. Civil commitment of the mentally ill has always served
these two purposes. During the 1970s, the criteria for civil commit-
ment of mentally ill persons changed from mentally ill and in need of
treatment to mentally ill and dangerous to self or others (Stromberg
1982). This emphasis on dangerousness has allegedly increased the
number of homeless, mentally ill persons wandering the streets.
Statutes related to civil commitment of substance abusers have
probably followed the trend toward a criterion of dangerous to self
or others. A study is needed of current State statutes for civil
commitment of substance abusers, and the extent to which they are
used.
SUMMARY
The unstable motivation of the addicted person has represented a
major problem in the treatment of opioid dependence. Only a
minority of voluntary patients remained in the two PHS hospitals for
treatment beyond withdrawal. Early followup studies at the two
hospitals indicated that treatment under legal coercion, especially
when combined with compulsory posthospital care, had better
outcomes, but not markedly better, than did voluntary treatment.
A large proportion, one-third to one-half, of the patients admitted to
the hospitals for examination prior to civil commitment were found
not suitable for treatment, mainly due to their disruptive or danger-
ous behavior. Due to attrition after examination and during 6 months
of hospital treatment under commitment, only about one-third of the
civil commitment patients admitted were discharged to aftercare. The
high attrition rate may have been partly due to intensive psychosocial
treatment. Patients who absconded from treatment were not prose-
cuted; consequently, civil commitment provided only a weak coercion
to treatment. Two followup studies suggested that the short-term
outcomes of the civil commitment patients were somewhat better than
those of voluntary patients.
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Limited and inconclusive research exists on the relation of coercion
to long-term stable abstinence.
Methadone maintenance is accompanied by improved social adjustment,
but it retains in treatment only a minority of opioid drug users. One
study suggests that 16 to 30 percent of the population of chronic
opioid users in the community is not in treatment.
Civil commitment, as one of an array of social and legal coercions,
can probably bring some opioid users into treatment who would not
voluntarily enter. It has several limitations. Civil commitment
cannot overcome deficits in treatment services. Civil commitment, or
any other kind of external coercion, can bring drug users into
treatment but cannot assure that patients will participate in treat-
ment. Finally, civil commitment is restricted by constitutional
guarantees of individual liberty.
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The Criminal Justice Client in
Drug Abuse Treatment
Robert L. Hubbard, James J. Collins,
J. Valley Rachal, and Elizabeth R. Cavanaugh
INTRODUCTlON
The assumed relationships between drug use and crime (Ball et al.
1981; Gandossy et al. 1980; Panel on Drug Use and Criminal Behavior
1976), the finding that successful drug abuse treatment reduces crime
(Simpson et al. 1978; McGlothlin et al. 1977; Nash 1976), and
criticisms of traditional criminal justice approaches to dealing with
drug-abusing offenders (Lipton et al. 1975; Carter and Klein 1976) led
to the development of programs to refer drug abusers in the criminal
justice system to treatment. Clients referred from the criminal
justice system have been shown to stay in treatment longer than
other clients (Collins et al., in press). Their longer retention leads
to an expectation that these criminal justice system clients will have
better treatment outcomes than other clients. The literature has not
provided consistent results to support this expectation.
Legal involvement alone may motivate some drug abusers to seek
treatment as a way to reduce sentences. There are various formal
and informal mechanisms to identify and refer drug abusers in the
criminal justice system to treatment. The major model is the
Treatment Alternatives to Street Crime (TASC) program. TASC pro-
grams have been developed with Federal funds under local adminis-
tration and were intended to become institutionalized under State or
local auspices at the expiration of their Federal grants. The goals of
the TASC programs have been to identify drug abusers who come into
contact with the criminal justice system, to refer those who are
eligible to appropriate treatment, to monitor clients’ progress, and to
return violators to the criminal justice system. Through TASC and
other types of formal or informal referral mechanisms, linkages
between the criminal justice system and the drug treatment system
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have been developed in many cities to assist criminally involved drug
abusers to obtain treatment.
This chapter summarizes the findings from the Treatment Outcome
Prospective Study (TOPS) to examine the question of whether or not
referral to drug abuse treatment through the criminal justice system
benefits the client and society. Because of the crime reduction
impact of drug abuse treatment (Harwood et al., this volume),
treatment of drug abusers in the criminal justice system is thought to
have more positive cost benefits for society than treatment of clients
with no legal involvement.
Formal referral programs such as TASC may increase the number of
drug abusers in the criminal justice system who are treated. Drug
abusers in the criminal justice system are thought to be more un-
likely than other drug abusers to seek treatment of their own accord.
Nonvolunteer clients, however, may be more difficult to treat than
clients who seek treatment on their own. Empirical evidence is
needed to determine if, and how, criminal justice system referral
contributes to treatment outcomes of clients compared to self-referral
and other sources of referral.
Clients who entered treatment through TASC or who were otherwise
involved in the criminal justice system are the principal focus of the
analyses presented in this chapter. Four important questions need
to be considered to assess the effectiveness of TASC programs and
other types of criminal justice system involvement compared with
clients with no legal involvement.
How do clients involved with the criminal justice system differ
from other clients entering treatment in terms of drug abuse
treatment history and treatment needs?
How successful are programs in retaining clients involved with the
criminal justice system?
Do TASC and non-TASC criminal justice system clients differ from
other clients in services received and satisfaction with treatment?
Do drug use and criminal behavior of clients involved with the
criminal justice system decrease during and after treatment?
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METHODOLOGY
TOPS is a large-scale prospective study of clients in 10 cities who
entered 41 publicly funded outpatient methadone, residential, and out-
patient drug-free drug abuse treatment programs from 1979 to 1981.
TOPS established baseline data on drug use, criminal behavior, and
other behavior in the year before treatment; gathered data on events
during treatment; and reinterviewed samples of clients at 3 months or
1, 2, or 3 to 5 years after they left treatment. A major purpose of
TOPS is to determine the key factors that affect treatment outcomes,
including involvement with the criminal justice system.
As described in previous monographs, the characteristics and
behaviors of clients entering each modality differed greatly (Hubbard
et al. 1986). as did the nature of treatment received in each modality
(Allison et al. 1985). Table 1 illustrates major differences among the
modalities in the proportion of clients involved with the criminal
justice system. About one-third of the clients in residential and
outpatient drug-free programs were referred to treatment through the
criminal justice system. Less than 3 percent of the methadone
clients were referred by the criminal justice system. Because
relatively few methadone clients were referred to treatment through
the criminal justice system, and only about one in six reported any
involvement with the criminal justice system at admission, the
subsequent analyses were conducted only for residential and
outpatient drug-free clients.
The analyses for the residential and outpatient drug-free modalities
were conducted separately, because each modality treats very dif-
ferent client populations and has a different approach to treatment.
Furthermore, the analyses were limited to clients in the five cities
that had TASC programs. The analyses of intake data compare with
those referred to treatment through TASC programs (n=502), those
involved with the criminal justice system but not TASC at admission
to treatment (n=855), and clients without any current involvement
with the criminal justice system or TASC (n=1,078).
No direct self-report measure of a client’s perception of legal pres-
sure is included in the TOPS data. Clients with various types of
involvement with the criminal justice system were distinguished using
self-report questionnaire items on TASC supervision, current legal
status, and source of referral. The responses to these items were
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TABLE 1. Referral source by modality
Referral
Source
Outpatient Outpatient
Methadone Drug-Free Residential
Percent Percent Percent
Self-referral 47.7 19.4 24.2
Family/Friends 31.2 20.6 19.0
TASC or Other
Criminal Justice System 2.6 30.9 31.2
Other 18.5 29.1 25.6
100.0 100.0 100.0
n= 4,184 2.914 2.991
SOURCE: Data are from entire TOPS population, 1979-1981,
examined to develop definitions of (1) TASC clients; (2) other (non-
TASC) criminal justice system clients; and (3) clients with no legal
involvement.
TASC clients were defined as those who reported being under TASC
supervision at admission to a treatment program. Non-TASC criminal
justice system clients were those who did not report being under
TASC supervision but reported a current legal status of probation,
parole, on bail, in jail or prison, or identified their principal source
of referral to treatment as an agent of the criminal justice system,
such as an attorney, judge, or probation or parole officer. Clients
not classified as TASC or non-TASC criminal justice clients were
assumed to have no legal involvement at admission to treatment.
These comparison groups facilitate the differentiation of TASC effects
from the effects of other criminal justice system involvement on
client behaviors during and after treatment. Data are drawn from
four periods: the year before treatment, the first 3 months in
treatment, the second 3 months in treatment, and the first year after
treatment.
All TASC clients who were admitted to one of the outpatient drug-
free and residential programs in 1979 and 1980 and who completed an
intake interview were selected into the followup samples. Clients
involved with the criminal justice system other than through TASC
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and those who currently were not involved with the criminal justice
system were randomly selected at rates that satisfied the sampling
precision requirements for the overall TOPS followup samples.
Samples of 603 of 1,281 outpatient drug-free and 496 of 1,154
residential clients were interviewed 1 year after leaving treatment.
Descriptive analyses comparing TASC, non-TASC criminal justice, and
no legal involvement clients on legal status and prior treatment are
presented. More detailed comparisons of sociodemographic charac-
teristics, drug use, and other behaviors reported in Collins et al. (in
press) are summarized.
Multivariate analyses were also conducted to identify the influence of
TASC or other criminal justice system involvement on retention and
outcomes during and after treatment, particularly predatory illegal
acts. Prior research has found that all crime decreases after treat-
ment, and that crimes that are directly drug related, most particularly
drug sales, decrease much more than other crimes (Ball et al. 1981).
For that reason, analyses of crime were restricted to the predatory
illegal acts that victimize members of the general population (assault,
robbery, burglary, theft, forgery, fraud, embezzlement, and dealing in
stolen property).
CHARACTERlSTlCS OF CLIENTS DIFFERING IN CRIMINAL JUSTlCE
SYSTEM INVOLVEMENT
Systematic differences in legal status were found between the three
categories of clients entering treatment in the outpatient drug-free
and residential modalities. About one-half of TASC clients in
residential programs and non-TASC criminal justice clients in both
outpatient drug-free programs and residential programs were on pro-
bation at the time of admission to drug abuse treatment (table 2).
Half of the TASC clients in outpatient drug-free programs were on
bail, indicating pretrial or presentencing diversion. These findings
indicate that TASC and non-TASC criminal justice clients were
referred to the two drug abuse treatment modalities at different
stages of the legal process.
The criminal justice system clients, especially TASC clients (85
percent), were disproportionately male, compared with no legal
involvement clients (57 percent). Probably, because they were not
considered eligible, few clients under 18 were in TASC. TASC and
other criminal justice clients in residential and outpatient drug-free
modalities were younger (average age 25) than were no legal
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TABLE 2. Legal status at intake by criminal justice system
involvement
Outpatient Dtua-Free Residential
Legal Status TASC
Non-TASC
Criminal
Justice TASC
Non-TASC
Criminal
Justice
No Legal Status
Probation
Parole
On Bail
In Jail
Other
n=
Percent Percent Percent Percent
9.1 6.0 5.1 2.5
20.3 57.8 57.0 48.8
8.1 13.2 5.7 8.8
51.3 12.0 6.3 17.2
5.9 3.7 23.4 19.7
5.3 7.3 2.5 3.0
100.0 100.0 100.0 100.0
328 338 174 519
SOURCE: 1979 and 1980 TOPS Admission Cohorts.
involvement clients (average age 27). Despite their lower average
ages, far more outpatient drug-free clients in each legal involvement
category had at least a high school diploma, compared with their
counterparts in residential treatment. No major differences in drug-
use patterns were noted.
The treatment histories of clients in different legal involvement cate-
gories in each modality appeared to be very similar (see table 3).
Residential clients were far more likely than outpatient drug-free
clients to have had previous drug abuse treatment experience (about
50 percent in each criminal justice system involvement category) and
three or more previous treatment episodes (21 to 25 percent). Within
modalities, there was little difference in the prior treatment histories
of the three categories of clients.
These descriptive analyses suggest the hypothesis that there are few
major differences between criminal justice system clients and clients
with no legal involvement. To examine this hypothesis further,
multivariate analyses were conducted to identify factors that were
significantly associated with self-reported referral through TASC or
another criminal justice mechanism. The characteristics of 30 percent
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TABLE 3. Prior drug treatment by TASC/criminal justice system involvement
Number of
Prior Admissions TASC
Outpatient Drug Free Residential
Non-TASC Non-TASC
Criminal No Legal Criminal No Legal
Justice Involvement TASC Justice Involvement
Percent Percent Percent Percent Percent percent
None 71.6 62.6 70.5 50.0 45.2 49.5
One 12.3 15.3 11.6 18.5 18.1 17.6
Two 4.2 7.1 6.1 10.3 11.4 11.3
Three or More 11.9 14.9 11.8 21.2 25.3 21.6
100.0 100.0 100.0 100.0 100.0 100.0
n= 328 336 617 174 519 461
SOURCE: 1979 and 1980 TOPS Admission Cohorts.
of the clients who reported the criminal justice system as the
primary source of referral are contrasted with the other 70 percent
of the clients, who reported other sources. This procedure more
directly tests the basic hypothesis by focusing on the effect of active
referral by the criminal justice system. Odds ratios for sex, age,
race, drug-use pattern, and prior treatment were calculated by
logistic regression procedures.
Table 4 presents the comparisons where significant differences were
found. In general, males, clients aged 21 to 25, and clients with no
prior treatment were more likely to be involved with the criminal
justice system. Marijuana or alcohol users were more likely to be
referred than heroin users, especially in outpatient drug-free pro-
grams. Clients who reported no use or less than weekly use of
alcohol or drugs in the year before treatment (minimal users) had the
highest relative likelihood of referral. The high rate of criminal
justice referral of marijuana/alcohol users and minimal users may be
attributable to the fact that criminal justice system clients are likely
to be referred to treatment early in their drug-use careers, or that
many criminal justice clients (especially those in residential programs)
had recently been in jail or prison and were unlikely to be more than
minimal users of any drug. A second multivariate analysis, comparing
all criminal justice system clients with those with no legal
involvement, yielded similar results.
BEHAVlOR BEFORE AND DURING TREATMENT
Given the high rate of illegal activity of criminal justice clients
before treatment, reductions during treatment have societal benefits,
even if the reductions are not maintained after the clients leave
treatment. Table 5 displays percentages of primary problem drug use,
depression symptoms, predatory illegal acts, and full-time
employment reported by outpatient drug-free clients in the year
before treatment and during the first 6 months of treatment.
Outpatient drug-free TASC clients reported improvement during treat-
ment for each outcome measure of table 5; clients with lower per-
centages reported regular use of their primary problem drug, fewer
reported depression symptoms, only a few reported predatory illegal
acts, and more reported working full time most of the time. The
other outpatient drug-free criminal justice clients also improved after
entering treatment. Primary problem drug use and depression symp-
toms decreased, and fewer reported predatory illegal acts. There was
little or no improvement in full-time work during the first 6 months
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TABLE 4. Effects of demographic characteristics and pretreatment
behaviors on the odds of criminal justice system referral
for outpatient drug-free and residential clients
Risk Factors
Outpatient
Drug Free
(n=1,281)
Residential
(n=1,154)
Male vs. Female
White vs. Other Race
Age 21-25 vs. 31 and Over
No Prior Treatment vs. Three
or More Prior Treatments
Minimal Users vs. Alcohol/
Marijuana
Heroin vs. Alcohol/Marijuana
2.51*** 1.65***
.74** 1.43***
2.07*** 1.62***
1.38* 1.60**
1.26 2.57***
.53*** .87
*p<.05.
**p<.01.
***p<.001.
SOURCE: 1979 and 1980 TOPS Admission Cohorts.
in treatment for other criminal justice clients. The outpatient drug-
free clients with no legal involvement also showed improvement in
each outcome category. Their improvements, however, were not as
marked as those of one or both of the legally involved client groups
for each outcome measure. The results of these findings during
treatment must be cautiously interpreted, however, because the
numbers of cases were small, and other factors such as opportunity
to use drugs, work or commit crimes were not integrated into the
analysis. Despite these limitations, the findings are promising; results
indicate improvement in almost every treatment-outcome measure.
Data for residential clients are not shown in a table because clients
who are monitored 24 hours a day have virtually no drug use or il-
legal activity and usually are not allowed to work outside the pro-
gram, at least in the early stages of treatment. TASC clients and
other criminal justice clients reported less reduction in depression
symptoms during treatment, however, than did similar clients in out-
patient drug-free programs or clients who are not legally involved in
either residential or outpatient drug-free programs.
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TABLE 5. Outpatient drug-free clients who reported weekly or daily use of their primary problem drug,
depression symptoms, predatory illegal acts, and full-time employment 75 percent of the time for
pretreatment and intreatment periods
Weekly or
Daily Use
of Primary
Drug
Depression
Symptoms
Predatory 75 Percent
Illegal Full-Time
Acts Work
Year Before Treatment
First 3 Months in Treatment
3 to 6 Months in Treatment
n=
Year Before Treatment
First 3 Months in Treatment
3 to 6 Months in Treatment
n=
TASC
65.1 44.2 63.2 29.5
15.0 25.0 4.9 46.5
12.5 16.3 2.3 59.1
41 43 40 43
Non-TASC Criminal Justice
54.8 36.7 40.0 25.0
17.9 6.5 17.2 22.6
14.3 12.9 11.5 26.6
29 31 26 30
TABLE 5. (Continued)
Weekly or
Daily Use
of Primary
Drug
Depression
Symptoms
Predatory 75 Percent
Illegal Full-Time
Acts work
No Leqal Involvement
Year Before Treatment 76.4 72.5 34.9 41.2
First 3 Months in Treatment 29.4 45.1 6.5 52.0
3 to 6 Months in Treatment 21.6 39.2 6.9 49.0
n= 50 50 50 50
NOTE: Only clients who remained in treatment at least 6 months are included in this table.
SOURCE: 1979 and 1980 TOPS Admission Cohorts.
TREATMENT RETENTION
Treatment retention is an important contributor to treatment effec-
tiveness (Simpson 1981; Hubbard et al. 1988). If an individual leaves
treatment within a few days, it is unlikely that treatment has
permanently changed the characteristics or conditions that are
related to his or her drug problem. Treatment lengths of 6 or more
months were found necessary to produce significant reductions in
drug use (Hubbard et al. 1988). Furthermore, as seen in the pre-
ceding table, criminal behavior is reduced while individuals are in
treatment (Demaree and Neman 1976; Long and Demaree 1975;
Harwood et al., this volume).
Analyses described in Collins et al. (in press) showed that more TASC
clients stayed in outpatient drug-free and residential treatment at
least 3 months (48 percent and 57 percent) than did other criminal
justice clients (35 percent and 51 percent) and clients with no legal
involvement (30 percent and 41 percent). The differences between
TASC and other criminal justice clients were not statistically signif-
icant beyond the .05 probability level. The differences between TASC
clients and clients with no legal involvement were statistically
significant beyond the .05 level in both modalities. All differences
were statistically significant when TASC and other criminal justice
categories were combined into a single category and compared to the
no legal involvement groups within each modality. These results
suggest that both TASC and non-TASC criminal justice involvement
contributed to longer retention in treatment.
As described previously, there are systematic differences in the
characteristics and behaviors of clients in the three legal involvement
categories. These differences, not the TASC programs or criminal
justice involvement, may explain the differential retention findings.
Regression analyses were conducted to address the effects of legal
pressure on treatment retention more fully.
The multiple regression model included variables controlling for sex,
age, race, number of prior treatment admissions, and drug-use pattern
in the year before treatment. Both involvement with the criminal
justice system and TASC referral were associated with longer reten-
tion. Table 6 shows that TASC referral to the outpatient drug-free
modality was associated with longer retention than other criminal
justice involvement, although both variables predicted longer reten-
tion. After controlling for the other variables in the regression
model, outpatient drug-free TASC clients stayed 45 days longer and
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TABLE 6. Estimated effect on retention in treatment of criminal
justice referral
Category of
Criminal Justice
Involvement
Outpatient Drug free Residential
n=1,281 (n=1,154)
Additional Days Additional Days
TASC vs. No Legal Involvemant 44.6*** 50.1**
Non-TAX Criminal Justice vs.
No Legal lnvolvement 16.7* 51.0***
*=F ratio significant>.05.
**=F ratio significant>.01.
***=F ratio significant>.001.
SOURCE: 1979 and 1980 TOPS Admission Cohorts.
other criminal justice clients stayed 17 days longer than clients with
no legal involvement.
TASC and other criminal justice residential clients stayed longer
than clients with no legal involvement. After controlling for the
other variables in the regression model, TASC clients stayed 50 days
longer and other criminal justice clients stayed 51 days longer than
clients with no legal involvement. Based on the magnitude of the
unstandardized regression estimates, the effect of TASC on treatment
retention was stronger in the residential than in the outpatient drug-
free modality.
SERVICES RECEIVED AND TREATMENT SATISFACTION
Clients entering treatment from the criminal justice system may have
a unique set of treatment needs that require more intense and
different types of services. Furthermore, the degree of coercion
used to get them to enter and remain in treatment may affect their
treatment responses. There are clear differences between the out-
patient drug-free and residential modalities in the number (see table
7) and type (see table 8) of services delivered to each client group
during the first 3 months of treatment.
Outpatient drug-free clients with no legal involvement were twice as
likely to receive three or more types of services (29 percent) as
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were TASC referrals (15 percent) or other criminal justice clients
(17 percent). Over a third of the TASC clients and almost 3 out of
10 other criminal justice clients in outpatient drug-free programs did
not report receiving any of the 7 types of services. This pattern of
lower service delivery to TASC and other criminal justice clients was
also found for medical, psychological, and family services. TASC
clients (37 percent) were also less likely to receive psychological
services than other criminal justice clients (53 percent). Program
directors and counselors may have assumed that TASC clients needed
fewer services than other clients, because TASC clients had less
extreme drug-use patterns. The high reports of drug-related problems
by TASC clients entering outpatient drug-free programs make such an
assumption questionable.
There were no major differences by criminal justice involvement in
the number of service types or the specific services delivered in
residential programs. In some cases, TASC clients reported receiving
more services. The similar level of services across all legal involve-
ment categories is consistent with the uniform therapy process for
every client in a residential program.
Three measures of satisfaction were included during intreatment
interviews in TOPS: help in reducing drug use; help with other pro-
blems; and general satisfaction with treatment. Clients with no legal
involvement were more likely to be very satisfied with their treat-
ment than TASC and other criminal justice clients. In general, both
outpatient drug-free and residential TASC clients seemed somewhat
less satisfied with all aspects of treatment. About half the TASC
clients and other criminal justice clients were very satisfied (see
table 9) and felt treatment had helped them reduce their drug use
and had helped them with other problems.
POSTTREATMENT CRIMINAL BEHAVIOR AND OTHER OUTCOMES
The analyses in this section focus on predatory illegal acts before
and after treatment. The effects of criminal justice system involve-
ment on other outcomes including drug use are also summarized.
lnvolvement in Predatory Illegal Acts
Multivariate analyses were conducted to compare the impact of TASC
and other criminal justice system involvement on the number of
predatory illegal acts in the year after treatment. Regression
models were developed which included sex, age, race/ethnicity,
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TABLE 7. Number of types of services by TASC/criminal justice system involvement
Number
of Types
of Service TASC
Outpatient Drug Free
Non-TASC
Criminal
Justice
No Legal
lnvolvement TASC
Residential
Non-TASC
Criminal
Justice
No Legal
lnvolvement
Percent Percent Percent Percent Percent Percent Percent
None 35.4 27.6 16.1 4.4 10.4 7.2
1-2 49.5 55.1 54.6 46.1 43.5 43.9
3 or More 1 5 . 1 1 7 . 3 2 9 . 1 5 5 . 5 46.1 4 8 . 9
100.0 100.0 100.0 100.0 100.0 100.0
n = 156 117 164 99 264 166
NOTE: Only clients who remained in treatment at least 3 months are included in this table.
SOURCE: 1979 and 1980 TOPS Admission Cohorts.
TABLE 8. Types of services by TASC/criminal justice system involvement
Types of
Service TASC
Outpatient Drug Free Residential
Non-TASC Non-TASC
Criminal No Legal Criminal No Legal
Justice Involvement TASC Justice Involvement
Medical
Psychological
Family
Legal
Education
Employment
Financial
n =
percent Percent
16.5 27.5
37.2 52.6
26.6 23.2
5.5 9.7
10.7 18.1
14.4 9.7
9.8 3.2
156 117
Percent Percent Percent Percent
35.8 83.1 86.6 83.8
72.7 61.2 56.4 50.8
51.5 36.9 29.7 43.0
1.2 26.2 32.0 4.7
12.4 41.2 44.3 45.2
13.4 16.0 14.7 26.6
6.2 22.8 9.2 12.2
Muitiple Response
184 99 264 188
NOTE: Only clients who remained in treatment at least 3 months are induded in this table.
SOURCE: 1979 and 1980 TOPS Admission Cohorts.
TABLE 9. General satisfaction with treatment by TASC/criminal justice system involvement
Level of
Satisfaction
Outoatient Drug Free Residential
Non-TASC Non-TASC
Criminal No Legal Criminal No Legal
TASC Justice Involvement TASC Justice Involvement
Very Satisfied
Somewhat
Satisfied
Not At All
Satisfied
n =
Percent
46.2
40.2
3.6
100.0
156
Percent
40.7
46.7
2.6
100.0
117
Percent
60.0
36.2
1 . 8
100.0
164
Percent
49.1
45.1
5.8
100.0
99
Percent
46.9
51.3
1.8
100.0
264
Percent
54.1
44.5
1.4
100.0
166
NOTE: Only clients who remained in treatment at least 3 months are included in this table.
SOURCE: 1979 and 1980 TOPS Admission Cohorts.
pretreatment drug-use patterns, previous treatment admissions, TASC
referral or other criminal justice involvement, length of time in
treatment, and drug abuse treatment after the TOPS treatment ex-
perience. In addition, reports of predatory illegal acts in the year
before treatment were subject to comparative multivariate analysis
along with regression model data.
The regression results in table 10 show how particular characteristics
are associated with posttreatment predatory illegal acts. A risk
factor greater than one indicates that an individual with a particular
characteristic is more likely to commit predatory illegal acts than
similar individuals without that characteristic. A risk factor less
than one indicates an individual with that characteristic is less likely
to commit predatory illegal acts posttreatment.
The former clients were categorized as committing one or more pre-
datory illegal acts in the year after leaving treatment or as not
committing any such act. Table 10 shows the effects of comparative
risk for the four major variables of interest in this analysis: prior
treatment, pretreatment predatory illegal acts, retention in treat-
ment, and criminal justice system involvement.
Outpatient drug-free clients who had been in drug abuse treatment
before TOPS were 1.67 times (p<.05) more likely to commit predatory
illegal acts after TOPS treatment than those who had not been in
drug abuse treatment previously. An opposite (though not statis-
tically significant) relationship was found for residential clients;
those with prior treatment were .73 times (p=<.20) as likely to commit
predatory illegal acts in the year after treatment. This suggests that
the risk of posttreatment predatory illegal acts is somewhat higher
when the first treatment admission is to a residential program
through the criminal justice system. On the other hand, clients
with prior treatment experiences may be more successful in
residential treatment.
Short retention was strongly related to higher posttreatment involve-
ment in predatory illegal acts. Both outpatient drug-free and
residential clients staying in treatment 4 weeks or less almost doubled
their chances of committing predatory illegal acts compared with
those staying in treatment more than 3 months (p<.05). A stay in
treatment between 4 and 13 weeks increased the risk of committing
predatory illegal acts 1.25 times (p=.42) for outpatient drug-free
clients and 2.43 times (p<.001) for residential clients.
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TABLE 10. Effects of treatment and criminal justice system involve-
ment on the odds of committing predatory illegal acts in
the year after treatment
Risk Factors
Outpatient Drug Free
(n=603)
Residential
(n=498)
Prior Treatment
Prior Treatment for Drug Abuse
vs. No Prior Treatment
Predatory lllegal Acts
1.67* .73
1-10 Predatory Acts Before
Treatment vs. No Acts
11 or More Predatory Acts
Before Treatment vs. No Acts
Retention in Treatment
2.59*** 1.58
4.33*** 2.26**
4 Weeks or Less vs. 3 Months or More
4-13 Weeks vs. 3 Months or More
Criminal Justice System Involvement
TASC vs. No Legal Involvement
Non-TASC Criminal Justice System Other
1.91**
1.25
1.10
1.83*
2.46***
1.22
than TASC vs. No Legal Involvement 1.54 .72
*p<.05.
**p<.01.
***p<.001.
SOURCE: 1979 and 1980 TOPS Admission Cohorts.
The TASC and criminal justice involvement variables did not predict
significant variation in the likelihood of posttreatment predatory
illegal acts when the other factors in the models were controlled.
Similar findings were obtained when time-at-risk corrected measures
of number of predatory illegal acts were used as the dependent
variables (Marsden et al. 1986). Longer retention is associated with
lower numbers of predatory illegal acts so, by increasing retention,
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criminal justice referrals may have a greater impact on posttreatment
predatory illegal acts than is indicated in the regression analysis.
Other Outcomes
Criminal justice system involvement may affect drug use, depression,
employment, and other client behaviors. The effect of a legal source
of referral rather than self-referral for other behaviors in the year
after treatment was examined in a multivariate model. The results
indicated that a legal source of referral significantly affected weekly
or daily use of the primary problem drug but not the use of other
drugs, depression, criminal behavior, or employment. After treatment,
criminal justice system-referred residential clients were .62 times
(p<.05) less likely and outpatient drug-free clients were .61 times
(p<.10) less likely to use their primary problem drug weekly or more
often than their self-referred counterparts. These results suggest that
a more elaborate model of the direct and indirect effects of criminal
justice involvement is needed to better delineate the overall impact
of criminal justice system involvement.
CONCLUSIONS
The results of the analyses support the basic belief that criminal
justice clients do as well or better than other clients in drug abuse
treatment. TASC programs and other formal or informal criminal
justice system mechanisms appear to refer individuals who had not
previously been treated and many who were not yet heavily involved
in drug use. This early interruption of the criminal and drug-use
careers may have important long-term benefits in reducing both crime
and drug use among treated offenders. Criminal justice system
involvement also helps retain clients in treatment. The estimated 6
to 7 additional weeks of retention for TASC referrals provided pro-
grams with considerably more time for rehabilitation efforts. There
also seemed to be more substantial changes in behavior during treat-
ment for other criminal justice clients. These findings support
efforts to continue and expand criminal justice programs such as
TASC. Other results suggest the need for careful assessment of how
TASC and other criminal justice programs might be improved.
TASC programs have a broad mandate to identify and refer drug
abusers in the criminal justice system to treatment. It is clear,
however, that a large number of individuals entering drug abuse
treatment are involved with the criminal justice system but not a
TASC program. Whether these individuals were not identified by
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TASC program. Whether these individuals were not identified by
TASC; were not considered to be eligible by TASC; were not allowed
to enroll for other reasons, such as the decision of a judge or
prosecutor; or chose not to participate in TASC needs to be studied.
The TOPS data do not indicate the structure and process of formal
criminal justice programs and referral processes other than TASC.
Further, studies are needed to identify these mechanisms and to
determine how they complement the TASC programs.
One major finding in this research is that few TASC clients and
other criminal justice clients enter outpatient methadone programs.
The reasons for the low numbers in methadone programs need to be
explored. There appear to be many heroin addicts in the criminal
justice system who could benefit from methadone treatment to reduce
their criminal behavior.
A second finding is that TASC and other criminal justice system
clients in outpatient drug-free programs received fewer services than
other clients in the same program. Although TASC and other crim-
inal justice system clients reported fewer drug-related problems than
clients with no legal involvement, they still reported a wide array of
problems. Differential service delivery for clients from various
referral sources should be carefully examined.
A third finding is that, although treatment itself reduced crime, those
referred by TASC or involved with the criminal justice system did
not report fewer predatory illegal acts after treatment than those
who were not currently involved with the criminal justice system.
The analyses described in this report may not fully identify the
positive effects of TASC and other criminal justice system involve-
ment on criminal behavior. Retention, which was positively related
to reduction in risk of predatory illegal acts and arrest, was
controlled in the multivariate analyses. Thus, the indirect effect of
TASC and other criminal justice system involvement through increased
retention was not estimated. A more complex model such as path
analysis would be a more appropriate way to demonstrate the overall
impact of TASC and other criminal justice involvement. lt should be
noted that TASC and other criminal justice clients appeared to be at
earlier stages of their drug-use and criminal careers. lt is reasonable
to expect that drug abuse treatment moderates the increasing seri-
ousness of drug use and criminal behavior for younger TASC and
other criminal justice clients. More intensive aftercare services may
be needed to maintain the reduction in drug abuse and crime achieved
during treatment. An appropriate new role for TASC might be the
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provision or coordination of long-term aftercare services to help
reinforce the behavior changes achieved during treatment.
TASC programs have been shown to identify and refer more indivi-
duals than would be expected from a less formal, nonprogrammatic
referral system. Furthermore, some potential differential outcomes of
TASC clients and other clients involved in the criminal justice system
may be obscured by differences in clients’ motivation for treatment
which were not included in the analyses for this chapter. The
evidence of the efficacy of criminal justice referral demonstrated in
the TOPS data support the belief that a formal and comprehensive
program such as TASC should produce benefits that far outweigh
their costs.
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Legal Status and Long-Term
Outcomes for Addicts in the
DARP Followup Project
D. Dwayne Simpson and H. Jed Friend
INTRODUCTlON
From 1969 to 1973 approximately 44,090 drug abusers were admitted
to 52 federally funded and community-based treatment agencies in the
Drug Abuse Reporting Program (DARP). Over the course of several
years, a series of during-treatment studies were conducted on this
treatment population (Sells 1974; Sells and Simpson 1976), and samples
of these drug abusers were later followed up at about 6 years and
again at 12 years after admission to treatment (Simpson and Sells
1982; Simpson et al. 1986a; Simpson et al. 1986b). This chapter
examines these longitudinal data concerning the influence of judicial
status on client performance during and after treatment.
Previous findings from DARP during-treatment evaluations and
followup research data relevant to legal status are reviewed, and new
analyses are presented that focus specifically on pretreatment judicial
status in relation to treatment retention and long-term behavioral
outcomes, including opioid use, criminality, and employment. How-
ever, the DARP data did not emanate from civil commitment agencies,
and there were differences among agencies, with regard to the role
legal status played in treatment referrals. Overall, 40 percent of the
DARP treatment population were admitted with some form of legal
status, such as probation, awaiting trial, or parole, but the client’s
legal classification was not necessarily reflected in the source of
referral. Some of the legally involved clients reported being referred
to DARP treatment from courts, parole/probation officers, and police
but others did not. Thus, client motivations recorded retrospectively
in the 12-year followup as major reasons for entering drug abuse
treatments were also examined in relation to treatment history and
long-term outcomes.
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DESCRlPTlON OF THE SAMPLE
Data are presented below for black and white male daily opioid users,
which is the subsample most representative of the DARP population.
For instance, among the almost 44,000 admissions to the DARP, 75
percent were male, 81 percent were either black or white, and 64
percent had used opioid drugs (heroin, illegal methadone, or other
opiates) daily during the P-month pretreatment period. Male addicts
were also the major focus of the 12-year foilowup study, even though
a subsample of female addicts was studied in detail by Marsh and
Simpson (1986). In the present study, therefore, the research sample
was limited to male daily opioid users. This limitation reduces the
confounding of results on drug use, criminality, and employment
outcomes by avoiding baserate differences involving males/females and
addicts/nonaddicts.
Out of the nearly 44,000 original DARP admissions, 27,460 subse-
quently entered treatment with acceptable data and were studied in
the DARP during-treatment research phase (Sells 1974; Sells and
Simpson 1976). Table 1 shows that among the subgroup of 11,920
black and white male addicts in this population, 5,704 were treated in
methadone maintenance (MM) programs, 1,767 were treated in thera-
peutic communities (TC), 1,232 were treated in outpatient drug-free
(DF) programs, and 3,217 were treated in outpatient detoxification
(DT). This treatment sample is described in table 1 with regard to
race, age, legal status at admission, source of referral, days spent in
treatment before termination, and reasons for discharge.
Followup Samples
The 12-year longitudinal data were obtained from a cohort sample of
opioid addicts admitted to DARP treatment programs during the
period of June 1969 through May 1972. However, the first wave of
(6-year) followup interviews was conducted with a stratified random
sample of 4,107 addicts and nonaddicts from 25 different DARP
agencies located across the United States (Simpson and Joe 1977); 87
percent of the cases were located, and successful interviews were
completed with 3,131 respondents. The 6-year DARP foilowup studies
(Simpson and Sells 1982) focused on evaluation of posttreatment
outcomes. Sample stratification factors for this followup study
included DARP treatment classification, time in treatment, race/ethnic
group, sex, age, and treatment agency or clinic. Clients were
selected to represent MM, TC, DF, and DT programs, as well as an
intake only (IO) group, whose members completed intake and
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TABLE 1. Description of black and white male daily opioid users admitted to DARP during 1969-1973
MM
Type of DARP Treatment
(percent)
TC DF DT
Total
(percent)
Race:
Black
White
80
20
53
47
60 66 70
40 34 30
Age:
Under 18 1
18-20 11
21-25 35
26-30 17
Over 30 36
Legal Status of Admission:
None 66
Probation 16
Parole 5
Awaiting Trial 12
7 8 4 4
26 22 19 16
40 43 45 39
10 12 13 15
17 15 19 26
34 48 55 57
35 23 22 21
9 9 8 7
22 20 15 15
TABLE 1. (Continued)
MM
Type of DARP Treatment
(percent)
TC DF DT
Total
(percent)
Source of Referral:
Legal/Court 7
F a m i l y / F r i e n d s  3 8
Other 56
Days in Treatment:
1-30
31-90
91-365
Over 365
5 26 25 44 21
10 24 30 40 22
36 32 36 15 30
49 18 7 1 27
Reason for Treatment Discharge:
Completed 28
Quit/Expelled 49
Jailed 6
Other 17
Sample Sizes: 5,704 1,767 1,232 3,217 11,920
31 22 10 13
24 26 30 32
45 52 60 55
20 13 21 23
71 77 73 61
2 4 3 5
7 6 3 11
admission procedures but did not return for treatment in the DARP.
The IO group in this study was viewed as an important comparison
group but not as a control group, since treatment samples were not
formed through random assignment.
From the completed 6-year interviews, a second wave of 697 DARP
admissions was selected for a 12-year followup study of opioid
addiction careers. Sample selection was based on pre-DARP drug use
history, treatment classification, race/ethnic group, sex, and treat-
ment agency or clinic. Only clients who were daily opioid users at
the time of DARP admission were included in the 12-year study (this
sampling restriction was made, in part, because of funding limita-
tions). The sample targeted equal numbers of black and white males
from all five treatment groups; black and white females were included
only in the MM treatment group due to sampling limitations in other
treatments. The final sample was drawn from 18 different treatment
agencies, as explained in more detail by Simpson (1984a).
The fieldwork for the DARP followup studies, involving the location
and interviewing, was carried out under contract with the National
Opinion Research Center. For the 12-year study, 558 (80 percent) of
the target sample were located during 1982 and 1983,490 (70 percent)
were interviewed after granting informed consent, 52 (8 percent) were
deceased, and 13 (2 percent) refused to be interviewed. The
remaining 142 (20 percent) were not located before time and
resources for the fieldwork ran out. Analysis of intake and 6-year
followup data, however, revealed no evidence of systematic sampling
bias associated with these nonlocated cases (Simpson 1984a).
The 1 P-year followup interviews were conducted face-to-face with
trained interviewers who followed strict procedures to protect con-
fidentiality. The average time for each interview was about 2 hours,
for which the respondent was paid $15. The interview focused on
behavioral changes and outcomes over time, as well as historical
assessments of psychological and social factors involved throughout
their addiction careers. The major treatment outcomes measured
were illicit drug use, drug abuse treatment, alcohol use, employment,
and criminality. Comparisons of self-reported information with
urinalysis results, criminal justice records of post-DARP incarcer-
ations, and checks for internal consistency indicated a high level of
data reliability and validity (Simpson 1984b).
The final interviewed sample of 490 former opioid addicts included 18
percent females and 62 percent males and 51 percent blacks and 49
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percent whites, with a median age of 34 at the time of the 12-year
followup interview (19 percent were over 40 years old). As previ-
ously noted, the present study includes only male addicts (n=405)
because females were fewer in number and because they differed
systematically from males on several behavioral measures, particularly
employment and criminality.
DARP TREATMENT ADMISSIONS AND PROGRAM PERFORMANCE
About 40 percent of the opioid addicts who entered treatment in the
DARP during 1999 to 1972 reported some form of legal involvement at
the time of admission; 17 percent were on probation, 14 percent were
awaiting trial, and 8 percent were on parole. There were large dif-
ferences between treatment modalities, however. For instance, only
34 percent of admissions to MM were legally involved, compared to
66 percent for TC, 52 percent for DF, and 45 percent for DT. These
differences, especially between MM and TC programs, were further
illustrated by the sources of treatment referral that were reported by
clients at the time of their admission. For MM programs, 7 percent
of the admissions were court referred and 47 percent reported being
self-referred; for TC programs, these percentages were 31 percent
and 30 percent (Simpson et al. 1978).
Early DARP studies of retention in treatment conducted by Joe
(1974), Joe and Simpson (1978a), and Joe and Simpson (1978b) exam-
ined legal involvement at admission as a predictor variable. These
studies found that predictions of treatment tenure from legal status
were inconsistent across treatment categories and were usually statis-
tically nonsignificant. Legal status was also unrelated to during-
treatment drug and alcohol use, employment, and criminality (Spiegel
and Sells 1974; Gorsuch et al. 1976a; Gorsuch et al. 1976b). Thus,
legal status at intake, as well as source of referral to treatment, was
not a useful predictor in the DARP during-treatment research.
Since these earlier studies of legal status were based on combined
samples of addicts and nonaddicts in a multiple regression analytic
model, the present study narrowed the focus to black and white male
addicts. In particular, treatment performance indicators (length of
time in treatment and reason for discharge) were compared between
clients who were legally involved when admitted to DARP (i.e., on
parole, probation, or awaiting trial) and those who had no legal
status. These comparisons answered the question of whether legal
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pressure at the time of treatment admission was associated with (1)
the length of time the addict remained in treatment, and (2) the
addict’s reasons for leaving.
The findings are summarized for each treatment modality in the upper
portion of table 2. In short, legal status and treatment tenure
showed no significant relationship (using chi-square) in any of the
four treatment groups. Reason for discharge was also generally
unrelated to legal status. However, MM clients with legal status had
slightly lower treatment completion rates (25 percent vs. 30 percent
for those without legal status) and higher rates of termination due to
incarceration in jail (10 percent vs. 4 percent for those without legal
status); although these were statistically significant differences
(p<.01), they have small practical implications.
To test for the further possibility that legal status might be differen-
tially important for certain age ranges, similar analyses were con-
ducted separately within age categories (i.e., under 18, 18 to 25, and
over 25). Again, the results showed no evidence that pretreatment
legal pressures were related to retention and to cause of discharge.
POSTTREATMENT OUTCOMES
The first wave of DARP followup interviews was conducted about 6
years after treatment admission. The focus was on using post-
treatment outcomes to assess treatment effectiveness, especially in
the first year after termination from DARP treatment. Simpson and
Sells (1982) reported that clients in the major treatment modalities
(MM, TC, and DF) had significantly better posttreatment outcomes on
opioid use, criminality, and employment than clients in DT and the
comparison group of IO clients. Longer retention in these treatments
was also predictive of better outcomes.
Client demographic and background measures used in the DARP pro-
vided small but statistically significant predictions of posttreatment
outcomes. Examination of pre-DARP legal status, in relation to
posttreatment outcomes, is summarized in the lower portion of table
2. In the MM, TC, and DF treatment groups, jail or prison was
significantly more likely in the first year after DARP among those
who were legally involved before admission. This relationship is not
surprising, since some of these incarcerations were probably the
direct result of pre-DARP legal problems. None of the other out-
comes, however, in years 1 or 6, were significantly related to pre-
DARP !egal status. In addition, analysis of variance comparing
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TABLE 2. Treatment performance and outcome indicators by legal involvement at time of admission to DARP
treatments
TABLE 2. (Continued)
NOTE: “Some” legal involvement indicates the addict was on parole, probation, or awaiting trial when admitted to DARP.
posttreatment outcome scores between clients with specific types of
legal status (parole, probation, awaiting trial, and not legally in-
volved) also indicated that there were no significant differences
associated with subcategories of legal status.
In year 12 after DARP treatment admission, the followup sample con-
tained 39 percent who had used opioid drugs (including 26 percent
who had used opioids daily) in 1 or more months during that year.
Marijuana was used in year 12 by 61 percent, and other nonopioid
drugs (mostly cocaine) were used by 47 percent, while 31 percent had
spent time in drug abuse treatment during the year (Simpson et al.
1988).
With regard to other outcomes, 27 percent consumed an average of
over 4 ounces of 80-proof liquor equivalent per day, 29 percent spent
time in jail or prison, and 64 percent worked during 6 or more
months (28 percent had not worked at all in year 12). As reported
in more detail by Simpson et al. (1986), these outcome levels for year
12 changed very little from those in year 6, but this was not merely
a result of the long-term stability of outcomes over time. For in-
stance, about one-half of the sample maintained the same level of
opioid use from year 6 to year 12 (42 percent were abstainers in both
years and 9 percent used opioids daily in both years), but one-fourth
increased their use and the remaining one-fourth decreased their use
across this time period.
Lehman and Simpson (1984) reported that long-term predictions of
12-year outcomes, that is, using predictors based on pre-DARP infor-
mation, are generally poor. For instance, even the significant treat-
ment group differences in behavioral outcomes found during the first
year following DARP “fade out” over time as other treatments and
life changing events accumulate. lt is not surprising, then, that most
of the year 12 outcome measures were also statistically unrelated to
pre-DARP legal status of black and white male addicts. These data
are summarized in table 3, and they show that year 12 opioid use and
employment rates did not differ due to pre-DARP legal status. How-
ever, it was found that addicts who were legally involved when they
entered DARP treatment did have a significantly higher incarceration
rate in year 12 (37 percent vs. 27 percent).
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TABLE 3. Twelve-year followup outcomes for clients grouped by
pre-DARP legal status
With Pre-DARP Without Pre-DARP
Legal Status Legal Status
(Percent) (Percent)
Any Opioid Use in Year 12 35 33
Daily Opioid Use in Year 12 25 20
Any Jail in Year 12 37 27
Employed for 6 Months
in Year 12 46 47
Sample Sizes: 294 201
ADDICTION CAREERS
Longitudinal analyses of opioid use patterns over time illustrate the
long-term threat of addiction relapse (Simpson and Marsh 1966). For
instance, 65 percent of the DARP sample quit for a month or longer
during the 12-year followup, only to relapse to daily opioid use one
or more times. More encouraging, however, were the findings that 25
percent of these addicts never returned to daily opioid use over the
12-year followup period, and, by year 12, 63 percent had not used
opioids daily for at least 3 years. As expected, longer periods of
abstinence from opioid addiction were also associated with less
legal involvement as well as with more employment in year 12.
The DARP treatment evaluation studies have consistently indicated
that drug abuse treatment is effective in improving client post-
treatment outcomes (Simpson and Sells 1962). Data from the 12-year
followup interviews give further support to this conclusion, since 56
percent of the sample that had quit opioid use by year 12 reported
being in a treatment program when they quit. A detailed treatment-
history study of these addicts in the 12-year followup indicates the
complexity of treatment experience when viewed from a longitudinal
perspective (Marsh et al. 1965). The average length of time from the
first to the last daily opioid use was 10.5 years. This period of time
averaged 9 years for those who had quit before year 12, compared to
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16 years for those who were still addicted. The average number of
drug abuse treatment episodes per client was 6.2. As expected,
addicts who were primarily treated in DT throughout their addiction
career had the highest average, with 9.9 treatment episodes, compared
to 5.1 for those usually treated in MM, 4.6 for TC, and 3.4 for DF.
Comparisons between these mutually exclusive groups classified by
lifetime treatment experiences, however, showed that they were not
significantly different in client sociodemographic characteristics (i.e.,
age, race, marital status, and educational levels), in reasons usually
given for entering treatment (discussed later), and in drug use or
criminal involvement in year 12. On the other hand, analysis of
addicts according to whether they had ever been treated in each sep-
arate treatment modality (using partial regression weights) showed
that those treated one or more times in a TC had the most favorable
year 12 outcomes on drug use, alcohol use, employment, and time in
jail (Marsh et al. 1985).
As part of the 12-year followup interview, DARP respondents were
asked to review their lifetime of treatment experiences and to rate
the overall importance of their reasons for entering treatment. Al-
most 9 out of 10 (89 percent) indicated that “deciding for self” was
important (i.e., “very” or “somewhat” important) for entering treat-
ment. Family was an important reason for 73 percent, but only 28
percent remembered friends as being important. Legal reasons were
also considered important by about half the sample—49 percent
acknowledged “legal problems” and 41 percent “probation or parole”
(the four-point ratings of importance for these two items correlated
at 0.62). A smaller percent indicated that drug availability or quality
were important treatment motivations, that is, 32 percent for “poor
quality of drugs” and 20 percent for “unavailability.” Finally, only 16
percent said medical problems were important in making treatment
decisions.
Legal and family incentives for treatment were also statistically
associated with larger numbers of lifetime treatment episodes. For
example, 50 percent of those who reported parole/probation as impor-
tant treatment motivations had five or more treatments, while only 37
percent of those who reported parole/probation as being unimportant
had as many treatments. Likewise, 48 percent of those who consid-
ered family reasons as important reported five or more treatment
experiences, compared to only 26 percent of those for whom family
reasons were unimportant. Thus, addicts who entered treatment more
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frequently were subject to greater influence from legal pressures and
family concerns.
In table 4, the data show that addicts who were originally admitted
to DARP treatment with legal involvement also reported in year 12
that parole/probation and legal problems had previously been impor-
tant treatment incentives. In addition, they were less likely to
report “decisions for self” as being important. None of the other
reasons for entering treatment were significantly related to pre-DARP
legal status. The total number of career treatment episodes was also
unrelated to pre-DARP legal status.
TABLE 4. Important reasons for treatments for clients grouped by
pre-DARP legal status
With Pre-DARP Without Pre-DARP
Legal Status Legal Status
(Percent) (Percent)
“Parole/Probation” Was
Important 53 29
“Legal Problems” Were
Important 63 35
“Decided for Self” Was
Important 84 95
Finally, analyses of relationships between reasons for entering
treatment and year 12 outcomes revealed only two statistically sig-
nificant findings. First, year 12 incarcerations in jail or prison for
one or more months was more likely among those who rated proba-
tion or parole as important reasons for entering treatment (42 per-
cent vs. 24 percent, p<0.01). Second, employment in year 12 (for 6
or more months) was less likely among addicts who reported medical
or physical problems as important reasons for entering treatment (27
percent vs. 47 percent, p<0.01).
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CONCLUSIONS
The DARP research team has been asked many times during the past
15 years if reasons for admission to treatment (sometimes
characterized as “involuntary admissions,” “legal referrals,” or “civil
commitments”) are related to during-treatment behavior and to post-
treatment outcomes. After several caveats, the answer has always
been a cautious “No, we can’t say they are!” These caveats empha-
size that DARP samples and variables might not be generalizable to
other situations. The study reported here focuses on a reduced
sample of black and white male addicts who were examined at
different points in time throughout a 12-year followup period.
The simple question posed was “Does the pretreatment legal status of
addicts relate to length of stay in (DARP) treatment, to why they
left treatment, and to their behavioral performance after treatment?”
With few exceptions, pretreatment legal status did not predict sub
sequent outcomes. That is, within each separate treatment modality
(MM, TC, DF, and DT), the length of time in treatment, reasons for
discharge, and posttreatment outcomes were similar for addicts who
were legally involved and those who were not. Exceptions usually
involved outcome measures representing incarceration, which some-
times occurred as a direct consequence of the legal status (such as
awaiting trial). However, there were some long-range associations of
these criminality indicators that suggested habitual criminal involve-
ment among some addicts.
Compared to more recent treatment populations, the DARP clientele
was usually younger, more opiate-dependent, more legally involved,
and had fewer prior treatment admissions (Hubbard et al. 1988).
Especially significant is the fact that over 80 percent of the addicts
admitted to DARP programs had one or more prior arrests, and over
half had already spent time in jail or prison. Thus, legal status at
the time of DARP admission may not have been a very discriminating
variable in this relatively homogeneous sample of primarily young,
inner-city, criminally active “street addicts.” Source of referral was,
therefore, examined in an extended effort to refine this definition of
legal pressure. Of special interest were addicts referred by court or
legal sources, which presumably carried more pressing legal implica-
tions. These clients were compared to those referred by family,
friends, self, and others. The results, however, were no different
from those using the original measure of legal status—in particular,
DARP treatment retention for court-referrals was not significantly
different from other referrals. Because these results were consistent
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with others in this study focusing on legal status, these analyses
were not elaborated. It is possible, however, that this measure could
also have been too general or incomplete to reflect a high degree of
pending legal liabilities.
In spite of the negative findings of this study, there are still
unresolved questions about judicial pressures on treatment success.
Clinical judgments vary on this point. As Indicated above, there is a
lack of precision in the simple classification of “legal status.”
Indeed, legal status does not necessarily imply legal pressure; there
are important methodological distinctions in comparing clients “with”
and “without” legal status versus those who differ only in degree of
legal pressure. Ideally, effects of legal pressures might be tested
most appropriately using clients otherwise matched for criminal
history and legal status, even though this is not easy to achieve in
practice.
There is evidence from the DARP and other treatment evaluation
studies that treatment is effective in improving behavioral outcomes.
Treatment effects vary, however, and making accurate outcome
predictions on the basis of pretreatment data is difficult. Staying
longer in treatment tends to increase the chances for posttreatment
success, but legal pressures at DARP treatment entry did not seem
very important. More precise data concerning legal and other
environmental incentives, as well as the client motivations and
readiness for change, might help with these predictions, as suggested
by De Leon and Jainchill (1986).
lt is clear that future use of civil commitment will add more stress
to the drug abuse treatment resources available in this country. It
is, therefore, important to continue searching for ways to maximize
treatment impact by identifying those most likely to benefit from
various therapeutic efforts and then to define and improve the
critical elements of treatment process and aftercare supervision.
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Treatment Alternatives to Street
Crime1
L. Foster Cook, Beth A. Weinman et al.2
lNTRODUCTlON
Treatment Alternatives to Street Crime (TASC) provides a bridge
between the criminal justice system, which employs legal sanctions
that reflect community concerns for public safety, and the treatment
community, which emphasizes therapeutic relationships as a means
for changing individual behavior and reducing substance abuse and
other problems. Under TASC auspices, community-based treatment is
made available to drug-dependent individuals who would otherwise
become involved with the criminal justice system.
TASC programs were initiated nearly 15 years ago in response to
recognized links between substance abuse and criminal behavior. The
mission of TASC is to participate in criminal justice processing, as
early in the continuum as acceptable to participating agencies. TASC
identifies, assesses, and refers appropriate drug- and/or alcohol-
dependent offenders accused or convicted of nonviolent crimes to
community-based substance abuse treatment, as an alternative or
supplement to existing criminal justice sanctions and procedures.
TASC then monitors the drug-dependent offender’s or client’s
compliance with individually tailored progress expectations for
abstinence, employment, and improved social/personal functioning.
TASC then takes responsibility for reporting treatment results back
to the referring justice system component. Clients who do not follow
or who violate conditions of their criminal justice mandate, TASC, or
treatment agreement are usually returned to the criminal justice
system for continued processing or for sanctions.
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THE TASC MODEL
TASC combines the influence of legal sanctions for probable or
proven crimes with the appeal of such innovative dispositions as
deferred prosecution, creative community sentencing, diversion,
pretrial intervention, probation, and parole supervision: the goal is to
motivate treatment cooperation by the substance abuser. Through
treatment referral and closely supervised community reintegration,
TASC aims to permanently interrupt the vicious cycle of addiction,
criminality, arrest, prosecution, conviction, incarceration, release,
readdiction, criminality, and rearrest.
TASC programs encourage participants to improve their lifestyles
while retaining important community ties. TASC programs also
provide important incentives to other criminal justice and treatment
participants. TASC can reduce costs and relieve many substance
abuse-related processing burdens within the justice system through
assistance with such responsibilities as addiction-related medical
situations, pretrial screening, and posttrial supervision. The
treatment community also benefits from TASC’s legal focus, which
motivates and prolongs clients’ treatment cooperation and ensures
clear definition and observation of criteria for treatment dismissal or
completion. Public safety is also increased through TASC’s careful
supervision of criminally involved clients during their community-
based treatment.
In 1962, a landmark Supreme Court decision, Robinson v. California,
defined chemical addiction as an illness rather than a crime. It also
held that the State could force an addict to submit to treatment and
could impose criminal sanctions for failure to comply with the
treatment program. In the context of the times, when penal coercion
was disavowed as an effective rehabilitation incentive and community-
based treatment for substance abuse was only slowly gaining
acceptability and credibility, alternatives to routine criminal justice
system processing for drug-dependent offenders were initiated.
In the years following, several conceptual and strategic models were
developed to implement these new understandings. By the early
1970s a Presidential-appointed Special Study Commission on Drugs
established a definite link between drugs, particularly narcotics, and
crime. A small number of addicts were found to be responsible for a
large percentage of crimes, and a disproportionate share of criminal
justice system resources were being absorbed by their recidivism.
Discussions on how to link treatment with the judicial process and
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how to interrupt the relationship between drugs and property crimes
took place among the Law Enforcement Assistance Administration
(LEAA), the Special Action Office for Drug Abuse Prevention
(SAODAP), and the National Institute of Mental Health’s Division of
Narcotic Addiction and Drug Abuse (DNADA)-predecessor to the
National Institute on Drug Abuse (NIDA). The resulting Federal
initiative, modeled after earlier experiments with diversion programs
and two demonstration projects in New York City and Washington,
DC, was funded by the Drug Abuse Office and Treatment Act of 1972,
and named TASC. The first TASC project opened in Wilmington, DE,
in August of that year, and provided pretrial diversion for opiate
addicts with nonviolent criminal charges who were identified in the
jail lockup by urine tests and interviews. After assessment of their
treatment suitability and needs, arrestees who volunteered for TASC
were referred and escorted to appropriate community-based treatment
and monitored for continued compliance with treatment requirements.
Successful completion usually resulted in dismissed charges.
LEAA issued program guidelines for replication of the TASC model,
which focused on pretrial diversion and sentencing alternatives for
drug-dependent offenders, and awarded “seed” grants, with the
understanding that successful demonstration projects would gain local
or State funding to continue the programs within a 3-year period. In
1972 to 1973, 13 TASC projects were initiated by local jurisdictions
in 11 States. By 1975, 19 more such projects had started, making a
total of 29 operational sites in 24 states. Before Federal funding was
withdrawn in 1982, TASC projects were developed at 130 sites in 39
states and Puerto Rico. TASC is currently operational in 18 states.
Many of these local programs also continued communications with
each other through a National TASC Consortium, which was reestab-
lished in 1984.
LEAA made a special effort to fund TASC programs in a variety of
geographic areas and jurisdictions, including large metropolitan areas,
smaller cities, suburban and rural counties, regional conglomerations,
and statewide networks of sites. Original client participation criteria
were also expanded to include polydrug and alcohol abusers; juveniles;
and, in some places, domestic violence and mental health demonstra-
tion projects. TASC services to the alcohol- and drug-related traffic
offender were also evolving.
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EVALUATION OF TASC PROGRAMS
All of the TASC programs funded by LEAA were required to conduct
independent evaluations. More than 40 of these local assessments
were completed over the 10-year period from 1972 to 1982. Although
a few evaluators found some TASC programs had overly optimistic
expectations for client success or were underutilized, the majority
concluded that local TASCs effectively:
intervened with clients to reduce drug abuse and criminal activity;
linked the criminal justice and treatment systems; and
identified previously untreated drug-dependent offenders.
During the same period, three national assessments of the TASC
program focused on the success of multiple sites in meeting general
TASC goals. Evaluators of five early TASC projects (System
Sciences, Inc. 1974) concluded that those sites included a substantial
proportion of repeat offenders with long histories of addiction,
initiated more than half of the identified clients (55 percent) into
their first treatment experience, and reduced criminal recidivism.
A 1976 study of 22 operational TASC sites (Lazar Institute 1976)
found several commonalities in the success of TASC programming,
which included: (1) the broad-based support of the justice system
gained by TASC; and (2) the support of the treatment system,
because TASC’s legally sanctioned referral mechanisms to treatment
were more effective than informal treatment initiations. TASC’s
monitoring function improved clients’ treatment performance, and
TASC involvement seemed to reduce rearrest rates. Only 8 percent
of clients in all sites were known to have been rearrested for new
offenses while in the TASC program. However, TASC had no solid
data base or data collection mechanism in place that would allow for
long-term evaluation and comparison of the program’s impact on
drug-related crime or on the processing burdens of the justice
system.
A subsequent evaluation of 12 TASC sites (System Sciences, Inc. 1978)
found that:
the TASC model offered a beneficial and cost-effective alternative
to the criminal justice system for drug-abusing offenders;
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its major functions and procedures were effective;
a majority of clients were admitted to TASC prior to trial;
TASC’s threat of legal sanctions added a positive factor to the
treatment process;
TASC projects achieved remarkably progressive success rates with
clients (considering the seriousness of the crimes and the drugs
involved); and
staff quality was more important to program success than were
organizational and other factors.
Poor recordkeeping and information management, however, were
widespread among TASC programs.
A report from the National Institute on Drug Abuse’s Treatment
Outcome Prospective Study (TOPS) (Collins and Allison 1983)
examined the impact of TASC or similar programs for drug-dependent
offenders on clients’ intreatment and posttreatment behavior. This
study compared criminal justice-involved clients (in TASC and under
other justice system supervision) with voluntary controls on
demographic characteristics, treatment retention, treatment progress,
and predatory behaviors in the year following treatment termination.
The findings were that criminal justice-referred clients were more
likely to be male, nonwhite, and younger and to have had previous
justice system involvement in the year before treatment than their
volunteer counterparts. More important, TASC clients improved as
much with regard to drug use, employment, and criminal behavior as
other clients during the first 6 months of treatment. TASC clients
under legal coercion also tended to remain in both residential and
outpatient drug-free treatment modalities 6 to 7 weeks longer than
other criminal justice-referred or voluntary clients—a finding usually
associated with better treatment outcomes. The monitoring/case
management function of TASC seemed to encourage this longer
treatment participation. However, predatory crime and arrest before
treatment were still the most consistent predictors of criminal
reinvolvement, as measured by arrest records and self-reports in the
first posttreatment year.
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SUMMARY
These studies point to TASC’s success and effectiveness in
programming through specific critical program elements. The specific
program elements shown to be successful through various studies
were: the establishment of the broad-based support by the criminal
justice and treatment systems; the use of an offender eligibility
criteria that assists in the early identification, assessment, and
referral of the previously unidentified drug-dependent offender, and a
comprehensive monitoring or case management system that holds the
client accountable and has proven to reduce client rearrest rates and
improve the treatment performance of the drug-dependent offender.
Conversely, these studies have also shown that the lack of data
collection and evaluation has hindered TASC programming.
FOOTNOTES
1. This is an abridged version of the TASC Program Brief published
by the Bureau of Justice Assistance, Office of Justice Programs,
U.S. Department of Justice, 1985. (The TASC Program Brief is
available directly from the Bureau of Justice Assistance or the
National Association of State Alcohol and Drug Abuse Directors.)
2. Over 300 authors from the National Association of State and
Drug Abuse Directors and the Bureau of Justice Assistance
contributed to this chapter.
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The Criminal Justice System
and Opiate Addiction:
A Historical Perspective
Herman Joseph
INTRODUCTION
Within the past 30 years, agencies affiliated with the criminal justice
system in New York City developed various programs to assist
arrested narcotic addicts. The existence of these programs offers
more than a historical record of attempts to solve a seemingly in-
tractable problem. Historical experiences and available research
findings can provide guidelines for future planning.
In New York City, persons convicted of misdemeanors or felonies may
be sentenced to probation as an alternative incarceration. They are
supervised in the community by a probation officer and must adhere
to orders of probation approved by the sentencing judge (i.e., obtain
employment and contact the probation officer as directed). Parole is
similar except that individuals have served time in prison and are
released to the community under the supervision of a parole officer
for the remainder of their sentences. Parolees must adhere to con-
ditions similar to the orders of probation, but mandated by the New
York State Board of Parole.
During the period of 1956 through 1965, the New York State Division
of Parole and the New York City Office of Probation established nar-
cotics units with specially trained officers to supervise convicted
narcotic addicts. It was assumed that the authority of the court,
coupled with the intensive supervision and guidance of a trained
probation or parole officer, would be sufficient to assist addicts to
abstain from drugs, become employed, and lead crime-free lives.
Research from both agencies, however, showed the majority of addicts
supervised in these programs were unable to make acceptable adjust-
ments in the community (Joseph and Dole 1970).
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The Narcotic Offender Unit of the New York State Division of Parole
was established in 1956 for the purpose of supervising addicted
parolees (Diskind and Klonsky 1964). Of the 673 parolees who were
placed on parole in this unit between November 1, 1956, and Decem-
ber 31, 1961, 27 percent either completed parole successfully or were
considered to be in good standing. The remaining 73 percent either
relapsed to the use of drugs, were rearrested, or were reinstitution-
alized on parole violations. A postparole followup study of 66 suc-
cessfully terminated cases showed that after parole 30 individuals
were known to have relapsed and 34 amassed 99 rearrests. The post-
parole study was undertaken approximately 2 years and 9 months fol-
lowing the successful termination of the 66 parole cases. Therefore,
about 80 percent of the 673 parolees were unable to adjust in the
community during parole and the immediate postparole period. The
unit was terminated in 1961.
From 1963 through 1965, the New York City Office of Probation and
the Washington Heights Rehabilitation Center, a now-closed public
health agency that treated addicts, created a program to treat addict-
ed probationers (Brill and Lieberman 1969). A team comprising pro-
bation officers, public health nurses, and social workers worked with
selected probationers. A drug-free counseling approach was employed
by the staff. Urine testing was administered to probationers parti-
cipating in the program by their supervising probation officers in the
men’s room of the probation office or at the time of home visits.
The tests were analyzed by the Department of Health’s laboratory. If
urine tests were administered on field visits, the specimens were
delivered by the probation officers to local drug stores, which were
designated as pick-up stations for the Department of Health.
During the first year of treatment, about 78 percent of the 159 pro-
bationers reverted to heroin use in varying degrees, about 48 percent
were rearrested, and 25 percent were convicted. Although a group of
probationers did achieve abstinence from opiates for 45 percent of
the time they were enrolled in the program, about 50 percent of the
probationers had used heroin in varying degrees during any given
treatment month. In general, the rate of relapse paralleled the un-
successful efforts of the New York Riverside Hospital to rehabilitate
addicts (Brill and Lieberman 1969). In summation, the overwhelming
majority of the probationers who participated in this program were
unable to achieve the goals of drug abstinence, employment, and a
law-abiding life. As with all programs, however, there are success
stories: the current Director of the New York State Division of
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Substance Abuse Services, Julio Martinez, was a probationer in this
program for about 3 years.
In 1963, the probation office of the Kings County Supreme Court es-
tablished Daytop Lodge, later known as Daytop Village, a drug-free
therapeutic community. Unfortunately, there are no followup studies
that would document the subsequent adjustments of the residents and
probationers who entered and left treatment at that time. However,
several narcotic addicts who entered Daytop during its formative
years subsequently became leaders in the therapeutic community
movement.
PROBATION CLINICS
As abstention programs appeared to fail for the majority of the ad-
dicted parolees and probationers in the 1950s and the 1960s, other
methods of treatment had to be considered. The New York City Pro-
bation Methadone Program was established in response to a need for
methadone maintenance treatment in New York City. In 1970, addicts
who applied for methadone maintenance had to watt from 8 to 12
months before being accepted for treatment. The Probation Depart-
ment was unable to obtain adequate medical treatment for addicted
probationers from community sources and, therefore, under the direc-
tion of this writer, developed its own methadone maintenance program.
From 1970 to 1973, the New York City Office of Probation operated
five methadone maintenance clinics in Manhattan, the Bronx, Queens,
and Brooklyn (Joseph 1973). Medical institutions that cooperated with
Probation in this program were the Beth Israel Medical Center, the
Psychiatric Clinic of the Courts of New York City, the methadone
program of the Albert Einstein College of Medicine, and the New
York City Health Services Agency.
Four of the clinics were located within Probation offices. Medication
counters and examination rooms were set up and all aspects of meth-
adone treatment were carried out in the probation office: intake inter-
views, physical examinations, stabilization on methadone, ongoing
treatment, administration of urine tests, counseling, and methadone
detoxification. However, the Manhattan Beth Israel Probation Unit
was housed in a satellite hospital clinic with two psychiatrists from
the Psychiatric Clinic of the Courts of New York serving as clinic
doctors. In all clinics, probation officers functioned as counselors.
The medical institutions provided doctors, nurses, medication, physical
examinations, and addiction specialists. The latter were successful
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methadone patients who assisted the professional staff with counsel-
ing of clinic patients.
The program was open to addicted probationers over 18 years of age
with an addiction history of 2 or more years. In the 3 years of op-
eration, close to 1,000 addicted probationers were treated in five pro-
bation clinics. About 18 percent of these patients were terminated
because they failed to cooperate with program regulations, continued
drug abuse, were incarcerated following conviction or rearrest, or
requested voluntary detoxification. Patients wishing to continue
treatment after completing probation were transferred to methadone
units operated by hospitals and physicians (Joseph 1973).
Unemployment was a major problem in the Probation Methadone Pro-
gram. In November 1972, approximately 53 percent of the active
patients were unemployed, 33 percent were working, 7 percent were
in school or training, and 7 percent were homemakers. Most of the
probationers were high school dropouts with an estimated fifth-grade
reading level. They were unable to compete in a job market that
was changing from manufacturing to service and that demanded spe-
cific technical skills as well as advanced education. Referrals were
made with varying degrees of success to community agencies for job
placement. Eventually, it was necessary to obtain a governmental
grant with the Federation Employment and Guidance Service of New
York City to counsel, educate, and locate jobs for patients in the
Bronx Probation Clinic. This clinic served a particularly disadvan-
taged Hispanic and black probation population between the ages of 18
and 30. This particular program was in operation for about 4 years
but was discontinued due to cutbacks in funding.
Unemployment appeared to be related to the arrest rate. During 34
months of operation, 94 patients (10.4 percent of the first 900 admis-
sions) were rearrested while in treatment. Approximately 77 percent
of the rearrested probationers were unemployed, as compared to an
overall unemployment rate of 53 percent for the program. Of the re-
arrested group, about 23 percent had jobs.
The New York City Probation Methadone Program’s policy was to ad-
minister daily methadone doses of 80 to 100 mg. At this level, the
tolerance to methadone diminishes or eliminates the euphoric effects
of heroin, relieves the yen or physical craving to compulsively use
heroin, and protects patients from overdose reactions if large amounts
of illegal or unprescribed opiates are ingested. Also, at 80 to 100 mg
per day, patients develop tolerance to the tranquilizing, euphoric, and
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narcotizing properties of methadone. Thus, the patient is potentially
able to function in conventional society without incapacitating nar-
cotic effects. When methadone maintenance is correctly prescribed,
the medication acts as a normalizer rather than a narcotic.
In 1973, methadone treatment became available citywide without a
long waiting period for admission. The probation clinics were even-
tually phased out, and patients were transferred to methadone treat-
ment near their homes or jobs.
MANHATTAN PROBATION OFFlCE
The office of Probation in Manhattan operated two methadone clinics:
one was a satellite clinic of Beth Israel Medical Center and the
other, located in the Probation Office, was operated in conjunction
with the New York City Health Services Administration. A survey
administered by this writer to 1,414 misdemeanor probation cases
active at the Manhattan Probation Office during the first 2 weeks of
March 1973 identified current use of heroin and treatment-status
referrals. Use of heroin was verified by urine tests, the proba-
tioner’s reports, and official records. Approximately 83 percent of
the 1,414 cases surveyed were known to have had histories of heroin
abuse. The probationers, at the time of the survey, were all over
the age of 18. The majority (57 percent) were enrolled in methadone
maintenance treatment with the probation department program or with
other agencies (see table 1). However, methadone maintenance was
not the only treatment of choice: probationers were referred to ther-
apeutic communities as well as to other drug-free programs. Also, a
small percentage of probationers appeared to abstain from heroin for
unknown periods of time, without treatment. Those probationers who
were known to be using heroin were referred to treatment. In sum-
mation, 85 percent of the probationers who had known histories of
heroin abuse were either in methadone treatment, in drug-free pro-
grams, or appeared to be abstaining without treatment.
COURT DIVERSION AND PRISON PROGRAMS
Another type of program diverted addicts from the criminal justice
system to treatment programs within the community. In the early
1970s, the New York City Commissioner of Corrections, Benjamin
Malcolm, asked Dr. Vincent P. Dole of The Rockefeller University to
set up a medical unit in the New York City jails to detoxify heroin
addicts. In 1974, the Montefiore Medical Center in the Bronx as-
sumed responsibility for the Department of Correction’s detoxification
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TABLE 1. Treatment status of addicted probationers in Manhattan
Status
Probation Methadone Clinics 225 26
Other Methadone Clinics 274 31
Drug-Free Programs 126 14
Abstain No Program 124 14
Using No Program 66 7
Questionable Use 17 2
Bench Warrant Status 40 5
Jail 14 1
Total
Number Percent
886 100
program and established wards at the correctional facility on Rikers
Island. The program is still in operation and has been expanded to
include the initial stages of long-term methadone treatment. Between
1985 and 1986, there were 15,828 admissions to this opiate detoxifica-
tion program (New York State Division of Substance Abuse Services
1986).
As a result of his experiences working within the jails, Dr. Dole origi-
nated the idea of screening incarcerated addicts for treatment in the
community. Arrangements were made with the judges and community
methadone programs to enroll arrested addicts in outpatient treat-
ment. The idea proved to be so successful that the now defunct New
York City Addiction Services Agency received a grant in 1972 from
the Federal Law Enforcement Assistance Administration to develop
the first Court Referral Project.
Arrested addicts were then diverted from the court system to treat-
ment. Referrals were made to outpatient drug-free programs, thera-
peutic communities, methadone maintenance, and the commitment
facilities of the New York State Drug Abuse Control Commission.
Retention data for 12 months in treatment for the years 1973 and
1974 showed methadone programs retained between 50 percent and
60 percent of those diverted to treatment; therapeutic communities,
between 12 percent and 18 percent; and ambulatory drug-free pro-
grams, between 12 percent and 32 percent (figures 1, 2, and 3)
(Addiction Services Agency 1974). The commitment facilities dis-
charged their referrals at various points in time from lockup centers.
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Therefore, the retention rate did not reflect voluntary behavior. In
1978, the State of New York assumed financial responsibility for the
treatment of drug addicts, and the Court Referral Project was
subsequently terminated.
FIGURE 1. Methadone maintenance-clients placed in 1973 and 1974
SOURCE: 1974 Report of the Court Referral Project of the New York City Addiction
Services Agency.
In 1974, after the closing of the probation clinics, the current State
agency, now known as the Division of Substance Abuse Services
(DSAS), in conjunction with the New York City Office of Probation
and the New York State Court System, developed a referral service to
community programs for addicted probationers. This was the Multi-
Purpose Outreach Program. Units were initially set up in probation
offices in New York City. By 1978, almost 50,000 persons known to
the courts and probation were interviewed throughout New York State
and about 30,000 were referred to treatment. This program, involving
a staff of over 100 workers, was phased out because of budget
considerations in 1978. Today a small unit works in the New York
112
FIGURE 2. Therapeutic communities—clients placed in 1973 and 1974
SOURCE: 1974 Report of the Court Referral Project of the New York Cty Addiction
Services Agency.
City courts and probation offices; however, in 1986 State workers
were assigned to the New York State Parole Office in Manhattan to
interview, evaluate, and refer drug-abusing parolees to community-
treatment facilities. This program, known as ACCESS, is based on
procedures and concepts developed in the Multi-Purpose Outreach
Program and will soon be expanded.
About 10 years ago, the “Stay’N Out” program was implemented at
the Arthur Kill Correctional Facility on Staten Island under the
direction of Mr. Ron Williams. This program utilizes the model and
concepts of a therapeutic community, Phoenix House, to assist
prisoners in resolving substance abuse and personal problems that
lead to relapse and criminal activities. The program is operated by
the New York State Department of Corrections and the New York
Therapeutic Communities and is evaluated through a National Institute
on Drug Abuse grant by Narcotic and Drug Research, Inc. The “Stay’N
Out” program is hierarchical in structure—namely, the resident
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FIGURE 3. Ambulatory drug-free programs—clients placed in 1973 and
1974
SOURCE: 1974 Report of the Court Referral Project of the New York City Addiction
Services Agency.
assumes greater responsibility within the program as improvements in
outlook and behavior become evident. Techniques to foster change
include individual counseling, encounter groups, and seminars. Upon
release from prison, parolees are encouraged to seek further treat-
ment in therapeutic communities. The results show that for those
who participated in the prison program from 9 months to 1 year,
there were lower recidivism rates and a higher proportion of positive
discharges from parole when compared to the parole outcomes of
participants in other drug-free-oriented counseling methods available
in prisons (Wexler et al. 1985).
Another example of a diversion project was developed in 1986 and
1987 by Charles Laporte, Assistant Director of the New York State
Division of Substance Abuse Services and Director of the agency’s
Bureau of Chemotherapy Services. This program, known as KEEP
(Key Extended Entry Process), was implemented to facilitate the
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entry of untreated heroin addicts into long-term treatment. Patients
are recruited from three major sources: walk-in applicants from the
streets who come to methadone programs in search of treatment; the
waiting list for methadone maintenance programs; and inmates incar-
cerated at the New York Correctional Facility at Rikers Island.
Patients who enter the KEEP program are initially stabilized on
methadone and placed on a detoxification schedule of up to 180 days.
During this period, patients are evaluated for placement in an appro-
priate long-term program—methadone maintenance, therapeutic com-
munities, etc. A decision about the patient’s long-term treatment
placement is based on the results of a medical examination; the dura-
tion of the patient’s addiction; the patient’s preferences; and an
evaluation of the patient’s adjustment, behavior, and needs.
KEEP programs in the community are affiliated with methadone treat-
ment programs. Most patients enrolled in methadone treatment either
curtail or stop criminal activities and their use of needles for the
injection of illicit drugs. Therefore, it is anticipated that problems
associated with addiction—criminality and the spread of infectious
diseases such as acquired immunodeficiency syndrome (AIDS) or hepa-
titis—may be reduced or brought under some control with the imple-
mentation of this program.
Patients recruited for KEEP from the detoxification wards at Rikers
Island are voluntarily maintained on either 30 or 40 mg per day of
methadone while in jail. This phase of the program is known as Pre-
KEEP, and was initially developed by Mr. Laporte’s staff in the
different correctional facilities located on Riker’s Island. The Monte-
fiore Medical Center in the Bronx, which operates the detoxification
service for the New York City Department of Corrections, currently
administers the medical and referral aspects of the KEEP program.
Inmates are on methadone when discharged to the community and are
instructed to report to specific community KEEP methadone programs
within 24 hours. The goals, therefore, of the Rikers Island program
are to prevent inmate relapse to drug abuse upon release from the
correctional facility; to reduce criminal recidivism; to limit the spread
of infectious disease, namely AIDS; and to initiate long-term treat-
ment. These goals are accomplished by linking the methadone treat-
ment received at Rikers Island to the methadone treatment received
in the community program. Preliminary program results are encour-
aging. Notwithstanding serious problems related to unemployment and
homelessness, over 70 percent of the inmates reported to the
programs when released.
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A diversion program was developed by ADAPT (Association for Drug
Abuse Prevention and Treatment) in 1986 to serve AIDS and AIDS-
related complex (ARC) patients at Rikers Island. Originally formed in
the late 1970s to merge the varying philosophies and approaches to
drug treatment, ADAPT was reconstituted as a voluntary organization
in 1985 to educate drug abusers about AIDS and to develop programs
to meet the AIDS epidemic. The organization, under the leadership
of its president, Yolanda Serrano, a counselor in a methadone clinic,
consists of persons employed in drug-treatment programs, recovered
and recovering addicts, health-care professionals, and other interested
parties.
Within the past year, ADAPT interviewed about 100 patients on the
Rikers Island Hospital AIDS ward. Patients were helped with legal
problems, family matters, grievances concerning conditions on the
ward, and, upon their release from jail, were referred for medical
treatment and social services. ADAPT is developing models for the
delivery of services to AIDS and ARC patients with addiction his-
tories. These models can be adopted by other cities and countries.
As of this writing, an ADAPT branch in Australia is being organized
based on the experiences and programs developed by the New York
City ADAPT (Serrano, personal communication 1987).
There are controversies concerning the effectiveness of civil commit-
ment. The New York State Civil Commitment Program operated from
1987 to 1979. The program was discontinued because it was not cost
effective, there were problems concerning the civil liberties of those
committed, and there were high relapse rates in the predominantly
drug-free outpatient components of the programs. In 1989, at a
hearing before senate and assembly committees of the state legisla-
ture, former Commissioner Pierce indicated that approximately 56
percent of the 1,893 persons known to the New York State Civil
Commitment Aftercare Division for a 21-month period either
absconded or relapsed. The rest (44 percent) were being supervised
and appeared to be abstaining from drugs for Unspecified periods of
time (New York State Legislative Hearings 1969).
The California Civil Addict Program is still operating, but in a modi-
fied and reduced form, because judges have been reluctant to use
civil commitment. Furthermore, findings from studies in the 1960s
differ from the results of recent long-term followup studies. For
example, of 456 persons known to the outpatient parole division of
the California Civil Addict Program in the 1960s, 16 percent remained
in good standing for 3 years; 81 percent either absconded, relapsed,
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or were recommitted or rearrested; and 3 percent were removed from
the program either by a writ of habeas corpus or by death (Kramer
et al. 1968). These findings are in contrast to the long-term results
of civil commitment described by Anglin (this volume). lt appears
that individuals who were supervised in the aftercare parole division
of the California program, When reinterviewed between 11 and 13
years after commitment, showed reductions in daily drug use and
Criminal activity. These results were found in three groups: active
users, minimal users prior to commitment, and those maintained on
methadone. Anglin (this volume) has reported that urine testing,
while an addict was under supervision to the parole division, was a
significant factor in these outcomes. However, alcohol problems
appear to be developing within the abstinent group (Anglin, this
volume; Anglin, personal communication 1987).
THE EFFECT OF LARGE SCALE METHADONE PROGRAMS ON
CRIME AND HEALTH STATISTICS
In New York City during the years 1971 through 1973, there was an
increase in the methadone census of about 19,900 cases, bringing the
number of patients in methadone treatment to over 34,000. Within
the same period there were dramatic decreases in the number of drug
arrests (-24,900) and complaints to the police department for crimes
usually associated with addiction—burglary, robbery, and grand
larceny (-77,000) (figure 4). Similar results were evident in 1976
When methadone maintenance was introduced on a large scale in Hong
Kong. Approximately 8,000 addicts were admitted to a network of
citywide clinics. For the period 1976 through 1980, there was a
sharp decline in the number of addicts admitted to prisons in Hong
Kong for drug offenses and other crimes (figure 5). Despite differ-
ences in culture and the periods of time involved, the phenomenon of
reduction in addict-related crime was evident in Hong Kong and New
York City when large-scale methadone treatment was implemented.
Also, in New York City during the period 1971 to 1973, there was a
substantial decrease in the number of reported cases of serum
hepatitis (-1,500) (figure 6) (Dole et al. 1981).
In a 1974 to 1976 followup study of over 1,500 active and discharged
methadone patients, Dr. Dole and this writer reported that arrest
rates were dramatically reduced after entry into methadone treatment.
There was a 60 percent decrease in arrest rates for patients who
remained in treatment for less than 1 year and an 63 percent
decrease for patients who remained in treatment for over 1 year.
However, it should be noted that patients who left during the first
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FIGURE 4. Relation between increase in number of addicts treated in
methadone clinics and reduction in criminal activity in
New York City
NOTE: Data from New York City Police Department.
year of treatment had higher pretreatment arrest rates than those
who remained in treatment for longer periods (Dole et al. 1981)
(figure 7).
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FIGURE 5. Reduction in number of narcotic addicts entering prison in
Hong Kong since introduction of methadone maintenance
program.
NOTE: Data provided by Peter E.I. Lee, Commissioner for Narcotics, Hong Kong.
Analysis of stored blood samples in New York City revealed the
presence of human immunodeficiency virus (HIV) antibodies in samples
from as far back as 1978. In 1984, 163 male heterosexual methadone
maintenance patients were tested for the presence of HIV antibodies.
For the 68 patients who entered continuous treatment prior to 1977,
31 percent tested seropositive, as compared to 51 percent of the 95
seropositive patients who entered continuous treatment after January
1, 1977. However, in another study, about 10 percent of 35 patients
enrolled in methadone treatment prior to 1978 tested seropositive.
Patients with positive reactions had continued intravenous drug abuse
while in treatment. In contrast to this finding, about 58 percent of
88 intravenous drug users studied in New York City were found to be
seropositive (Novick et al. 1986; Novick, personal communication
1987). Also, a recent study of risk behaviors that can result in the
transmission of the AIDS virus by methadone patients found that both
the frequency of drug injection and the frequency of injection in
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FIGURE 6. Relation between increase in number of addicts treated in
methadone clinics and reduction in serum hepatitis
NOTE: Data on hepatitis from Health, Education, and Welfare and New York State and
City Departments of Health.
shooting galleries are significantly reduced over time (Abdul-Quader
et al. 1987). lt appears, therefore, that prompt entry into methadone
maintenance treatment may play an important role in helping to
reduce the spread of the AIDS virus. Since methadone is orally
administered, most patients will eventually curtail or eliminate use of
needles. Therefore, over time, the majority of patients in methadone
treatment should be removed from, or participate less frequently in,
the network of transmitting AIDS through the use of shared needles,
syringes, and cookers.
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FIGURE 7. Drug and other arrest rates
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DISCUSSION
Available historical studies of the 1950s, 1960s, and 1970s in New
York City show that methadone maintenance may be the most cost-
effective outpatient treatment for the majority of arrested opiate
addicts under probation and parole supervision who remain in the
community and do not enter residential facilities. These early studies
show that addicted probationers who stay in methadone treatment
have lower arrest rates and remain in treatment longer than con-
victed addicts who are supervised in special narcotics units without
chemotherapy. However, methadone maintenance should not be the
only method of treatment available, since some opiate addicts respond
to a variety of drug-free approaches, including residential treatment
as well as individual and group therapy. Ideally, a choice of
treatment methods should be available to probationers and parolees
with the provision that programs undergo evaluation and monitoring
to determine cost-effective treatment approaches.
Many patients maintained on methadone have serious cocaine and
alcohol problems. Programs that use therapeutic community, Alco-
holics Anonymous, or Narcotics Anonymous approaches and that would
also allow patients or residents to remain on methadone should be
implemented and evaluated. One such program developed in New
York City by Charles LaPorte is called Short Stay. This therapeutic
community permits methadone patients to receive their prescribed
dose of methadone while resolving behavior, alcohol, and nonopiate
chemical-dependency problems. After a period of treatment from 3 to
6 months, residents are transferred back to their methadone programs
for continued treatment.
Addicts should not be coerced into a particular type of treatment. A
general condition of probation or parole to enter drug treatment is
more suitable than a condition to enter a specific therapeutic commu-
nity or methadone maintenance program. The authority and judgment
of the physician would be compromised if a judge or parole panel
ordered methadone treatment. Thus, with a general order of proba-
tion or parole, addicts and their supervising officers have a certain
amount of flexibility and leeway. In other words, if one program
does not work for the probationer or parolee, another type of treat-
ment can be used without jeopardizing the probationer’s or parolee’s
legal standing. Rigid conditions of probation or parole specifying
treatment may further disrupt lives and exacerbate the social prob-
lems that these agencies address. Court authorities should recognize
that methadone maintenance can help reduce crime that is related to
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drug abuse, but it cannot eliminate crimes, committed by patients,
that may be related to homelessness, poverty, and unemployment.
There has been concern in some quarters about the “moral issues” of
high-dose methadone and the duration of methadone treatment. For
hard-core addicts, high-dose methadone (80 to 100 mg/day) may be
more beneficial, especially during the first few years of treatment. A
goal of the former probation clinics in New York City was to help
convicted addicts obtain education and employment and desist from
street activities related to drug abuse. Low-dose methadone was not
efficient in that context since addicts could inject heroin and expe-
rience its euphoric effect. A primary concern for persons caught up
in the spiral of addiction, crime, and incarceration was to accelerate
social rehabilitation. This could be more effectively achieved on a
daily dose of methadone in the range of 80 to 106 mg than on a low-
dose regimen. After rehabilitation is achieved, when the patient no
longer abuses drugs, stops criminal activity, and is productively
employed, the dose of methadone may either be reduced or kept at a
high level. In either case, the dose can be kept constant over an
indefinite period of time without impairing the patient’s health or
behavior.
A New York City followup study, conducted from 1974 through 1976,
found that only 8 percent of the 846 discharged patients were alive
and doing well (i.e., not in jail or rearrested, abstaining from
narcotics use and the excessive use of nonopiate drugs and alcohol).
About 34 percent of the 167 patients who left in good standing
appeared to be free of the problems associated with drug addiction
and alcoholism. Furthermore, those who were described as well after
discharge had shorter periods of addiction and longer periods of
treatment than those who experienced problems after termination
from methadone treatment. Therefore, to expect a high rate of
abstinence after 3 or more years of treatment is unrealistic for the
addicts with histories of 2 or more years of addiction. Many
methadone patients may have to be maintained for longer periods or
for the duration of their lives in order to prevent relapse to illicit
narcotics (Dole and Joseph 1978).
Methadone maintenance, if correctly implemented, can have a number
of cost-effective benefits. For addicts who enter programs, treatment
can help curtail or bring under control pathological problems associ-
ated with addiction (i.e., crime, unemployment, drug and alcohol
abuse, high death rates, AIDS, and hepatitis). Methadone main-
tenance, however, is not a panacea. It will not eliminate the problem
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of illicit opiate addiction, which is partially determined by the
availability of illicit opiates. New heroin addicts are constantly
created from the thousands of susceptible individuals found in all
societies. Also, there is a group of heroin addicts who do not enter
treatment. Therefore, the implementation of a well conceived range
of treatment programs including methadone maintenance, drug-free
programs, and combinations of approaches can be a humane, cost-
effective measure that will benefit both the addict and the larger
society.
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Some Considerations on the Clinical
Efficacy of Compulsory Treatment:
Reviewing the New York Experience
James A. Inciardi
INTRODUCTION
The philosophical basis of civil commitment and other forms of
compulsory treatment for drug abuse seems to have considerable logic.
The theory of civil commitment holds that, of the numerous types of
heroin and other substance abusers, some are motivated for treat-
ment, but most are not. Therefore, there must be some lever for
structuring treatment for those who ordinarily do not seek assistance
on a voluntary basis. This lever has often been referred to in the
literature as “rational authority” (Brill and Lieberman 1989; Melselas
and Brill 1974)—a late 1960s euphemism for not necessarily punitive
but, nevertheless, mandatory treatment.
Compulsory treatment is not a new concept, having been proposed for
the first time in the United States shortly after the passage of the
Harrison Act of 1914. As early as 1919, the Narcotics Unit of the
Treasury Department urged Congress to set up a chain of Federal
“narcotics farms” where heroin users could be incarcerated and
treated for their addiction (Brecher 1972). The first of these farms
was the U.S. Public Health Service Hospital in Lexington, KY, which
opened in 1935, with a second facility established in Fort Worth, TX
a few years later. The Lexington-Fort Worth approach was simple
and to the point. As Lexington’s director, Dr. Harris Isbell, once
commented:
Drug addicts were to be treated within the institution,
freed of their psychological dependence on drugs, their
basic immaturities and personality problems corrected by
vocational and psychiatric therapy, after which they would
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be returned to their communities to resume their lives.
(Kramer 1971, p. 666)
Dr. lsbell went on to note that this original approach had a number
of basic flaws. lt lacked (1) mechanisms for holding voluntary
patients until they had achieved some benefit from hospital treatment;
and (2) some provision for intensive supervision and aftercare. Dr.
lsbell was reacting to the growing number of reports suggesting that
the Lexington and Fort Worth programs were almost total failures.
Followup studies had indicated, for example, that between 1935 and
1984 there were 87,000 admissions to the two centers, of which
63,600 were voluntary patients and 23,400 were Federal prisoners. Of
the voluntary cases, 70 percent had left against medical advice, and
of all the patients, 90 percent had relapsed into drug use within a
few years (U.S. Comptroller General 1971; Cole 1987).
The followup studies of the Lexington-Fort Worth experience received
considerable criticism (O’Donnell 1965). Nevertheless, the general
belief that the Federal model had been an almost total failure,
combined with rumors of success with a parole-based narcotic project
in New York, influenced legislators and clinicians of the 1960s
contemplating the civil commitment approach, to take several things
into account.
(1)
(2)
(3)
(4)
(5)
(6)
The 6- to 12-month period of treatment at Lexington had been
far too short.
A mandatory minimum length of stay would be necessary even
for voluntary cases.
Intensive inpatient vocational and counseling services were
highly desirable.
A period of community aftercare was necessary.
Close supervision in the community after release might improve
success rates.
For criminal and civil commitments alike, the threat of
reinstitutionalization might enhance aftercare response.
Guided by this philosophy, as well as by fears of growing drug-
related street crime and public demands for “getting addicts off the
street,” a series of new programs based on a rational authority design
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were established during the 1960s. in 1961, California launched a
large-scale civil commitment program for narcotic addicts, which
included institutionalization for up to 7 years, without first being
convicted of a crime. At the Federal level, the Narcotic Addict
Rehabilitation Act of 1966 (NARA) provided for the compulsory
treatment of drug users charged with committing nonviolent Federal
crimes, treatment instead of sentencing for drug users convicted of
Federal crimes, and the voluntary commitment of drug users not
involved in criminal proceedings. Also in 1966, New York State
announced a civil commitment program of its own, to be operated by
the newly created Narcotic Addiction Control Commission (NACC).
Throughout the 1960s, much attention was focused on the New York
approaches to compulsory treatment. in addition to the NACC’s
statewide civil commitment program, there was also a New York City-
based parole project that received considerable recognition as an
apparent “breakthrough” in the treatment of addiction. Both
approaches represent rather unusual case studies in the history of
drug abuse treatment—the parole experiment for its alleged high
success rates and the civil commitment undertaking for its
overwhelming failure. Although each may have been unique in its
own way, much can be learned from the New York experience as it
relates to future considerations of compulsory-treatment programming.
THE NEW YORK PAROLE PROJECT
In 1956, the New York State Division of Parole announced its Special
Narcotics Project, a new approach for the community supervision of
parolees with histories of narcotics use. The plan called for “inten-
sive supervision, using the casework approach in an authoritative
setting” (Diskind 1960, p. 57). The parole officers used in the
project were reported to have been “specially selected and trained.”
in addition, their caseloads were small, thus permitting closer and
more intensive supervision. An initial followup of the first cohort of
cases found that some 45 percent had abstained from drugs while
under supervision (Diskind and Kionsky 1964a). Subsequent studies
reported even more remarkable successes (Diskind and Kionsky 1964b;
Diskind et al. 1963), suggesting to observers of the rational authority
approach that compulsory treatment might indeed be the key for
curing heroin addiction.
But there was much that was misleading in the New York parole
findings.1 First, most of the parole officers in the project were not
particularly well trained for the task. Some had been “specially
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selected” on the basis of previous experience in caseloads that had
high numbers of heroin users, while other parole officers were
relatively new recruits, with no prior involvements with parolees,
heroin users, criminal justice, treatment, or casework. Moreover, the
training was minimal, generally limited to a few lectures on social
work approaches, one or two visits to local treatment programs, and
the reading of selected journal articles on drug abuse problems.
Second, not all drug cases, at least at the outset, were assigned to
the Special Narcotics Project. Case selection was rather
discriminating, generally limited to those parolees whose records
suggested at least some chance of success.
Third, one measure of failure was rearrest for a new crime, but, as
subsequent studies have so dramatically demonstrated, arrest is a
rather poor measure of the incidence and prevalence of criminal
activity (Inciardi and Chambers 1972; inciardi 1979; lnciardi 1988). A
second measure was drug use, and, in this respect, concerted efforts
were undertaken to make the project appear better than it actually
was. Parolees who were found to be using drugs were often not
declared delinquent, and their drug use never became a matter of
record. Similarly, a number of project subjects who failed to make
their office reports to parole officers-typically because of drug use—
were also never declared delinquent.
Fourth, parolees who had reverted to drug use generally knew how to
beat the system. “Arm checks,” the periodic examination of a
parolee’s arms for needle marks, was the typical mechanism for
determining reversion to drugs. Urine tests were never used, and it
did not take parolees long to figure all of this out. Subsequent to
the first followup study, it was learned that many parolees were
injecting heroin into their groins or were snorting heroin and/or
cocaine to avoid detection. One female parolee on the project had
actually admitted to her parole officer that she had been injecting
heroin into her vagina. Yet procedures for drug detection were
never changed, and many regular users of heroin and other drugs
were reported as successes in the followup studies.
Fifth, on numerous occasions, when project parolees were found to be
using heroin and/or in possession of drugs or stolen property, their
parole officers elected not to report the fact to supervisors, in the
hope of building a more effective therapeutic relationship with
clients.
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in 1969, a parole prediction study focusing on cases in the Special
Narcotics Project targeted an additional problem (Inciardi 1971a).
Two cohorts of parolees were followed up. Adjustment was defined
as “unfavorable” if, within 1 year of release from prison, the parolee
had been returned to prison for violation of parole, had been arrested
for a new offense and not restored to parole supervision, had
absconded, had been declared criminally insane, or had died as the
result of the commission of a crime or from a drug overdose. Ail
other outcomes were defined as “favorable.” Although more than 50
percent of the parolees in each cohort were defined as having
successful parole adjustment, the study uncovered a factor that
further tainted the findings of the narcotics project studies. lt
appeared that, given the growing racial tension in New York City
during the 1960s, the predominantly white, middle-class parole staff
were making fewer supervision contacts in those minority
neighborhoods where rates of addiction and crime were high. In fact,
there were times when certain parts of New York City were
specifically designated “not to be visited.” Therefore, in many
instances, the parole officers were not particularly well informed as
to parolee behavior.
in contrast, there were two aspects of the Special Narcotics Project
that demonstrated significant clinical efficacy but were never
reported in the literature. in 1985, a special arrangement was made
between the Division of Parole and Daytop Village, a therapeutic
community located on New York City’s Staten Island. Although the
intake procedures at Daytop were rigorous and the waiting list for
admission was often lengthy, parolees would be given special
preference under four conditions. First, ail cases had to be assigned
to one parole officer, who would visit the facility three times a week
and participate in seminars and group encounters; second, that officer
had to move into Daytop for a 1-month period as a resident for the
sake of better understanding the therapeutic community process.2
Third, should a parolee admitted to Daytop split from the program
prior to the typical 18- to 26-month stay, such an action would
result in an automatic violation of parole and a return to prison.
Fourth, in the event that a parolee considered splitting from the
program, the assigned parole officer (or his backup) had to be on call
at all times. The intent was to do whatever was necessary—either
counseling or threats—to keep the parolee in treatment, even if it
meant arriving at Daytop with handcuffs and an arrest warrant and
taking the parolee into custody as he or she exited the facility.
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The Division of Parole unofficially agreed to these requirements and,
from 1965 through 1967, a total of 43 parolees were accepted into
Daytop Village. By June 1968, 16 of the 43 parolees had remained
for the duration and graduated from Daytop. Although no formal
followup of these cases was ever undertaken, other studies have
demonstrated a strong relationship between length of stay and
treatment success (Chambers and lnciardi 1975; De Leon 1984).
A second positive feature of the parole project was a rudimentary
form of multimodality programming. One of the options available to
parole officers assigned to the Special Narcotics Project was referring
relapsed cases to local programs for treatment. Yet, during the
better part of the project’s first decade, few public treatment
services were available. As a result, referrals were generally based
on one or two personal contacts established by each officer; treat-
ment was generally limited to a 21-day detoxification program, a 6-
month stay at a State hospital, or a train ticket to Lexington. By
the mid-1960s, however, treatment services had begun to expand in
New York City; therapeutic communities, outpatient detoxification,
group therapy, and methadone maintenance were added to the existing
inpatient detoxification programs. Furthermore, in 1966, 5 of the
project’s 22 parole officers volunteered for a 9-month (2 evenings per
week) training program sponsored by the New York City Addiction
Services Agency. The officers were schooled in peer-group and
reality therapy approaches as well as a number of diagnostic tools for
assessing which type of treatment might be most appropriate for any
given case. Although the clinical efficacy of this experience was
never empirically assessed, these parole officers did observe that
their parolee’s retention-in-treatment rates were better than those of
their lesser-trained colleagues.
THE NARCOTlC ADDICTION CONTROL COMMISSION
The Narcotics Control Act, passed by the New York State legislature
in 1966, served to establish the NACC—a drug treatment system that
proved to be both the largest and the most costly in history. A
focused analysis of the NACC experience seems warranted here, not
because of any clinical successes, but because it dramatically
illustrates what not to do when contemplating the structuring of civil
commitment for the treatment of drug dependence.3
Why the NACC was established in the first place is a perplexing
question. lt was a civil commitment program in which individuals
could be judicially certified to treatment for 3 to 5 years. Subjects
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eligible (or at risk) for certification included those arrested for drug-
related crimes (drug law violations as well as offenses committed for
the sake of supporting a drug habit); volunteers; and others whose
friends, family members, or relatives petitioned the courts. The
treatment process included a period of institutional commitment
followed by community aftercare. The perplexing aspect was that
previous research had not convincingly demonstrated that incarcer-
ation alone, incarceration plus treatment, or incarceration plus
intensive aftercare supervision were effective approaches to the
rehabilitation of narcotic addicts. Thus, a planned expenditure of
$200 million during the first 3 years for the treatment of 4,500
addicts and alleged addicts, was based on a rather unsubstantial
foundation. This was the NACC’s first mistake.
The NACC’s second mistake was in its selection of institutional
facilities. Many of the “rehabilitation centers,” as they were called,
had been purchased from the New York State Department of
Corrections. They were actually medium and maximum security
institutions with high walls, barbed wire, observation towers, cell
blocks, bars, and all the other visible trappings of penitentiary life.
in addition, when the facilities were purchased, civil service
regulations required that their existing custodial staff be retained.
As a result, a characteristic feature of most of the NACC’s
rehabilitation centers was former prison guards patrolling halls and
cell blocks with riot clubs tucked in their belts—a situation hardly
conducive to creating a therapeutic atmosphere.
The NACC’s third mistake was in the selection of its treatment
facility directors. Rather than seeking out individuals with demon-
strated clinical and administrative skills, the NACC filled the majority
of these positions with political or civil service appointments. The
result was a collection of parole officers with seniority and an ability
to pass civil service examinations, combined with local politicians,
community leaders, and members of the clergy. Few of these appoin-
tees had any experience rehabilitating addicts or running treatment
facilities.
The NACC’s fourth mistake was in the way it structured its aftercare
program. Although the NACC officials vigorously denied that the
supervision approach had been modeled after that of the parole
system, the NACC’s Associate Commissioner in charge of aftercare
had been the founder and the director of the parole Special Narcotics
Project. in addition, a significant number of the NACC’s aftercare
officers and supervisors had come to the new agency directly from
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the Division of Parole. As a result, the aftercare supewision model
was a carbon copy of that found in parole—but with two significant
exceptions. First, caseload size in the NACC aftercare centers was
too large to permit close supewision. Second, unlike parole officers,
the NACC’s “aftercare officers” were not armed peace officers, with
the authority to arrest a client in the community for violation of his
or her aftercare conditions. Thus, abscondence rates were
exceedingly high.
The NACC’s fifth mistake was its loss of public support through a
number of lapses and omissions. For example, by early 1970, having
spent more than $345 million, it still had published no statistics from
which a success rate might be calculated. indeed, things were not
going well with the program and data were closely guarded. An
analysis by a member of the NACC research staff compared escapes
from NACC’s facilities with those of the State’s prison system, and
abscondance rates from the NACC aftercare with those of the parole
system. The data showed NACC abscondance rates to be 12 times
higher and NACC escape rates 80 times higher (Inciardi 1971b). The
NACC’s officials were, in this writer’s opinion, less than candid in
their public statements about the program’s results. Relatively little
in the way of research findings was released by the NACC staff, and
responses to inquiries about program success tended to be formal and
selective. In 1971, the NACC’s research director testified before a
Congressional committee that a relatively small number of people had
been processed through the entire civil commitment process, and that
of those “25 percent are currently abstinent, according to physical
followup” (Chambers 1971).
in spite of these guarded efforts, the NACC encountered a wave of
bad publicity. A report by the New York City District Attorney’s
office indicated that the NACC was playing a curious role in
contributing to the overcrowded conditions in the city jails (New
York Times, February 22, 1971). Arrested addicts, the report stated,
preferred a short prison sentence to a 3- or 5-year civil commitment.
Hence, prosecutors were able to convince arrestees to plead guilty
and go to jail; if not, they would be threatened with commitment to
a State treatment center. Also, there was the report of the New
York City Health Policy Advisory Center:
The program promises to return the addict to a useful life
“through extended periods of treatment in a controlled
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environment followed by supervision in an after-care
program.” The emphasis is in “controlled.” The addict
receives about as much in rehabilitation as the criminal
prisoner with about as much result—the recidivist rate for
addicts is much higher than for criminals. Moreover, the
rehabilitation centers are run like prisons. There are
guards, most of whom receive training for prison work—
one guard for every two inmates, recalcitrant addicts are
beaten up and placed in isolation on reduced diets; inmates
are sexually abused; there is no separation of the young
from the old. The few rehabilitation programs that do
exist are staffed by instructors and therapists who have
received little or no training. For the 5,000 or so inmates
in the 14 separate institutions there are only 4
psychiatrists, 16 psychologists, and 78 teachers and
vocational instructors. The prison-like atmosphere has
caused a large percentage of the addicts to try to escape.
(New York City Health Policy Advisory Center 1970,
pp. 16-17)
The NACC officials repeatedly stated that the purposes and
approaches of New York’s civil commitment program were
“misunderstood” (Meiselas 1971; Meiseias and Briii 1974). On the
other hand, New York Governor Nelson A. Rockefeller, who had high
hopes for the NACC when he launched it in 1966, was more candid.
in 1970 he conceded failure, stating:
it is a god-damn serious situation. I cannot say we have
achieved success. We have not found answers that go to
the heart of the problem. (Moritz 1970)
By 1971, the NACC officially had been deemed a failure, and, in
subsequent months, its gradual dismantling began.
DISCUSSION
In retrospect, the New York parole experiment was little more than a
treatment initiative that had been poorly conceived, inappropriately
designed and studied, and considerably misrepresented. The political
environment within which the NACC had been created initially
resulted in a leadership that was ill-experienced and ill-equipped to
deal with the magnitude of its task, and, ultimately, in a bureaucracy
gone out of control, concerned more with its own survival than with
therapeutic efficacy. But, in light of subsequent developments and
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recent research findings, the New York experience can now be viewed
as significantly more important than just a historical anecdote In the
annals of drug abuse treatment.
Conscious of the dubious outcome of civil commitments in New York,
but, nevertheless, convinced of the need for coercing heroin and
other drug abusers into treatment, President Richard M. Nixon’s
Special Action Office for Drug Abuse Prevention developed, in 1972, a
national compulsory treatment strategy of its own. Initially funded
by the Law Enforcement Assistance Administration, the idea was to
divert drug-addicted criminal offenders out of the court system and
into appropriate community-based treatment facilities. Known as
TASC (Treatment Alternatives to Street Crime), the approach sought
to establish a multifaceted intervention strategy featuring jail
screening, comprehensive medical and clinical diagnosis, referral to
suitable treatment facilities, monitoring of patient progress, and
custodial counseling. To eliminate many of the difficulties associated
with civil commitment, TASC was structured initially as a court
diversion program. Drug-using arrestees were diverted into the array
of existing, ongoing treatment facilities in the local community. The
offender’s original criminal charge was held in abeyance until
treatment was completed. Failure to remain in treatment could result
in the offender’s arrest, a visit to court, and prosecution on the
original charge. Later TASC activities were established in parole
settings, and subsequent studies of TASC clients, as well as
commitments to the California Civil Addict Program, began to
demonstrate that compulsory treatment did indeed have its successes
(De Leon 1994; De Leon and Rosenthal 1979; McGlothiin et al. 1977).
The recent indications of success with compulsory treatment, when
contrasted with the overwhelming failure of New York’s NACC,
provides an important lesson for the future direction of mandatory
treatment initiatives—that the implementation of any new approaches
should avoid, at all costs, the creation of new, large-scale treatment
bureaucracies. Part of the NACC’s problem was an all too hastily
structured treatment and control system as a response to the hysteria
surrounding the growing epidemics of heroin use and drug-related
street crime. It was likely for this reason that the NACC’s staffing
structure became so tainted by politics and inexperience. Moreover,
by creating new treatment facilities and a comprehensive aftercare
network, the NACC had committed itself to large capitalization costs.
Finally, it was the fact that the NACC was almost exclusively a
political entity, with its awesome expenditure of tax dollars, that
contributed decisively to its failure.
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With the growing concern about AIDS and the position of the
intravenous drug user in the transmission of this disease in the
heterosexual community, it is not unlikely that many observers and
legislators might reconsider a NACC-like entity as a mechanism of
quarantining the addict for the purpose of AIDS control. But the
same mistake should not be made. The obvious alternative to the
NACC approach is the expansion of compulsory treatment in an
already existing infrastructure—such as TASC. Such an arrangement
delegates rehabilitation to established treatment structures and
management and control activities to the courts, parole, and
probation.
Should compulsory treatment expand in a TASC-like direction, then
the New York parole experiment offers some guidelines. The first is
the notion of some type of treatment contract. The apparent success
of parolees placed in Oaytop Village was, in part, the result of the
parole system’s agreement to Daytop’s requirements. In future
initiatives, perhaps there should be written contracts between client,
clinician, and criminal justice representative, which spell out each
participant’s expectations, requirements, and responsibilities.
The second issue relates to evaluation. There was much going on in
the New York Parole system that project researchers and evaluators
were either unaware of and/or chose to ignore. There were so many
uncontrolled-for variances in training, supervision approaches, parolee
behavior, parolee/parole officer interaction, case assignment, and
decisionmaking that whatever data were collected were far too
tainted to be of any value. Therefore, research endeavors to
evaluate program effectiveness must go beyond their traditional
concerns to focus also on the structure and policies of criminal
justice system components that manage clients receiving compulsory
treatment.
FOOTNOTES
1. The observations reported here are those of the author, who was
a parole officer in the Special Narcotics Project from 1962 to
1968.
2. The author of this essay was the officer assigned to Daytop
Village.
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3. From June 1968 through October 1971, the author was Associate
Director of Research for the Narcotic Addiction Control
Commission, and a number of the observations recorded here are
unreported in the literature.
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Identifying Drug-Abusing Criminals
Eric D. Wish
INTRODUCTlON
This chapter describes issues relevant to the identification of drug
abusers within the criminal justice system. In the first section, some
of the reasons why the identification of drug-abusing offenders may
be an important role for the criminal justice system are discussed.
This is followed by a review and comparison of available methods for
screening large numbers of offenders for recent drug use. The
chapter concludes with a discussion of the implications for estab-
lishing compulsory treatment programs within the criminal justice
system.
WHY IDENTlFY THE DRUG-ABUSING OFFENDER?
To Identify Active Criminals
During the past decade, substantial information collected from diverse
offender populations has converged to show that addicted offenders
are especially likely to commit both drug and nondrug crimes at high
rates (Wish and Johnson 1986). Heroin addicts in Baltimore reported
committing six times as many crimes during periods when they used
narcotics frequently as in periods of lesser use (Ball et al. 1981;
McGlothlin 1979). Violent predators, the most criminally active class
of incarcerated persons, were distinguishable by their histories of
juvenile drug abuse and adult high-cost heroin habits (Chaiken and
Chaiken 1982). Offenders’ drug abuse has been prominent in many of
the more useful criminologic scales designed to predict recidivism
(Blumstein et al. 1986). Recent studies of arrestees in Washington,
DC and New York City have found that persons who test positive by
urinalysis at arrest for one or more drugs (usually cocaine, heroin, or
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PCP) had a greater number of rearrests than did arrestees with a
negative test result (Toborg et al. 1986; Wish et al. 1986a). Perhaps
most important, treatment-induced reductions in narcotics use have
been associated with concomitant reductions in individual crime rates
(McGlothlin et al. 1977). While early research focused primarily upon
the link between heroin use and crime, a number of recent studies
have documented the growing role of cocaine in street crime (Collins
et al. 1985; Hunt et al. 1984; Johnson et al. 1985).
There are a number of reasons why drug abuse and crime are
associated. In some instances, persons are so dependent upon a drug
that they are driven to commit income-generating crimes like theft,
robbery, drug selling, and prostitution. For other persons, drug abuse
appears to be merely one of the many deviant behaviors they engage
in; while for still others, crime may be the result of a violent,
bizarre reaction to a drug. In planning effective responses for each
person, it may be necessary to understand which of the above
motives apply.
Because drug-abusing offenders account for a disproportionate share
of all crime, a policy that focuses upon identifying drug-abusing
offenders and applying appropriate interventions has promise for
producing a substantial impact on community crime and the
overburdened criminal justice system. Certainly, one would prefer to
apply limited criminal justice resources to the most active offenders.
There is growing evidence that criminal justice referral of offenders
to drug abuse treatment programs, often accompanied by urine
monitoring, can result in persons remaining in treatment longer and
in a reduction in both drug use and crime (Anglin and McGlothlin
1984; Collins and Allison 1983; Stitzer and McCaul, in press). There
is also the possibility that one might reduce jail and prison
overcrowding by referring drug-abusing detainees to treatment and/or
urine monitoring programs. In addition, because younger offenders
are less likely to inject drugs and to use heroin, identification of the
youthful offender, who is abusing such drugs as marijuana, PCP, or
cocaine, has promise for enabling society to intervene and prevent
the progression to more extensive drug use (Dembo et al. 1987; Wish
et al. 1986a).
To Identify Persons in Need of Drug Abuse Treatment and Health
Care
Drug abusers, especially persons who inject drugs, are at high risk
for health problems (Goldstein and Hunt 1984). Intravenous drug
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users are especially at high risk for contracting AIDS by sharing
dirty needles that contain blood from infected fellow addicts (Marmor
et al. 1984). Prostitutes are also likely to have serious drug abuse
and associated health problems. The probability of a urine positive
for drugs was higher for female arrestees in New York City than for
male arrestees (Wish et al. 1986a). More than 89 percent of the
prostitutes among the female arrestees studied in New York City in
1984 were positive for cocaine. These females frequently reported
instances of childhood sexual abuse and protracted histories of
emotional and health problems. Because prostitutes usually receive
fines or very short sentences (often as time served), they are usually
back on the streets of New York within hours of arrest, with no
effort made to identify and treat their drug abuse or health problems.
Given that more than one-half of the arrestees in Washington, DC
and in New York City have been found to test positive for one or
more drugs, it would seem that the criminal justice system offers an
unusual opportunity to society for identifying persons in need of
immediate health care.
To Monitor Community Drug Use Trends
As illicit drugs become available in a community, more deviant
persons can be expected to be among those who first use them. In
time, use spreads to the larger society. One might, therefore, predict
that changes in the level of illicit drug use in an offender population
would be a leading indicator of community drug use. A comparison
of urine test results for arrestees in Washington, DC with the
traditional indicator of community drug use showed this to be the
case (Wish 1982; Forst and Wish 1983). In Washington, DC, the rise
in heroin use between 1977 and 1980 showed up in the statistics from
the arrestee urine testing program 1 to 1.5 years before it appeared
in local statistics on overdose deaths, hospital emergency room
admissions, and drug abuse treatment program admissions. Results
from the arrestee urine testing program in Washington, DC and
research in New York (Wish 1986b) have also documented the rising
use of cocaine in these cities in the 1980s.
By operating a program of arrestee drug testing on a regular basis,
communities may derive a secondary bonus of being able to detect
drug epidemics earlier and being able to plan community responses.
The potential benefit of offenders’ urine testing for tracking drug
crime trends has prompted the National Institute of Justice to
establish a national Drug Use Forecasting (DUF) system based on
urine samples obtained periodically from arrestees in large cities
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(Science 1968, Wish 1987). The impact of law enforcement and other
interventions designed to reduce drug use and production can also be
measured by an ongoing drug testing program. A study, conducted in
the 1970s establishing the feasibility of urine screening in jail
facilities serendipitously uncovered the availability of propoxyphene in
the community. These results alerted law enforcement agencies to
the problem, so that action to locate the suppliers could be taken
(National Institute on Drug Abuse 1979).
HOW CAN ONE IDENTIFY THE DRUG-ABUSING OFFENDER?
For a civil commitment program to operate within the criminal justice
system, there must be a feasible means available for screening large
numbers of persons for recent drug use. The methods utilized must
be low in cost, accurate, and capable of being implemented with
minimum disruption to the already overburdened criminal justice
systems in most large cities. Four methods are used: offenders’
self-reports, criminal justice records, urinalysis tests, and
radioimmunoassay of hair (RIAH). Blood tests are excluded from
consideration because of the general difficulty presented by drawing
blood from large numbers of detainees, as well as because of the fear
of AIDS transmission. Also excluded are breathalyzer tests, because
alcohol is a licit drug and is not in itself an indicator of high-rate
criminal activity (Wish et al. 1986b). Physical and behavioral signs of
drug use as well as intoxication are also excluded, primarily because
they are already widely employed to identify the sick drug-abusing
offender who is experiencing withdrawal symptoms or strong drug
reactions, but also because they are less useful for identifying other
users. Hair analysis is also discussed, even though it is in an
experimental stage and still very expensive, because it has some
interesting potential advantages over the other techniques. A more
detailed description of these techniques can be found in Wish (1986b).
Offenders’ Self-Reports
There is a long tradition in social science research of being able to
obtain valid self-reports about deviant behaviors, including illicit drug
use. Some of the best estimates of drug use have come from studies
involving personal interviews or self-administered questionnaires
(Robins 1974; Elliott and Huizinga 1984; O’Donnell et al. 1976;
McGlothlin et al. 1977; Johnston et al. 1977). Much of what is known
about the relationship of drug abuse to crime has also come from
studies that have relied upon offenders’ self-reports. The validity of
the information obtained in these studies has usually been tested and
142
confirmed by comparing the respondent’s self-reports with information
in official records or the results of a urine specimen obtained at the
conclusion of the interview (Wish and Johnson 1986; Harrell 1985).
Even when we have interviewed active criminals in our secure,
confidential research storefront in East Harlem, we have found
considerable agreement between self-reported drug use and the urine
tests (Wish et al., unpublished manuscript: Wish et al. 1983). Among
the most important reasons why the respondents in these studies
appear willing to disclose sensitive information about themselves are
that the data are collected voluntarily, for research purposes only, in
a safe environment, and that the anonymity and confidentiality of the
information is assured.
These are conditions that do not exist when attempting to identify
drug-using offenders detained in the threatening criminal justice
system. The evidence is convincing that detainees will severely under
report their recent drug use, even in a voluntary, confidential
research interview. Table 1 compares self-reported drug use,
obtained in a research interview, with urine analyses for an arrestee
population. The Enzyme Multiplied Immune Test (EMIT) was used to
analyze the urine samples. It is clear that twice as many arrestees
were found positive for any drug by urinalysis than admitted to
recent use in a confidential, voluntary research interview in
Manhattan Central Booking. Arrestees who refused to participate in
the confidential research interview had a high likelihood of rearrest,
similar to that found for arrestees who provided a urine sample that
was positive for multiple drugs. When the pretrial release interview
information was compared with their urinalysis test results, arrestees
in Washington, DC were also found to underreport their recent use of
drugs by about one-half (Toborg et al. 1986). Similar findings were
obtained from a recent study of probationers assigned to the
intensive supervision probation program in New York City (Wish et al.
1986c). In that study, only 24 percent of the probationers admitted
to recent drug use in a confidential research interview in the
probation department office, while 68 percent tested positive by
urinalysis (table 2). Moreover, probation officers, who indicated that
they relied the most on the probationer for information about his
current drug use, also underestimated by 23 percent the prevalence of
current drug use in their cases.
If valid self-reports of recent drug use cannot be obtained in a
voluntary, confidential research interview held within the criminal
justice system, it is obvious that they cannot be obtained when the
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TABLE 1. A confidential research interview: Extent to which
arrestees underreport their recent use of drugs
(n=4,847 specimens from male arrestees in Manhattan
Central Booking in 1984)
Repotted Using Drug
24 to 48 Hours Positive by EMIT
Before Arrest at Arrest
(Percent) (Percent)
Cocaine 20 42
Opiates 14 21
Methadone 6 8
PCP 3 12
Any of the above: 28 56
2+ of the above: 11 23
TABLE 2. Estimates of recent drug use in probationers from self-
reports, urine tests, and probation officer ratings
(n=66)
Drug
Probationer
Reported Use
in 24 to 48
Hours Before
Interview
(Percent)
Probationers Rated
by Probation Officer
as Using Drug
In Past Month
(Percent)
Urine Test
at Interview
(Percent)
Marijuana 24 21 42
Cocaine 3 9 52
Heroin 3 3 2
PCP 0 0 2
Methadone 2 3 0
Any of the Above 24 23 68
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information is to be used to require a person to enter treatment or
a urine-monitoring program.
In spite of these limitations, there are important reasons for using
self-reports to identify drug abusers detained by the criminal justice
system. Although self-reports would detect only a small portion of
drug users, persons who do admit to drug use are a bona fide group
for further action. A study of juvenile detainees (Dembo et al. 1986)
found that youths who tested negative for marijuana but admitted to
recent marijuana use had detention records that were more similar to
persons who tested positive than to youths who were negative by test
and self-report. The authors conclude that it would be beneficial to
target for further assessment youths who were positive by urine test
or who reported recent drug use.
Furthermore, in our study of New York City arrestees, our research
found that self-reports of current drug dependence or of a need for
treatment were valuable in differentiating which of the persons who
tested positive were more seriously involved with drugs and crime.
Table 3 shows that, among all arrestees who tested positive, those
who admitted to drug or alcohol dependence at arrest or to a need
for treatment were much more likely to report recent drug use,
injection of cocaine, and prior treatment. The dependent persons
also had more extensive criminal records than did nondependent
persons.
Thus, while many drug abusers will conceal their drug problems, those
who do report serious drug problems while in the criminal justice
system may be a valid group for further assessment and diversion to
treatment. Jurisdictions wishing to implement some immediate, low-
cost action to identify drug abusers could assign persons to interview
detainees and to refer them to treatment programs. Although many
drug abusers would go undetected, the number of persons identified
would probably be what most cities could handle, given the usually
overburdened and limited treatment resources.
In summary, self-report information can be very valuable for
obtaining indepth details about drug abuse, if the offender is willing
to disclose the information. It is a poor method to use as the
primary tool for screening detained drug users. The most promising
use of offender self-reports for the criminal justice setting is
probably to combine them with other evidence of drug use to
motivate the offender to discuss his behavior.
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TABLE 3. Drug use and criminal history in male arrestees who tested
positive for drugs (New York City, 1983) by self-reported
dependence or need for treatment
Not Dependent
(n=1,651)
(Percent)
Dependent*
(n=926)
(Percent)
Drug Use (From Self-Reports)
Reported Using
24 to 48 Hours Prior to Arrest
Cocaine
Heroin
Marijuana
Downers
Illicit Methadone
PCP
Injects Cocaine
Ever received drug
treatment:
Criminal History (from records)
Ever Arrested Before
Two or More Prior
Misdemeanor Convictions
Two or More Prior
Felony Convictions
Had a Prior Arrest for
a Drug-Related Offense
15 61
6 53
34 36
2 12
1 8
3 6
9 61
11 60
76
32 60
10
33
91
14
59
*Male arrestees who tested positive for one or more drugs (opiates, cocaine, PCP. or
methadone) and who reported current dependence on drugs or alcohol or a need for
treatment.
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Criminal Justice Records
The criminal justice system maintains extensive information files on
offenders. In view of the preceding discussion, and the fact that
much of the information in these records is obtained from the
offender, it is not surprising to find that information about the
offender’s involvement with drugs is often minimal and unreliable
(Goldstein 1986).
Even when an arrest report has a place to enter information about
the arrestee’s drug use, it typically is not completed. This is
probably because the police officer is often unaware of the arrestee’s
involvement with drugs and because information not of immediate
relevance to an officer tends not to be reliably entered into a data
system. Even in Washington, DC where the U.S. Attorney has
installed the prosecutor’s management information system (PROMIS)
to track case information, the arresting officers identified only 22
percent of those who were found positive for drugs at arrest by
urinalysis (Wish et al. 1981). Presentence investigation reports should
contain more information about the offender’s background. However,
in the absence of urine tests, the investigator must rely upon the
defendant’s admission of drug use or information from a family
member. In large cities, the time and resources available for
soliciting such information is limited.
If records do not contain detailed information about drug involve-
ment, can a person’s arrest record of drug offense convictions serve
as an accurate indicator of drug use? The evidence indicates that
persons charged with the sale or possession of controlled substances
are most likely to be drug users (table 4).
Almost three-quarters of male arrestees in New York City (and of
arrestees in Washington, DC) charged with these offenses in 1984
tested positive for opiates, cocaine, methadone, or PCP. However,
more than half of the persons charged with robbery, burglary,
larceny, or murder were also positive for drugs (Wish et al. 1986a).
Fifty-six percent of these arrestees were positive for a drug, while
only 20 percent of the sample were charged with a drug offense.
Only 10 percent of the 17,000 male and female arrestees who were
drug positive by urinalysis in Washington, DC in 1973 and 1974 were
charged with a drug offense (Wish et al. 1981). Thus, while
offenders with a history of drug offenses are most likely to be using
drugs, it is clear that offenders charged with a variety of other
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TABLE 4. Charges most associated with a positive urine test,
male arrestees in New York in 1984
Arrest Charge Number
Percent
Positive*
Possession of Drugs
Sale of Drugs
Possession of Stolen
Property
Forgery
Burglary
Murder/Manslaughter
Larceny
Robbery
Weapons
Stolen Credit Cards
Criminal Mischief
Gambling
Sexual Assault
Public Disorder
Assault
Fare Beating
Fraud
Other Offenses 269 45
Total 4,833 56
615 76
355 71
474 61
94 60
348 59
64 56
667 56
676 54
157 53
56 52
66 48
147 45
79 41
108 37
506 37
98 37
54 30
*Positive by EMIT for opiates, cocaine, PCP, or methadone.
offenses may be drug users. By relying solely upon a drug offense to
identify the drug user, the majority of users are missed.
Urinalysis Tests
In recent years, urinalysis tests have received considerable attention
as a source of information about an offender’s drug use (Wish 1982;
Forst and Wish 1983). It should be noted, however, that researchers
have used urinalysis for the past 15 years to validate information
obtained in interviews about recent drug use, and drug abuse
treatment programs have often monitored patients’ drug use by
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urinalysis (McGlothlin et al. 1977). Urine tests were employed
successfully by the Department of Defense to screen army personnel
before they left Vietnam for the United States in the 1970s, and have
been used in recent years to combat a growing drug use problem.
Furthermore, in the initial years of the federally sponsored Treatment
Alternatives to Street Crimes (TASC) program, urinalysis was used to
identify drug-using offenders for diversion into treatment programs.
Urine tests have been used by the U.S. Department of Probation and
by local probation departments to screen suspected drug users. Mass
screening of offender populations for drugs has been used only in
Washington, DC, however, where all arrestees detained in the
Superior Court lockup prior to court appearance have been tested
since 1971.
There are a number of possible urinalysis techniques, and a common
error made by persons assessing the validity of drug testing is their
failure to consider the type of test used. Until recently, most urine
testing of offenders in the criminal justice system and in treatment
programs was conducted using a Thin Layer Chromatography (TLC)
general screen. This technique is especially economical because it
can screen for a variety of drugs, but it is an extremely subjective
process requiring experienced technicians to interpret the results.
Primarily because of their low cost, sensitivity, and ease of use, the
most commonly used urine test today is the EMIT. The EMIT
involves a chemical reaction of the specimen with an antibody
designed to react to a specific drug. The chemical reaction causes a
change in the specimen’s transmission of light. This change in
transmissibility is detected by a machine that provides a quantitative
reading that is compared with the reading from a standard solution
containing a known concentration of the drug. If the reading from
the specimen is higher than that of the standard, the specimen is
positive for that drug. Because the determination of a positive is
based on specific numbers, the level of subjectivity involved in the
EMIT is less than that for TLC. TLC appears to be more economical
because, for approximately $2, as many as 20 different types of drugs
can be tested. EMITS are specific to one drug and cost between $1
and $5 for each drug tested. (These are high volume, reduced rates
charged to researchers by the New York State Division of Substance
Abuse Testing Laboratory.)
Table 5 presents a comparison of the results from 4,647 specimens
obtained from arrestees in New York City and tested by TLC and the
EMIT technique by the New York State Testing Laboratory.
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TABLE 5. Drugs detected in urine specimens from male arrestees by
type of test (n=4,847 specimens from arrestees in New
York City in 1984)
Drug Detected TLC (Percent) EMIT (Percent)
Cocaine 14 42
Opiates (Morphine) 9 21
PCP NA 12
Methadone 4 8
Table 5 makes clear that the TLC test underdetects the common
street drugs by almost two-thirds. Many laboratories have used a
two-test approach to identifying drugs. These labs first screen for
drugs using TLC and then confirm any positive result by an EMIT.
Such procedures would clearly result in many drug users escaping
detection. As a result of the above findings, EMITS are being
substituted for TLC tests across the country.
The growing popularity of the EMIT has brought several legal
challenges. The primary criticism is that the EMIT has too high a
rate of false positive errors. That is, the test falsely indicates the
presence of a drug. Much of the debate surrounds the possibility
that some common licit drugs can cross-react with the test’s reagents
to produce a positive result (Morgan 1984). The ingestion of poppy
seed bagels has produced a positive test result for opiates.
Furthermore, the EMIT for opiates will detect heroin (morphine) as
well as prescribed drugs such as codeine. Sloppy recording
procedures by laboratory staff and failure to maintain the chain-of-
custody for the specimen can also produce serious test errors.
There are other urinalysis techniques available for detecting drugs,
including radioimmunoassay and gas chromatography/mass spectrometry
(GC/MS) (Hawks and Chiang 1986). Some of these techniques have
not been used frequently in the criminal justice system, and sufficient
case law does not exist regarding whether the courts consider them
to be valid. GC/MS is too costly and time consuming to be used as
the initial test in large-scale screening programs, although it has
been required by some courts as a confirmation test.
A study by the Center for Disease Control (CDC) has been cited for
revealing substantial errors in the results from the 13 labs surveyed
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(Hansen et al. 1985). In a blind experiment, CDC sent a group of
blank urine specimens as well as specimens containing known
quantities of drugs to the labs for analysis (the specific urinalysis
tests used by the labs were not specified). The study found that
while some labs failed to detect specific drugs contained in the
specimens, few instances occurred where a lab reported a drug in one
of the blank specimens. In fact, the average accuracy of the
analyses of the blank specimens was 99 percent; there were so few
false positive results that the analyses of this issue were limited.
There were too few false positive results to permit analysis of their
occurrence.
The experience of this writer in using urine tests in offender
populations also indicates that the problem of false negatives is much
larger than that of false positive errors. In contrast to controlled
laboratory experiments, tests for illicit drugs in offenders cannot
control for many of the factors that influence the drug concentration
in the urine. The quantity of the drug taken, its purity, and its time
since ingestion are unknown. It is, therefore, somewhat amazing
when a test does detect a drug. Studies by this writer show that
even when a person admits to taking a drug 1 or 2 days before the
test, it is found in only 70 to 80 percent of the cases. Many drug
users will, thus, escape detection by urinalysis.
It is probable that the future of urine testing in the criminal justice
system will depend on a satisfactory solution of the problem of false
positive errors. Preliminary NIDA guidelines for testing state that all
positive test results from immunoassay tests should be confirmed by
GC/MS. GC/MS is the most accurate technique currently available
for identifying drugs in the urine, but it costs about $70 to $100 per
specimen. It seems appropriate to require such a procedure when a
single test result may cause a person to lose their job or liberty.
However, when a test result is used solely to trigger further
investigation of whether a person is involved with drugs, it may be
that confirmation by other methods (urine monitoring or diagnostic
interview) would be equally acceptable. The courts have yet to
decide this issue.
Even though urine tests do contain some degree of error, the
evidence is strong that the tests have a high degree of validity. The
EMITS have been ruled valid by judges, although courts have differed
on the need for confirmation of positive results (Wish 1986).
Furthermore, the construct validity of urine tests, the evidence that
the relationships found with the tests are consistent with the current
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knowledge about drug use, is impressive. Studies of arrestees and
probationers in New York City and Washington, DC have found
hypothesized relationships between detected drug use and age, prior
arrest history, type of arrest charge, and recidivism (Wish and
Johnson 1986; Wish et al. 1986a; Toborg et al. 1966). A positive test
for marijuana was related to greater lifetime use of marijuana and a
greater number of juvenile detentions in Tampa, FL (Dembo et al.
1986). In fact, this writer first discovered the lesser sensitivity of
the TLC test because the analyses of specimens from unapprehended
offenders interviewed in a research storefront in East Harlem did not
confirm the heavy drug use that these persons were reporting. Only
after the EMITS were used was the claimed drug use verified by the
urine tests (Wish et al. 1983). Perhaps of primary significance is
the finding from studies in Washington, DC and New York City that
not only the presence of a drug, but also the number of drugs
detected was related to criminal behavior. For all age groups,
arrestees positive for two or more drugs (usually cocaine and opiates)
had the greatest number of rearrests (figure 1). Furthermore, 60
percent of the rearrests for multiple drug users were for offenses
other than the sale or possession of drugs.
The proportion of offenders who are found positive and are seriously
involved with drugs is unknown. For this reason, a positive urine
test should be used with other information (self-reports, criminal
justice records, or repeated urine testings) to determine if the
offender chronically abuses drugs and is in need of treatment.
RIAH
RIAH is an experimental procedure with potential for drug detection.
As hair is formed in the scalp, the cells are nourished by the blood,
and drugs present in the blood are deposited in the cells at the root
level. One can extract the drugs from the hair for analysis by
radioimmunoassay. Researchers have found that the level of the druG
taken is correlated with the amount deposited in the hair cells.
Perhaps of most importance is that a historical record of a person’s
drug use level can be obtained. While hair at the scalp level
contains evidence of current use, hair further from the root contains
evidence of use months before the root was formed. Thus, by
analyzing sections of hair, especially in persons with long hair, a
trend in drug use over time can be obtained (Thanepohn 1986;
Witherspoon and Trapani 1983), and procedures are available for
detecting the most commonly abused drugs.
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FIGURE 1. Mean number of rearrests by urine test and age,
Washington, DC and New York City, 1984 (n=4,847 male
arrestees in New York City in 1984)
NOTE: Rearrests are measured in an 11- to 17-month period after the index arrest.
These findings do not control for time-at-risk on the street. Differences
would be expected to be more extreme, however, because drug users were
somewhat more likely to be remanded after arraignment than were nonusers.
SOURCE: Wish et al. 1986a.
One possible advantage of RIAH is that the test cannot be easily
falsified. For example, an individual cannot suspend use before a
scheduled test to avoid detection. Once the drug is stored in the
hair, it remains there permanently. The technique of obtaining hair
is noninvasive and less objectionable to some persons than that of
obtaining urine. The analysis can provide evidence of the level and
trend of use over time. In addition, if the test is inconclusive or a
retest is required, a similar sample for analysis can be easily
obtained. The largest drawbacks to the test include the fact that it
requires radioactive materials and the types of precautions usually
needed in handling such substances, the cost (roughly $50 per drug
tested), the turnaround time of approximately 24 hours, and the
unavailability of standardized and accepted extraction techniques. In
addition, there is some possibility that hair content can be influenced
by environmental contaminants (Puschel et al. 1983).
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Even if current research confirms the utility of RIAH, the long
turnaround time for the analysis and the cost may prohibit the
adoption of the method for large-scale screening of offenders. In
addition, it will take considerable time for the courts and the
scientific community to acknowledge the validity of the new
technique. If the technique is eventually accepted and the analysis
time remains long, it will most likely be less useful than other
techniques for testing pretrial arrestees, where the judge typically
requires the results quickly at the time of arraignment. Perhaps the
most valuable use for RIAH with offenders will be for the
confirmation of other test results and for the verification of changes
in the person’s use.
Summary
In a criminal justice setting, urine testing is the most feasible and
accurate method now available for screening large numbers of drug-
using offenders. Self-report and record information can be
effectively used to verify and extend information about the
seriousness of use for those who test positive. The newer RIAH
methods offer promise for delineating patterns of drug use over time
if the method is valid, can be standardized, and gains acceptance
from the scientific and judicial communities.
CONCLUSIONS AND IMPLlCATlONS FOR COMPULSORY
TREATMENT
For the purpose of this chapter, compulsory treatment is defined as
the involuntary or voluntary ordering of persons from the criminal
justice system into some form of drug abuse treatment and/or urine
monitoring. The following conclusions may be drawn from the
research as presented here.
Fewer than one-half of the adults detained or supervised by the
criminal justice system will voluntarily admit to recent use of
illicit drugs.
Those persons who do report current drug abuse problems or
dependence tend to have serious problems and are a valid group
for treatment consideration.
Urinalysis can be an effective tool for screening large numbers of
offenders for recent drug use. However, the tests only indicate
probable use and must be followed by confirmation of the amount
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of drug involvement. Confirmation can be achieved through
repeated testing over time, confrontation and interview with the
persons, and information obtained from records or reports from
persons who know the detainee.
This discussion has intentionally been limited to the methods available
for identifying drug abusers within the criminal justice system.
Other papers in this volume describe the efficacy of various types of
treatment for persons who have been referred from the criminal
justice system. lt is important to note, however, that, because little
systematic screening for drug abusers has occurred in the criminal
justice system, most research has examined treatment process and
outcome for the select group of offenders who were referred from
the courts. Little is known, outside of the research from the pretrial
testing program in Washington, DC (Carver 1986), about the level of
effectiveness of such interventions for a larger, more diverse group
of treatment referrals that would result from a wide-scale urine
screening program. Additional research on matching criminal justice
referral clients to appropriate, effective interventions will be
necessary in order to make compulsory treatment a viable option for
the criminal justice system.
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Legal Pressure in Therapeutic
Communities
George De Leon
INTRODUCTION
Compulsory treatment as a legal mechanism for changing the behav-
iors of antisocial substance abusers is not new to therapeutic com-
munities (TCS). In the years 1965 through 1975, numbers of drug
abusers were court mandated to TCs as an alternative to Federal and
State treatment programs operated under civil commitment legislation.
After 1975, the civil commitment programs were largely replaced by
community-based treatment centers that have included TCs; accord-
ingly, civil commitment procedures were replaced by the less uniform
set of activities termed “legal referral.” Thus, our understanding of
compulsory treatment in TCs is mainly drawn from research and clin-
ical experience with legal referrals, rather than with civil commitment
per se.
The present chapter reviews what is known about compulsory treat-
ment in drug-free TCs. The initial section summarizes research on
posttreatment outcomes and retention in treatment for legally re-
ferred clients. The concluding sections discuss policy issues and
implications for research. The treatment research literature surveyed
is not exhaustive. It is primarily restricted to program-based studies
in TCs of acceptable design, which include variables termed “legal re-
ferral,” "legal status,” “criminal justice referral,” and “nonvoluntary
referral.” These different labels constitute a problem in assessing
outcome research, since they describe a variety of activities and pro-
cedures that are not necessarily similar across the studies.
There are approximately 500 drug-free residential treatment settings
in the United States, of which less than one-third label themselves as
160
traditional TCs. The latter have been characterized in other writings
(De Leon 1986a).
LEGAL REFERRAL TO THERAPEUTIC COMMUNITIES
TCs have always served clients referred from the criminal justice
system. Indeed, there are notable pioneering demonstration programs
in which TC models have been introduced directly into the correc-
tional system (Tech 1980). Contemporary variations on the TC within
the correctional system are described in the literature (Wexler 1986).
What is known about compulsory treatment for TC clients has been
learned mainly from those residential treatment programs that are
community based and are outside the correctional system.
Legal referrals constitute less than one-third of all admissions to
drug-free residential modalities documented in the Client Oriented
Data Acquisition Process (CODAP) (National Institute on Drug Abuse
1980). Most of these programs, however, are not representative of
the traditional long-term TC. Among the latter, legal referrals
approximate 30 percent (De Leon 1960). Although there are wide
program differences, some TCs serve criminal justice clients almost
exclusively.
Legal referral rates to TCs have varied across the years. For
example, more than 40 percent of admissions to Phoenix House in
1970 were legally referred, compared to less than 20 percent in 1985.
Other TCs have informally reported a similar decreasing trend in
legal referral.
Although not fully understood, trends in legal referral to TCs gener-
ally relate to at least two broad issues. First, there has been a
significant change in drug use patterns. Admissions to TCs now in-
clude significantly fewer opiate users and increasing numbers of non-
opiate abusers. This change in admissions to TCs may reflect an
actual decrease in the number of new heroin abusers, or it may indi-
cate a shift to other treatment modalities. Generally, the pervasive
use of drugs at all levels of society has resulted in more users who
are minors or who have noncriminal backgrounds. As a result, there
has been less need for TC programs to recruit clients from the crimi-
nal justice system.
Second, policy issues may affect referral rates. For example, criminal
justice enforcement policy on drug-related crimes has varied over
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time. Implementation of street arrest and sentencing practices shifts
in relation to a variety of social, economic, and political forces.
A subtle policy issue concerns the relationship between the criminal
justice and drug treatment systems. The criminal justice system has
remained either uninformed or unpersuaded about the positive role of
rehabilitation for the drug-abusing criminal offender. This view may
have influenced referral rates to community-based treatment after the
phasing out of civil commitment programs. Nevertheless, current
social pressures, crowded courtrooms and jails, and the threat of
AIDS spreading through the intravenous-drug-using population have
rekindled interest in treatment as an alternative to incarceration for
drug abusers.
THERAPEUTIC COMMUNITY OUTCOMES
The literature on the effectiveness of TCs has been reviewed in other
writings (De Leon 1965; De Leon and Rosenthal 1979). Some outcome
studies have been executed by investigative teams engaged in large-
scale multimodality comparisons that include TCs, e.g., the Drug
Abuse Reporting Program (DARP) and the Treatment Outcome Pro-
spective Study (TOPS). Others have been conducted on, and by, indi-
vidual TCs. Although cited here when relevant, the findings for the
multimodality studies are reported elsewhere in this volume. This
section summarizes the main findings of program-based studies.
All studies reveal that immediate and long-term outcomes for clients
are significantly improved over their pretreatment status. Drug use
and criminality decline, while measures of prosocial behavior, e.g.,
employment and/or school involvement, increase (e.g., Barr and Antes
1981; Brook and Whitehead 1980; De Leon 1984; De Leon et al. 1972;
De Leon et al. 1979; Pompi et al., unpublished manuscript; Wilson and
Mandelbrote 1978).
A few studies have utilized a composite index of successful outcome
combining measures of criminal activity, drug use, and employment.
In these studies, maximally or moderately favorable outcomes occurred
for approximately half the clients (De Leon 1984).
Studies that examine differences between clients who complete treat-
ment, i.e., graduates, and those who drop out indicate that graduates
are significantly better than dropouts on all measures of outcome.
Among dropouts, however, there is a positive relationship between
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outcome and length of stay in treatment (e.g., Barr and Antes 1981;
De Leon 1964; Holland 1983).
Research has yet to delineate a client profile that predicts successful
outcome. Several background correlates of positive outcomes on drug
use, criminality, or employment have been identified, e.g., lower
lifetime criminality, lower pretreatment baseline levels of drug use or
crime, and higher employment. Though significant, these associations
are small when compared with the effects of time in program.
Outcomes for Legal Referrals
Most TC followup studies report either small or no differences in
posttreatment improvement by legal referral, depending upon the
outcome measures employed (Barr and Antes 1981; Holland 1983;
Pompi et al., unpublished manuscript; De Leon 1984). For example,
followup status based upon agency records indicates that total arrest
rates are higher for legally referred clients, but the posttreatment
reduction in arrest rates for legally referred clients is equivalent to
that of voluntary clients (figure 1).
Using a composite measure of self-reported outcome status, the
Phoenix House studies reveal that “best success rates” (no crime and
no drug use) are somewhat higher for voluntary clients. Regression
analyses of the same data confirm that voluntary entry on admission
is a statistically significant correlate of posttreatment outcome
(De Leon 1964). The magnitude of the prediction is quite small;
controlling for criminal background eliminates the significance of the
legal referral variable.
The multimodality DARP and TOPS studies also find that legal
referral is not a statistically strong predictor of posttreatment
outcomes in TCs or other modalities (Hubbard et al., this volume;
Simpson and Friend, this volume). A similar relationship between
outcome and time in program for both voluntary and nonvoluntary
clients is also obtained from studies of European TCs (Wilson and
Mandelbrote 1976; Zimmer-Hoefler and Meyer-Fehr 1966).
Adolescent Legal Referrals
Among admissions to drug-free treatment, younger clients are more
likely to be legally referred than adults. For example, nearly half of
all male adolescent admissions to residential and outpatient programs
in the TOPS survey were legally referred (Hubbard et al. 1984). At
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FIGURE 1. Arrest fate for dropouts year by year, by legal status at
entry (age at entry 19 and older)
SOURCE: De Leon et al. 1979, Copyright 1979, Marcel Dekker, Inc.
Phoenix House, approximately 40 percent of the adolescent admissions
are legally referred, compared with less than 20 percent of adult cli-
ents. Indeed, there are TCs that serve legally referred adolescents
almost exclusively, e.g., Abraxas in Pennsylvania.
Findings are unclear for posttreatment outcomes of legally referred
adolescent substance abusers. For example, outcomes in DARP and
TOPS drug-free residential modalities do not differ by age; however,
analyses involving the interaction of age and legal referral are not
reported in those investigations. In Pennsylvania, a traditional TC
study of adolescents reported outcomes only for client status at
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discharge (Rush 1979). Results indicate that legal referral is not a
significant predictor of discharge outcomes in TCs or in outpatient
settings for adolescents.
Table 1 shows the main findings of a Phoenix House investigation of
age, legal status, and outcome assessed with a composite measure of
success (De Leon 1986b). Adolescent best success rates are similar to
those of adults, although more unfavorable outcomes were obtained
among clients under 19 years of age who had a legal status. Never-
theless, the evidence suggests that the TC exerts a considerable
effect on this more antisocial group of adolescents.
Retention and Legal Referral
Considerable research demonstrates a direct relationship between
retention and posttreatment outcome. For example, multivariate
studies identify time in treatment as the most consistent predictor of
positive outcome, even when the contribution of other client-related
variables is removed (Simpson and Sells 1982; De Leon 1984; Holland
1983; Barr and Antes 1981).
Because of its obvious importance, retention has increasingly been a
focus of investigation in TCs (De Leon 1985). A key conclusion from
this research is that client factors in general are not strong predic-
tors of retention. However, legally referred admissions remain signif-
icantly longer in TCs than do voluntary admissions. Similar retention
findings are reported in other data systems involving TCs and other
treatment modalities (Condelli 1986; Sheffet et al. 1980; Simpson and
Friend, this volume; Hubbard et al., this volume: Anglin, this volume).
TC research indicates that the relationship between legal referral and
retention is complex. In particular, figure 2 shows that, among legal
referrals to a national consortium of TCs (Therapeutic Communities of
America (TCA)), Qmonth retention decreases with age compared with
voluntary admissions, for whom retention increases with age (De Leon
1980), suggesting an age/legal referral/retention interaction.
This finding is further supported in large-scale comparisons of reten-
tion in TCs (Pompi and Resnick 1987). Figure 3 presents curves for
10 TCs displaying the characteristic temporal pattern of retention
described in the literature (De Leon and Schwartz 1984). Dropout is
maximal in the first 30 days of treatment and declines steadily there-
after. Although the shapes of the curves are similar, the level
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TABLE 1. Success at 2 years’ followup: Age and legal status
(males)
KEY: Success 4=most favorable (no crime and no drug use): 3=favorable (drug use, but
no crime); 2-unfavorable (crime, but no drug use); and 1=least favorable (crime
and drug use).
NOTE: Percents may not add to 100.0 due to rounding. Positive change from pre-
treatment distribution of success index is statistically significant. The actual
proportion of Individuals who changed is more clarly shown when absolute
success status is ignored. Almost 84 percent of the sample had the lowest
success Index (1) for the year prior to treatment. Positive change over pre-
treatment levels occurred in almost 60 percent of the sample and was signifi-
cant by age and legal status with the exception of the youngest legally
referred clients. They showed the smallest reduction in change for clients
with the lowest category.
of retention is markedly elevated, particularly in the first 30 days,
for one program, in which 90 percent of the admissions are adoles-
cent legal referrals. In the other TC programs, legal referrals
constitute considerably smaller proportions of all admissions.
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FIGURE 2. Retention of court-referred adolescents
NOTE: Retention cures for Abraxas (1979 to 1983 admissions); Gateway Foundation
(February 1981 to June 1983 admissions); Phoenix House (January to April 1981
admissions); and seven members of a TCA consortium (February 1 to
August 15.1979, admissions).
SOURCE: Pompi and Resnick 1987, Copyright 1987, Marcel Dekker, Inc.
The effects of legal referral on short-term retention appear more
evident in younger clients. However, results from recent Phoenix
House analyses indicate that longer retentions (1 year or more) and
program completion rates (graduation) are significantly correlated
with clients more than 27 years of age, legally referred to treatment
(De Leon, in preparation). Thus, although legal referral is clearly
associated with increased retention, age-related factors still need
clarification.
SUMMARY OF MAIN FINDINGS
Outcomes
There is little evidence for differential outcomes between legally
referred and nonlegally referred clients. Significant posttreatment
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FIGURE 3. Legal status (CODAP definition), age, and 9-month
retention for all admissions (February to August 1979)
to a consortium of seven member programs of TCA
SOURCE: De Leon 1980.
improvements in criminality, drug use, and employment occur for both
groups and are directly related to time spent in treatment. Some
regression studies report that legal status is a significant but small
predictor of higher posttreatment criminality. However, this mainly
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reflects the importance of criminal background, which is correlated
both with legal referral and posttreatment criminality.
Retention
Time in program is the largest and most consistent predictor of
treatment outcomes; legal referral relates significantly to retention in
treatment. In general, clients referred by the criminal justice system
to TCs (as well as to other modalities) remain longer in treatment
than do voluntary clients. Relatively more adolescents are legally
referred to drug-free treatments, particularly to TCs. However, the
relationship between age, legal referral, and retention needs to be
clarified.
On the whole, the main findings suggest a complex relationship
between legal referral and treatment outcomes. Posttreatment status
does not relate directly to legal referral. Nonetheless, retention in
treatment is the best predictor of outcome, and legal referral is a
consistent predictor of retention. Thus, there is an indirect
relationship between legal referral and outcome that appears to be
mediated through retention in treatment. Research has shown that
the more criminally involved client has a less favorable posttreatment
outcome. The retention-enhancing effect of legal referral offsets the
higher probability of negative outcomes among a number of the
criminally involved clients, which may explain the similar outcomes
for voluntary and legally referred TC admissions.
Legal Pressure
Several interrelated issues from research and clinical experience in
TCs have confounded interpretation of the research findings on legal
referral and, broadly, the efficacy of compulsory treatment. There
are relevant distinctions among the terms “legal referral,” “legal
status,” and “legal pressure.” The failure to make these distinctions
has been an important source of variance in assessing treatment
effectiveness for the criminal justice client.
Legal referral is an explicit procedure. lt may be one of a variety of
criminal justice procedures, e.g., parole, probation, court diversion, or
sentencing stipulations, that essentially direct drug abusers to a
treatment alternative.
Legal status denotes any form of legal involvement, e.g., warrants
pending, case pending, arrested, in jail, awaiting trial or sentencing,
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on bail, and may include the conditions of legal referral. Actually,
undetermined numbers of TC admissions are legally involved, i.e.,
enter treatment with a legal status, but are not legally referred.
Although the two terms are used interchangeably, they imply
different influences on treatment entry.
A further distinction concerns the term “legal pressure.” lt is
commonly assumed that legal referral, an action, is equivalent to legal
pressure, a presumed effect. However, legal referral procedures do
not assure the existence of the pressure, which is presumed to be the
effective element in a compulsory process. Perceived legal pressure,
or how individuals experience legal referral, is important. Those who
are legally referred may not experience any discomfort over the
consequences of noncompliance during treatment (leaving treatment,
the certainty of reincarceration, or even being in jail). Indeed, some
legally referred clients prefer jail to TC treatment.
The candidates most suitable for legal referral to drug treatment have
not yet been identified through research or clinical experience. In
part, this reflects the fact that the currently used dichotomy of
legally referred vs. nonlegally referred is too crude a classification to
capture the spectrum of addict differences, particularly with respect
to perceived legal pressure. Some voluntary clients may have histo-
ries of legal involvement and may experience legal pressure indirectly.
Conversely, as noted earlier, significant numbers of legally referred
drug abusers may not actually perceive or experience legal pressure
for compliance or change. Failure to distinguish among these sub-
groups of voluntary and nonvoluntary clients has introduced un-
measured error associated with the legal referral or legal status
variables commonly used in research.
lt is not within the purview of the present paper to detail a new
system for classifying legally referred or legally involved drug
abusers. Based upon the two factors of legal referral and perceived
pressure, at least four subgroups of clients could be specified: legal
referrals with and without actual perceived pressure; and legally
involved voluntary referrals with and without actual perceived pres-
sure. lf a third factor, such as motivation (intrinsic pressure), is
introduced, the number of subgroups multiplies accordingly. Clari-
fication of these subgroup differences is important in research on
compulsory treatment.
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Implementation Effects
The efficacy of legal referral procedures in yielding positive treat-
ment outcomes is also related to the fidelity of their implementation.
Legally referred clients who do not perceive consistency or uniform-
ity in the legal process may not feel pressed to comply with treat-
ment demands.
Implementation failures can occur at any stage in the referral proc-
ess. For example, the initial referral may contain ambiguities con-
cerning the consequences or options for clients who either refuse
treatment or arbitrarily leave a particular treatment program. During
treatment, consistency should be maintained with respect to drug use
surveillance by urine testing (ii regularity and the actions taken) or
monitoring non-drug-use infractions (detection and consequences).
Generally, effective implementation requires a strong working rela-
tionship between the criminal justice and treatment systems. In par-
ticular, interaction and communication must be maintained between
the two systems to maximize the rehabilitative effects. For example,
legal officers must be familiar with the approach, have regular con-
tact with clients, and routinely visit the treatment program. Pro-
grams should report regularly and promptly. Mutual agreements must
be developed on conditions for clients changing or dropping out of
treatment. An alliance must be forged in which a legal presence is
evident, and treatment is free to carry out its mandate.
Treatment Program Variance
An identified weakness in several of the civil commitment programs
initiated in the last 25 years has been the quality of treatment pro-
grams. For example, individual programs differ widely with respect
to philosophy, staff experience, program resources, and training.
Treatment technologies may not be explicitly described, or the rela-
tionship between the treatment model’s philosophy, or perspective,
and its practice is often abstract, distant, or weak. Moreover, even
well-designed protocols may not be faithfully executed. Thus,
program-related sources of variance have obscured the measurement
of treatment effectiveness for legally referred clients.
Recovery: The Role of Legal Pressure in Rehabilitation
Clinical experience and existing research underscore the multivariate
and interactional nature of behavioral change. Entire domains of
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variables, much less single measures, are inherently limited as
predictors of rehabilitation. lt is not surprising, then, that the
contribution to outcomes of one variable, such as legal referral, is
minimal, obscure, or ambiguous. This can be briefly illustrated in
terms of the recovery process in TCs.
The primary goal of rehabilitation is to facilitate the development of
a drug-free, prosocial lifestyle. This goal is achieved through a
social learning methodology that fosters maturation, skills training,
insight, and personal growth.
The process of change unfolds as a continuous interplay of client
factors, e.g., motivation, and treatment influences. Three stages of
the process can be characterized that reflect shifts in the factors
that influence treatment involvement and behavioral change:
(1) compliance—adherence to the rules and regulations of the TC to
avoid negative consequences such as disciplinary sanctions,
discharge, or reincarceration;
(2) conformity—adherence to the expectations and norms of the
group or community to avoid loss of approval or disaffiliation;
and
(3) commitment—adherence to a personal resolve to change one’s
lifestyle.
These stages are inclusive and interactive in that conformity requires
compliance, and commitment subsumes both conformity and compliance
toward achieving the personal goal of self-change. The appearance
of prosocial behavior in each stage does not necessarily imply its
causes or assure its stability. lf the commitment stage is not
attained, recovery is incomplete, and the potential is greater for
relapse to drug use or crime.
Thus, the recovery process itself may be the primary source of
variance affecting the measured efficacy of compulsory treatment.
Nevertheless, research and clinical experience in TCs do provide
hypotheses concerning the role of legal pressure in rehabilitation.
Some drug abusers require external pressure to seek, remain in, and
benefit from treatment. For these individuals, legal pressure is
viewed as having a limited but potent role in the recovery process.
Legal pressure can provide the initial force that sustains individuals
through the compliance stage of treatment, permitting the influences
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of maturation, therapy, and retraining that occur in the later stages
of recovery.
Broadly, the above perspective on recovery can be applied to various
ways that perceived legal pressure could affect individual change,
both within and outside treatment settings.
Legal pressure can maintain abstinence and prosocial behavior during
the period of surveillance only (duration of probation, parole, court-
mandated time). In this case of compliance only, behavioral change
is likely to be temporary and unstable after removal of the pressure.
Legal pressure in the form of surveillance can maintain compliance
until maturational factors assume a greater influence in the acquisi-
tion and maintenance of prosocial behavior. This undoubtedly has
been of major significance in some of the non-TC studies reporting
positive results of civil commitment (Angiin and McGlothlin 1994).
Finally, compliance can lead to rehabilitation when legal pressure
maintains compliance during the transition to the conformity and
commitment stages in the recovery process.
IMPLICATlONS FOR RESEARCH ON COMPULSORY TREATMENT
The efficacy of compulsory treatment is related to implementation,
client differences, and the multivariate complexity of the recovery
process itself. These issues can be better understood through
research in several ways.
Individual Differences
As yet, there is no typical profile of the client most suitable for a
compulsory treatment referral. However, important client factors can
be specified, particularly in terms of perceived legal pressure, moti-
vation, readiness, and suitability for treatment. Research can develop
criteria for classifying client differences and provide comprehensible
tools for criminal justice personnel to use for identification, assess-
ment, and referral.
Although new and appropriately designed studies are necessary to
demonstrate convincingly the contribution of compulsory treatment
approaches to outcomes, much information can be gleaned from fur-
ther analyses of data already collected. In particular, the complex
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relationships among legal referral, age, motivation, retention, and
outcome can be investigated to a certain extent in existing data sets.
Improved Implementation
Effective compulsory treatment requires an integrated involvement of
criminal justice systems and treatment systems. Models for develop-
ing links between the criminal justice and treatment systems must be
designed and tested. Such models should stress the following areas.
Education. The existing knowledge base with respect to treatment
effectveness must be disseminated to the Criminal Justice System,
which needs to be informed of the various treatment modalities, the
clients they serve, and their success and improvement rates.
Training. Treatment workers and criminal justice personnel, i.e.,
judges, correction officers, and district attorneys, must be trained to
work together in referral and rehabilitation. The focus should be on
mutual agreement of the goals of compulsory treatment for selected
clients, particularly in terms of the role of legal pressure in the
recovery process.
Uniform Procedures. Explicit and uniform procedures for referral and
surveillance must be established to maintain consistency in the legal
referral process.
Policy Considerations. Existing evidence suggests that treatment is
effective for some undetermined number of drug offenders who are
legally referred. Favorable outcomes for legal referrals appear in the
three major treatment modalities of methadone maintenance, drug-free
outpatient settings, and drug-free TCs. The latter modality, in par-
ticular, offers a unique alternative for criminal justice referrals.
Although posttreatment outcomes were stressed in the present review,
the impact of treatment is striking on all clients, voluntary and non-
voluntary, during their stay in the TC. Regardless of length of time
in program, there is virtually no crime or illicit drug use while cli-
ents are in residential treatment. Given their modest costs, the self-
help traditional TCs offer an extremely favorable cost/benefit
alternative to incarceration.
Unlike other modalities, the TC provides long-term treatment in a 24-
hour environment that attempts to change lifestyles. Its emphasis
upon resocialization accords with the goals of the criminal justice
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system and society in general for rehabilitating the drug-abusing
offender.
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Basic Issues Pertaining to the
Effectiveness of Methadone
Maintenance Treatment
John C. Ball and Eric Corty
OPIATE ADDICTION IN THE UNITED STATES: A HISTORICAL
PERSPECTIVE
In an era of renewed public apprehension about the spread of drug
abuse in the United States, it is meaningful to review basic issues
pertaining to the effectiveness of treatment for intravenous drug
users for three reasons. First, heroin addiction-with some 500,000
active addicts—remains a persistent part of the drug abuse problem in
the United States (Kozel and Adams 1986). Second, the fact that
most heroin addicts are intravenous drug abusers, who constitute a
high-risk group in the AIDS epidemic, has aroused a new level of
scientific interest in this population (Drotman 1987). Thirdly, the
problem of heroin/opiate addiction has a long history in the United
States, so that treatment and policy issues can be placed within a
historical and scientific framework.
Before considering basic treatment issues pertaining to heroin
addiction, it seems worthwhile to comment upon the history of the
opiate addiction problem in the United States, define opiate addiction,
identify particular populations under study, and delineate what we
know about the treatment of heroin addiction to provide a framework
for further discussion.
The problem of opiate addiction has a long history in the United
States (Terry and Pellens 1928). In 1878, Marshall (1978) reported on
the characteristics of 1,313 opium and morphine eaters in Michigan.
By 1918, a special committee of the Treasury reported that there
were 237,655 addicts in the United States (Terry and Pellens 1928).
More recently, O’Donnell and Jones (1968) investigated the origin and
spread of intravenous opiate abuse and found that this route was
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first utilized by U.S. addicts in the 1920s. This long history has also
produced a vast body of scientific and medical knowledge about the
life course of opiate addiction and its treatment (Bail and Chambers
1970; Lowinson and Ruiz 1981).
lt is important to note that demographic populations at high risk for
opiate addiction have differed by era and location within the United
States. Similarly, for those who do become addicts, age at onset of
daily opiate use and other characteristics of their addiction careers
also differ by period and place of residence. Furthermore, it is
significant that comparable or even greater variations in addiction
characteristics and consequences have been found in other nations
(Ball 1977; DuPont et al. 1979). Thus, the problem of opiate addiction
differs by nation and historical period, although most physiological
and pharmacological aspects of addiction, such as physical depend-
ence, remain constant (Cooper et al. 1983; Kreek 1979).
Studies of drug addiction have usually focused on particular popula-
tions of abusers, classified specific drugs of abuse, and formulated
definite scientific questions to investigate. Thus, it is necessary to
indicate which population (adult males, metropolitan slum dwellers,
teenage females, college students, army personnel, factory workers,
prostitutes, criminals, doctors, pregnant housewives, etc.) and which
drugs of abuse (heroin, morphine, PCP, cocaine, marijuana, barbitu-
rates, etc.) are to be studied. In addition, it is important to measure
frequency of use as well as to note route of administration (Ball and
Chambers 1970).
Studies of heroin addicts in the United States have found that most
compulsive users have both addiction and nonaddiction periods
following onset of daily use of opiates (Nurco et al. 1981). Each of
these addiction periods, or nonaddiction periods, commonly last a year
or longer. Nonaddiction periods are often periods of incarceration.
These consecutive periods of addiction, nonaddiction, or incarceration
provide a frame of reference for studying the life course of heroin
addiction. In this regard, the forces that cause the onset of
addiction are usually quite different from those that propel addicts to
continue daily abuse for many years. While the onset of heroin use
commonly occurs as a voluntary peer-group recreational endeavor
among inner-city youth, continuation of intravenous use leads to an
adult career in which the addict is enmeshed continually in a drug
abuse subculture.
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Once opiate addiction has been established for a number of years, it
has proved to be exceedingly difficult to reverse this process and
effect a cure. Indeed, it has been stated that no treatment regimen
exists that will permanently cure most opiate addicts (Ball 1972).
Adults can be withdrawn from drugs in a controlled environment (i.e.,
hospital or prison), but most ex-addicts quickly relapse without
followup services. The life course of opiate addiction is so intrac-
table to rehabilitation because this dependency is supported by a
complexity of physical, psychological, and social forces that reinforce
one another. Consequently, once intravenous heroin addiction is
established, the day-today pursuit of drugs becomes a way of Iife
that is not changed easily.
THE SOCIAL AND COMMUNITY CONTEXTOF HEROIN ADDICTlON
Drug addiction is learned repetitive behavior that is illegal and that
quickly becomes compulsive. Drug addiction is also social behavior
that commonly is learned from other abusers and is maintained by
means of their support. In this sense, drug addiction is socially
contagious. lt is not, however, an infectious disease like AIDS, and
it is not primarily a mental illness.
The 500,000 heroin addicts concentrated in metropolitan areas
constitute a major social problem for the nation, because of their
self-destructive lifestyle and antisocial behavior (Nurco et al. 1985).
in this regard, most addicts are involved continually in crime and
often find it difficult, or unrewarding, to pursue steady employment
(Ball et al. 1983).
Various public policies have been advocated to cope with the problem
of heroin addiction in the United States; many of these policies apply
to compulsive users of other illicit drugs, as well as heroin. lt seems
pertinent to comment upon current policies pertaining to drug abuse
because they often are advanced in conjunction with, or as substi-
tutes for, treatment. A major public policy focuses on educating
youth about the dangers of drug abuse as a principal means of
controlling or eliminating the problem of drug abuse. This emphasis
upon didactic or moral teaching has had only limited effect in
changing adolescent peer-group behavior and is only one aspect of
prevention. However, it has been found that there are three discrete
domains that need to be reached in prevention: knowledge, attitudes,
and behavior (Grant 1986).
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Countervailing institutional forces at work in society have limited the
impact of education. These forces include societal influences that
denigrate family life, religious values, and community responsibility,
while they extol drug abuse and other forms of deviant behavior.
The family also has a crucial role to play in the prevention of drug
abuse among children. However, many children do not have respon-
sible parents and, consequently, they are deprived of suitable early
socialization. In this regard, there are not only orphans and
unwanted children, but parents who are themselves opiate addicts,
criminals, or prostitutes (Goldstein 1979).
A word about the inner cities is in order. These extensive, yet
forgotten, neighborhoods are a principal breeding ground of heroin
addiction. In a very real sense, addiction is a community problem,
rather than merely an individual problem (Chein et al. 1964). This is
because addiction is maintained and spread by drug-using cohorts
from generation to generation in metropolitan slum areas
(Mieczkowski 1986). Furthermore, the fact that minority group
members constitute a major portion of inner-city dwellers only
exacerbates the problem of awakening public interest and support. So
the scope and complexity of the slum problem remain intact, and the
poorer areas of our cities continue to be ignored.
The role of law enforcement is crucial to any policy for controlling
heroin addiction. As with crime, it is necessary to develop policies
for reducing the spread and continuation of the problem. In this
regard, it is important that law enforcement efforts and programs be
integrated with community needs and interests.
Treatment alone cannot be expected to contain the problem. Support
for treatment proclaims that a legitimate human need exists and this
need has public support (Jaffe 1979). It follows from what has been
stated that no one approach or single institution will be sufficient to
meet the heroin addiction problem in the United States. Rather, a
coordinated societal approach is necessary, in which increased
resources will be organized to meet prevention, education, and
treatment needs of communities, occupations, and other populations.
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TREATMENT SERVICES PROVIDED TO METHADONE
MAINTENANCE PATIENTS IN NEW YORK, PHILDELPHIA, AND
BALTIMORE-RESEARCH FINDINGS
When consldering the role of treatment for opiate addiction in the
United States, it is pertinent to delineate the treatment services
commonly provided In methadone maintenance programs for various
types of addicts. Thus, the question of what types of patients profit
from methadone maintenance treatment can best be answered by
analysis of both patient characteristics and program characteristics.
Inasmuch as the analysis of treatment regimens and services delivered
has been largely Ignored, it seems appropriate to present research
findings pertaining to methadone maintenance treatment services.
Research pertaining to the scope, frequency, and variation in
treatment servicea provided to methadone maintenance patients was
obtained as part of a three-city National Institute on Drug Abuse
(NIDA) supported study of program effectiveness. Data collection
included confidential onsite interviews of each program’s staff,
indepth compilation of data from pharmacy and other clinic records,
and face-to-face patient interviews. Detailed program data were
collected at the clinics by four project staff members, which included
the authors, during a 2-year period (1985 to 1986).
The six methadone maintenance programs selected for study included
about 1,900 addict patients. The treatment services can conveniently
be classified under four headings: (1) attendance for oral methadone
medication; (2) urinalysis to detect illicit drug use; (3) counseling
services; and (4) medical services provided (table 1).
Attendance requirements at the six programs were quite strict.
Recent admissions and patients without take-home privileges were
required to attend the clinic every day—either 6 or 7 days per week,
depending upon whether or not the clinic was open on Sundays.
During this daily visit, patients were given an oral dose of methadone
by the dispensing nurse or pharmacist. At this time, patients were
also checked for obvious intoxication, provided an opportunity to
arrange for formal counseling services or medical services, and
monitored for treatment progress.
About 54 percent of the 1,898 patients earned take-home privileges;
that is, they were given one or more doses of liquid methadone in
bottles for consumption at home on days when they did not attend
the clinic. For those with take-home privileges, the mean number of
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take-home medications was three. Most of these patients then
attended the clinic three or four times per week. The average daily
attendance rate at the six clinics was 94.2 percent. Only 5.8 percent
of the patients missed their scheduled daily attendance for medica-
tion.
TABLE 1. Fourteen treatment services provided to 1,898 outpatients
at 6 methadone maintenance clinics
Type of Treatment Frequency of Service
1. Attendance for Oral Methadone
Medication
Average daily attendance rate
at clinic
Mean days of scheduled attendance
per week
Mean methadone dosage
2. Urinalysis to Detect Illicit Drug Abuse
Mean number of urine specimens
“dropped” per month
3. Services Provided by 55 Counseling Staff
Patients with designated counselor
Mean number of counseling sessions
per month
Mean time of individual counseling
sessions
Patients also receiving group
counseling
Receiving vocational services,
in month
Receiving educational services,
in month
4. Treatment Provided by 44 Medical Staff
Patients receiving medical treatment,
past 90 days
Patients receiving physical exams,
past 30 days
Receiving other medication,
past 30 days
Receiving psychotherapy in
past 30 days
94.2 percent
5.4 days
45.6 mg.
4.9
99.6 percent
2.2
36.5 minutes
22.2 percent
2.5 percent
1.9 percent
41.8 percent
15.6 percent
4.9 percent
0.2 percent
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A second major aspect of methadone maintenance treatment is
urinalysis. All patients were required to provide urine samples on a
regular basis. Commonly, this was done once a week on a random
basis, but in some programs it was done more often. On the whole,
4.9 urine specimens were obtained per patient per month. The
purpose of this urine screening was to monitor illicit drug abuse
(both opiates and nonopiates) and to check whether patients were
taking their take-home methadone.
Counselors represented the largest clinic staff group, and they
provided numerous treatment services to methadone patients. Each
patient was assigned a counselor at admission who had primary
responsibility for supervising the patient’s treatment progress.
Counselors provided regular individual sessions, with an average of
2.2 sessions per month, each lasting 37 minutes. In addition to these
individual sessions, 22 percent of the patients attended group
counseling sessions.
Although the counselor’s principal roles were individual face-to-face
conferences, daily monitoring with brief contacts, attendance checks,
and referrals, they also provided a variety of other services. For
example, 7 percent of the patients attended Narcotics Anonymous or
Alcoholics Anonymous meetings at the clinic on a monthly basis, 2
percent received family therapy, 2 percent attended educational
services, and 2 percent received vocational services.
When counseling was contrasted with educational and vocational
services, only 4 percent of the patients received either educational or
vocational services. Staff qualified to provide these services were
not available in most programs.
The 44-member medical staff at the 6 clinics included 11 physicians,
5 physicians’ assistants or nurse practitioners, 25 dispensing nurses,
and 3 pharmacists. Since many of these staff were part time, their
full-time equivalency (FTE) was about half that of the counselors—
29.2 FTE versus 53.0 FTE.
The treatment services provided by the medical staff consisted
primarily of dispensing methadone, conducting physical examinations,
and providing general medical care. Thus, most of the nurses’, as
well as most of the pharmacists’, workday was spent dispensing
methadone. In addition, 16 percent of the patients had had physical
exams in the past month, while 42 percent had received medical
treatment in the past 3 months. Only 0.2 percent of the patients had
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received psychotherapy in the past 30 days, and only 5 percent were
on prescribed medication other than methadone.
A review of the total treatment services provided to patients at the
six programs supports the following conclusions. First, clinic
attendance and monitoring, which is focused upon regular scheduled
methadone dispensing, provides an ongoing network of contacts and
services that has a daily effect on patients.
Second, urinalysis fulfills an important function. lt provides an
objective test of compliance with treatment goals and serves as an
important measure of patients’ progress.
Third, the important role of counselors and nurses in the clinics must
be emphasized. These two groups provide the daily contact as well
as most of the individual care and rehabilitative services that patients
receive.
Fourth, marked variations were found among the six clinics in
medical staffing patterns and services provided (Ball et al. 1986).
Some programs had extensive medical coverage, while others had
almost none. The effect of these differential medical services upon
patients’ outcome remains to be investigated.
The Effect of Legal Pressure on Admissions to Methadone
Maintenance
A cohort of male patients representing 104 admissions to the 6
programs was examined. Of these admissions, 31 were under legal
pressure (probation or parole) and 73 were not. These patients were
interviewed at admission and then reinterviewed a year later.
With respect to background characteristics, the compulsory treatment
patients (those under legal pressure) were more likely to be separated
or divorced (48 percent versus 27 percent), had more criminal convic-
tions (7.0 versus 3.6), had spent more time in prison (51 months
versus 18 months), and had more years of regular barbiturate abuse
(2.2 versus 0.6). However, the two groups did not differ significantly
with respect to age, race, employment history, age at onset of opiate
use, years of opiate use, or prior treatments for drug abuse.
The two groups of patients were quite similar at admission with
respect to their need for treatment, as measured by the Addiction
Severity Index (ASI). The only significant composite score
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differences on the ASI scales (i.e., medical, employment, legal, family-
social problems, drug abuse, alcohol abuse, and psychiatric problems)
were drug abuse and crime. The compulsory treatment patients were
lower on the drug scale and higher on the legal problems scale.
The two groups appeared to differ with respect to treatment reten-
tion, although this difference was not statistically significant. Thus,
only 19 percent of the compulsory patients were in treatment a year
later, compared with 40 percent of the other patients. These results
indicate that the majority of criminal addicts who are under legal
coercion do not remain in methadone maintenance treatment for 12
months. When such rapid dropout occurs, it seems that it may be an
indication that the patient treatment match was inadequate or that
the treatment modality was inappropriate.
SEVEN BASIC: ISSUES PERTAINING TO THE TREATMENT OF
HEROIN ADDICTION IN THE UNITED STATES
A first issue pertains to the causes of heroin addiction in the United
States. Clearly, there are numerous causes and combinations of
causes. A considerable body of research has addressed this issue
(Nurw 1979), and it has been reported that numerous factors promote
heroin use (e.g., peer-group friends who are addicts, residence in
metropolitan slums, and prior delinquency), while others inhibit such
use (e.g., non-drug-using friends, stable family life in better neigh-
borhoods, as well as the absence of delinquency). With no single
cause of heroin addiction, there is no simple or easy solution to this
social problem. As noted previously, epidemiological findings suggest
that populations at risk for opiate addiction change by historical
period, nation, and locale so that causal factors might also vary.
This is not to maintain, however, that significant causal factors
cannot be identified (e.g., drug-abusing peers and residence in a
metropolitan slum community).
A second issue pertains to whether or not education, religion, law
enforcement, or, indeed, any single institution can solve the problem.
The answer is no! None of these institutions has been able to stem
the tide of heroin addiction, much less eliminate the problem. As
stated, each of these institutions and others (mass media, sports, and
recreational enterprises) has a role to play. However, there is a lack
of consensus and coordination among these institutions.
A third issue pertains to the current role of treatment as a national
policy. It appears that there is an ambivalent attitude toward the
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treatment of heroin addiction and, indeed, toward the treatment of
drug abusers in general. On the one hand, a belief in rehabilitation
and reform is proclaimed, and, therefore, some treatment is provided.
On the other hand, the problem of intravenous heroin addiction is
denied, so an intellectual dichotomy persists.
A fourth issue relates to the effectiveness of methadone maintenance.
lt has been noted that all of the major treatment modalities for
heroin addicts are successful for some patients. In this sense,
methadone maintenance, therapeutic communities, psychotherapy,
group counseling, and individual therapy are all effective. The
question now becomes one of ascertaining which treatment modalities
are appropriate for which types of patients in which types of
neighborhoods or communities (McLellan et al. 1982). But the issue
of what constitutes successful treatment for heroin addicts is not
simple and straightforward (Tims and Ludford 1984). Getting addicts
completely off opiates, or all illicit drugs, is only one criterion of
success. Their criminal behavior, psychiatric difficulties, or other
aspects of their lives cannot be ignored. As a consequence of
diverse lifestyles and attendant problems, it is necessary to measure
improvement in a number of respects. The most widely used meas-
urement instrument for ascertaining addicts’ need for treatment and
progress in treatment, the ASI, uses seven specific areas of func-
tioning: medical status, employment, alcohol abuse, drug abuse,
crime, family/social life, and psychiatric status. Within this context,
treatment effectiveness is based upon demonstrable improvement in
each of these areas. To the extent that a treatment modality
produces improvement, it is more or less effective. Consequently,
treatment effectiveness is not a matter of success or failure, but a
question of how much improvement, for how many patients, over how
much time.
The fact that many methadone maintenance patients stay in treatment
for extended periods of time (a sizable number continue for 3 or
more years) raises the issue of whether or not these programs seek
to cure addicts by making them completely abstinent. The rationale
for methadone maintenance treatment is founded upon three funda-
mental objectives: stabilization, improvement, and cure (Dole and
Nyswander 1965; Dole and Joseph 1978). Each of these objectives is
an acceptable outcome for some patients. Methadone maintenance
programs are able to effect significant improvement for most patients
who remain in treatment. Thus, stabilization of an improved way of
life generally occurs after 2 years of treatment.
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A fifth issue, whether prolonged methadone maintenance treatment
tends to institutionalize patients and promote a welfarelike depend-
ency, is crucial to public policy deliberations. Three observations
seem appropriate. First, the 500,000 addicts pose numerous problems
for their communities and sometimes seem to threaten the very fabric
of society through their self-destructive predatory acts and criminal
behavior. The addicts do exist, and therefore, long-term treatment
must be considered. Second, most addicts who enter methadone
maintenance programs improve (especially with regard to a reduction
in drug abuse and criminality) while they remain in treatment. In
this sense, methadone programs are effective and are a major benefit
to society. Third, the degree of institutional dependency involved in
outpatient methadone maintenance treatment is minimal; most patients
make two to five brief daily visits to the clinic per week, and the
number of visits is decreased after the first year or two.
The effectiveness of compulsory methadone maintenance treatment for
heroin addicts represents a sixth basic issue. The consideration of
what types of criminal addicts might be suitable for admission to
methadone maintenance treatment presents a dichotomy of goals. The
goal of containing the most dangerous or difficult criminals and
thereby removing a threat from society is one objective. Conversely,
the goal of effecting change and rehabilitation among criminal addicts
represents something quite different. On the basis of present
knowledge, a policy of compelling hardcore criminal addicts to attend
existing methadone maintenance programs seems ill advised, since the
chances of effecting positive change seem minimal, while the likeli-
hood for program disruption seems high.
In addition, it would probably be necessary to establish separate
specialized clinics (or sections in clinics) to serve criminal justice
clients if they are mandated or court ordered to methadone mainte-
nance treatment. This course of action would follow the growing
recognition that there is a need for specialized treatment services for
various addict or ex-addict populations (e.g., females, adolescents,
those at highest risk for AIDS, the aged, and stable working adults).
Establishing and maintaining viable links between treatment programs
and the criminal justice system will be extremely difficult to imple-
ment. Apart from inherent differences in philosophy, staff training,
objectives, and day-today operations, treatment programs do not
currently have staff and program resources to implement a meaningful
policy of coordination and mutual support.
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A seventh possible issue is whether other modalities are more or less
effective than methadone maintenance in treating opiate addicts.
Perhaps a more appropriate question is how to determine the particu-
lar effectiveness of each treatment modality for specific types of
patients.
CONCLUSION
The problem of heroin addiction in the United States was discussed
from a historical and sociological perspective, with emphasis on
recent influences that have awakened concern about its scope and
consequences. The role of methadone maintenance treatment in
addressing the problem of heroin addiction in the United States was
considered. lt was concluded that methadone maintenance can be
effective, especially with respect to reducing illicit drug use and
crime. The question remains, however, as to which types of patients
can (and cannot) be treated successfully. In the present context, this
raises the issue of whether compulsory treatment will be effective for
persons involved in methadone maintenance treatment.
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Civil Commitment—International
Issues
Barry S. Brown
INTRODUCTlON
The effort to apply cost-effectiveness analysis to civil commitment
procedures, as called for in this review, points to a central concern
that civil commitment has posed for many. In developing effective-
ness studies of any type, it becomes necessary first to consider the
objectives of the interventions and then to construct outcome
measures appropriate to those objectives. In the case of civil
commitment procedures, the community institutes administrative or
judicial procedures, as permitted under civil law, to contain and
modify behaviors that the society finds inappropriate, typically
dangerously inappropriate. This suggests that a major, if not the
major, effectiveness measure for civil commitment procedures is the
reduction of disturbance in a community associated with the offending
behaviors. In that spirit, civil commitment procedures, as they relate
to drug abuse, have been more largely concerned with maintaining or
achieving a societal homeostasis than have other drug abuse treat-
ment procedures. While most would agree that all drug abuse
treatment, and arguably all forms of public health care, have as an
objective the protection of society in addition to the permitting of
individual well-being and accomplishment, a weighting in the direction
of societal protection appears particularly significant in the case of
civil commitment practice. Costs then become proportional to the
community’s felt need for social control and the potential societal
gains seen with the achieving of that control.
Those costs may be dear if the societal gains are deemed sufficiently
great. Thus, Mussa Hatam, the Malaysian Deputy Prime Minister,
could explain that civil commitment and enforcement strategies had
become necessary in his country because the drive toward
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modernization and accompanying economic prosperity was leading a
significant minority of youth to drug abuse or, and also highly
undesirable, toward an excess of religious zeal (Hatam 1985). Thus,
for Malaysia, some level of youthful deviance, in tandem with
stringent enforcement measures and a program of compulsory treat-
ment were seen as tolerable costs in paying for the nation’s economic
well-being. More commonly, costs are measured in the toll potential
for civil liberties since civil commitment can permit detention for
inappropriate behaviors without providing legal counsel, judgment by
one’s peers, or witnesses for one’s defense (Porter et al. 1986a).
Little wonder that Bejerot (1983) and Webster (1986) argue that
democratic countries cannot move massively against drug abuse
without clear evidence of strong public support. Van Bilsen and van
Ernst (1986) argue that, from the standpoint of their clinic in the
Netherlands, the marshaling of support to achieve such an objective
is unnecessary. They argue that behavioral change is potential within
the interaction of therapist and client and that controlled use of
drugs—including heroin—need not threaten the larger society. van
de Wijngaart (1988) notes that addicts are themselves ambivalent
about the use of heroin as opposed to methadone maintenance, and
that the Dutch must remain open to different strategies for coping
with addiction.
Perhaps with those assessments in mind, Webster (1986) argues, with
somewhat Machiavellian intensity that:
For a major intervention program to be successful,
especially one which places heavy reliance upon the use of
compulsion . . . . First, the problem must be isolated and
perhaps enlarged: it may even have to be created in
certain instances (italics added). Public interest has to be
won and the imperative need for a solution must be
propagated. Second, a remedy must be offered and
projected through the media. It is worth noting that the
inherent logic of the plan may be a relatively unimportant
ingredient. . . it is helpful to be able to project the ideal
to the public that the plan is humane, or. . . that it is
decidedly in the public interest. . . . The point is that the
public must be induced to share the rationale which itself
must be simple and straightforward . . . . (Webster 1986
p. 134)
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In a real sense, Webster (1986) and Hatam (1985) argue that civil
commitment can be justified where the level of risk to the society at
large, as posed by a health-care issue, is of such magnitude as to
warrant a use of social control or quarantinelike strategies. For
Webster, that risk is posed to societal maintenance; for Hatam, that
risk is posed to societal progress.
In fact, the laws of a substantial proportion of countries provide for
civil commitment procedures. Of 43 countries surveyed by Porter et
al. (1986a), 27 provide for civil commitment under selected conditions.
In addition, 47 countries are parties to the 1971 Convention on
Psychotropic Substances, a treaty which holds, in part, that each
government may mandate treatment either as an alternative to
conviction or punishment or in addition to conviction or punishment
(Noll 1977).
GROUNDS FOR COMMITMENT
The rationales used to implement civil commitment procedures differ
markedly and are associated with their legislative bases—whether they
are included under mental health legislation or under legislation
specific to drug abuse. In general, civil commitment under mental
health legislation requires evidence of psychiatric impairment
involving (1) threat to others; and/or (2) threat to self; and/or
(3) inability to care for oneself. Countries with mental health civil
commitment legislation are likely to include provision for commitment
both for threats to others and to self. In this regard, German,
Japanese, and Somalian laws provide for civil commitment where the
drug-related disorder constitutes an imminent threat to public safety
or where the individual poses a danger to his/her own life and
health. Other countries operating under mental health legislation
specify only the existence of psychiatric disturbance without elabora-
tion of threat (Bangladesh) or emphasize the individual’s inability to
provide for himself/herself and the need for supervision (Trinidad and
Tobago).
Where civil commitment is covered under legislation specific to drug
use, as is the case in 15 of the 43 countries surveyed by Porter
et al. (1986a), the rationale for civil commitment can be limited to
evidence of dependence or addiction (Mexico, Columbia, Peru,
Thailand, and Malaysia) or may include reference to the threat posed
to others and/or to the need for treatment (Argentina, Italy,
Australia, and Sweden).
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of the 15 countries with drug legislation, 11 also use mandatory
reporting of drugdependent persons (Porter et al. 1986b). In 10
countries, responsibility for reporting is vested in medical or law
enforcement personnel and, in one instance (Burma), the individual is
required to report himself/herself to the authorities.
Registration has several purposes. In Burma, a self-reported addict
can be remanded to the nearest medical treatment center. After
treatment, that person’s name may be removed from the central
registry. Registration in Hong Kong is used as an epidemiologic
device and as a means for evaluating the government’s treatment
programs. Thus, Hong Kong’s registry is used to monitor trends in
drug use and in the characteristics of the drug-using population, as
well as treatment reentry and the individual’s functioning at time of
government agency contact. Columbia’s national registry is used to
chart trends in illicit drug traffic throughout the country, while
Pakistan’s registry was actually used, in part, to provide opium to a
portion of the addict population. Specifically, opium addicts, 25 years
of age and older, could obtain opium ration cards from the Civil
Surgeon of Karachi, Pakistan, entitling them to purchase opium for
personal use from their locally authorized opium vendor.
WHO REQUESTS CML COMMITMENT FOR DRUG ABUSE?
Civil commitment applications may be made by the following 5 groups
in the 27 countries identified by Porter et al. (1986a) as providing
civil commitment:
(1) Family or community members, i.e., “significant others,” were
frequently cited. These individuals typically include spouse or
near relatives but may extend to a business partner (Australia),
to members of the worker’s collective (Hungary and the Russian
Soviet Federal Socialist Republic of the U.S.S.R.), or to any
person in the community when the individual creates a disturb
ance for his/her neighbors (Argentina).
(2) Private or public health-care providers may be required to
advise the government of known drug-dependent persons. In
Mexico, for example, the physician must report cases of drug
addiction to the Ministry of Health and Welfare within 8 days of
seeing the individual.
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(3)
(4)
(5)
Social service agencies may also have responsibility for imple-
menting civil commitment processes. In Malaysia, a social
welfare officer may apprehend an individual suspected of drug
dependence. However, they must then present that person to
the local magistrate within 24 hours.
The drug-addicted individual may also apply for civil
commitment.
Law enforcement agencies or governmental authorities are
frequently empowered to initiate civil commitment procedures.
In some instances, the police officer must be of comparatively
high rank to institute procedures (Australia and Malaysia): in
others, power is vested in the public prosecutor (Hungary) or a
comparable legal authority (Japan).
Frequently, of course, countries provide more than a single. method
for the initiation into civil commitment procedures.
REVIEW AUTHORITIES
There are three types of review authorities which decide if there are
sufficient grounds to justify civil commitment. Again, different
authorities frequently act in concert.
(1)
(2)
Courts are typically given the primary responsibility for
determining appropriateness of civil commitment procedures.
Argentina provides for defense counsel to make certain that no
other provision for care can appropriately be made for the
addict and, if commitment is ordered, to make certain that
commitment is not for any longer than “absolutely necessary.”
In Nova Scotia, a justice of the peace or police magistrate may
remand the addict to detention and treatment in any hospital,
jail, or place of detention in the Province.
An existing governmental agency or a specially created govern-
mental agency may be assigned jurisdiction over civil commit-
ment practices. In Burma, the Drug Addicts Registration and
Medical Treatment Supervision Board has been constituted to
oversee the compulsory treatment of addicted persons. In Japan,
the governor of the jurisdiction exercises that responsibility,
and in Singapore the Director of the Central Narcotics Bureau
acts in cases of civil commitment.
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(3) In some instances, the reviewing authority is a medical agency
acting alone. In Mexico, the Ministry of Health and Welfare
may require drug treatment; in Tunisia, authority is vested in
the Commission on Drug Dependence, a board of three physi-
cians acting on behalf of that nation’s Secretary of State for
Public Health.
In 24 of the 27 countries with compulsory civil commitment, medical
examinations were required. In several instances, those examinations
need not, by law, include medical personnel but do need to involve an
appraisal of the individual’s condition. In some instances, second and
even third medical opinions are required (Australia and British
Columbia).
TREATMENT PROGRAMMING
Treatment methods or requirements may be stated in law and/or in
ministerial regulation and directives. As might be expected, the
specifics of treatment selection and administration are the responsi-
bilities of local treatment agencies and authorities. Nonetheless, the
law may specify the existence of inpatient, residential, and outpatient
facilities (Australia); institutionalization (Hungary): or may specify
institutionalization only if outpatient treatment is unsuccessful (Italy
and Iraq).
In terms of treatment services, some legislation provides for a
comparatively wide range of treatment activities by naming the
services to be provided. For example, Thai law provides for educa-
tion, training, aftercare, and social reintegration as part of the
rehabilitative process. German (Hamburg) law includes medical and
psychosocial counseling, aftercare, social welfare assistance, and
medical services. Finnish law provides for individual counseling,
family counseling, medical services, continuing surveillance, and an
elaborate program of aftercare. The aftercare program includes, in
part, contact with prosocial companions, developing prosocial leisure
pursuits, and providing housing and job assistance.
Most statutes are considerably less explicit in describing treatment
services. Some specify detoxification only (Tunisia and Singapore) or
detoxification and unspecified rehabilitative services (Peru). Others
vaguely refer to services in such terms as rehabilitation or medical
care (Indonesia and Burma), while still others stipulate the process
for individuals to get treatment. For example, Malaysian law
specifies that the magistrate may order the individual to a
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rehabilitation center for a period of 6 months or to community
supervision by a social welfare officer for 2 years. In some
instances, laws provide broad outlines for treatment services and
clarify responsibility for the provision of services, e.g., Mexican law
gives to the Ministry of Health and Welfare responsibility for the
development and promulgation of treatment standards, issuance and
dissemination of a directory of drug abuse treatment facilities, and
consultation regarding referral to treatment programs, etc.
In other instances, statutes specifying treatment reflect societal
concerns or values that go beyond the immediate issue of drug abuse.
Hungarian law stipulates that, during treatment, the institutionalized
person will forego rights and obligations associated with membership
in the workers cooperative. Additional language specifies that the
individual will be assigned appropriate work within the institution and
may be coerced to work but must be remunerated for that work.
Swedish law provides that care must be based on respect for the
individual’s self-determination and privacy and must, as far as
possible, be planned and conducted in partnership with the individual.
LENGTH OF STAY
Laws governing the length of time an individual can be held in
treatment vary dramatically. Several countries set maximum periods
for stay, frequently with provision for an additional period contingent
on behavior in treatment—but again with a specified time limit. At
one end of the continuum, Australia provides for 7 days, with the
medical officer capable of adding an additional 7 days. German
(Hamburg) law provides for a stay of up to 1 year. Finnish law
provides for a stay of up to 1 year, unless the individual has been in
treatment during the preceding 3 years, in which case he/she may be
detained for 2 years. Hungarian law provides a maximum of 2 years.
Russian law (Russian Soviet Federal Socialist Republic of U.S.S.R.)
provides for detention for up to 10 years, with the capacity to add
up to 1 additional year if it is determined that treatment has been
evaded. Swiss law provides for commitment of drug abusers for up to
3 years and for the alcoholic until such time as he/she is no longer a
threat to the community. Malaysian, Thai, and Singaporean laws,
often seen as comparatively restrictive, each provide for up to 6
months detention, with additional periods of 6 months each. In
Singapore, 6-month periods of detention may be added to reach a
combined maximum of 3 years. Of the 15 countries with civil
commitment legislation specific to drug abuse, 8 do not specify the
length of stay.
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REVIEW PROCESS
Periodic reviews of individuals’ functioning while committed may be
provided by specially constructed review bodies, or by existing (and
typically judicial) review bodies. In Japan, the Narcotic Addiction
Examination committee is empowered to recommend to the governor
of the jurisdiction shorter or increased hospital stay. In Singapore,
the Director of the Central Narcotics Bureau or the specially
appointed institutional treatment review committee may discharge or
transfer detainees. In Thailand, the Secretary General of the
Narcotics Control Board determines whether an additional period of
commitment beyond the initial 6 months is required. In the Soviet
Union, Germany, and the United States, courts are empowered to
conduct reviews.
Review Procedures may be automatic at certain time intervals (every
6 months in Bavaria and every 3 months in Italy) and/or they may be
instituted after submission of a request by the detainee, concerned
relatives (Norway and United States), or by the treatment program
director (British Columbia, Canada). Again, in most instances, there
is no provision for periodic review of the detainee. In 8 of the 15
countries with drug abuse civil commitment procedures, there is no
provision for periodic review, according to data from Porter et al.
(1986a).
Of the 32 governmental jurisdictions in 27 countries with provisions
for civil commitment under legislation governing mental health or
substance abuse issues, 9 make no provision for length of detention,
appeal, or review procedures.
DISCHARGE FROM COMMITMENT
Discharge is based on the period of commitment coming to an end or
on treatment conclusion. The latter instance may involve referral to
the courts or other government agencies or officials or may be taken
by the treatment provider independently. Thus, in Italy, the treat-
ment center may advise the court that an individual no longer needs
treatment, and the individual is released. In Iraq, the psychiatrist in
charge of a case may discharge an individual at any suitable time. In
Norway and Australia, only the medical superintendent decides on the
individual’s release. In some instances, provision is made for
continued community supervision. In Malaysia, individuals are
supervised by the social welfare officer for 2 years. If the individual
fails to comply with all supervision requirements, he/she can be
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recalled to treatment. If the individual does not then return
voluntarily, he/she can be arrested and returned for a period up to 8
months. In Switzerland, supervision may extend for 2 years. In
Finland, individuals may be discharged prior to the 1-year period
provided in Finland’s civil commitment legislation; however, surveil-
lance is also provided for 1 additional year or longer if deemed
appropriate. Moreover, if the individual under surveillance continues
to use illicit drugs, he/she Can then be returned to treatment for the
remainder of the year originally assigned.
Again, 5 of the 15 countries with civiI commitment legislation specific
to drug abuse are mute on the issue of discharge procedures. In
addition, the same 9 of 32 governmental jurisdictions make no
provision either for length of stay, appeal, review procedures, or
discharge procedures.
Porter et al. (1986a), reporting on behalf of the World Health
Organization (WHO), made the following recommendations to member
nations regarding civil commitment:
(1)
(2)
(3)
(4)
persons in need Of short-term emergency commitment for
incapacitation due to drug dependence should be immediately
released from detention on completion of treatment, i.e., of
detoxification;
“Compulsory civil commitment (for other than emergency Care) is
justified Only when an effective treatment programme, as well as
adequate and humane facilities, are available”;
“the period of confinement should be limited . . . and a person’s
involuntary status subject to periodic review”;
“the person concerned should be afforded certain substantive and
procedural rights during the commitment proceedings,” e.g.,
“timely judicial hearing . . . counsel . . . a standard of proof,”
etc.
Porter et al. (1986a) also recommended that the civil commitment
process and associated treatment programming be a subject for action
by the relevant WHO interministerial coordinating committee.
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EFFICACY OF CIVIL COMMITMENT PROCEDURES
One can argue that the widespread use of drug abuse civil commit-
ment procedures represents an expression of considerable confidence
in treatment programming. By focusing our treatment expertise, a
significant impact can be made on a country’s drug abuse problem.
Admittedly, other explanations are possible. Civil commitment
procedures may also be a strategy for reducing pressure of the
judicial system and correctional facilities, while guaranteeing the
continuing surveillance of individuals who constitute some level of
threat to the community. Nevertheless, the emphasis on treatment
demands an effort to assess the efficacy of treatment services
provided under civil commitment. Unfortunately, such study, in terms
of the several countries providing for civil commitment, is almost
unknown; Most are content to maintain records of admissions,
dropouts, and periods of retention (Anti Dadah Task Force 1985;
Narcotics Control Board 1984). Others report data which are largely,
or solely, anecdotal in nature.
Babaian (1979) describes the virtual eradication of drug abuse in the
Soviet Union following the October Revolution. He reports that
cocaine and other drugs were widely used in major cities while opium
smoking was common in Central Asian regions of the U.S.S.R. under
czarist rule. He ascribes the disappearance of drug abuse largely to
the creation of new social conditions after the Revolution. In
addition, he believes that the imposition of severe penalties for
lawbreaking related to preparing, selling, or using narcotic drugs was
probably useful. When addicts are discovered in the Soviet Union,
they must be registered immediately and then are divided into those
who may be treated voluntarily and those who will need to be treated
against their will. The first stage of treatment is a period of at
least 60 days inhospital care followed by an extensive period of
outpatient care using a complex of “narcological” services. The
capacity to rehabilitate even unwilling addicts is viewed by Babaian
(1979) as essential to his country’s progress in this area.
In a similar fashion, Marek and Redo (1978) argue that compulsory
drug abuse treatment has given very positive results in Poland. They
cite a Polish-language study that suggests 3 months of treatment as
sufficient. In Poland, as in several countries, compulsory treatment
may also be provided in a correctional facility. The authors empha-
size the use of a drug abuse program. They also place reliance on
treatment and rehabilitation rather than punishment. Although they
do not cite treatment effectiveness data, the authors present survey
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and estimate data regarding drug abuse in Poland and cite Polish
language journals which report treatment effectiveness.
Reports of the efficacy of restrictive programming in containing drug
use routinely cite the actions taken by Japan and by the People’s
Republic of China. Bejerot (1983), McGlothlin (1980), Morimoto
(1957), and Nagahama (1968) all report on the national campaign
organized in Japan to contain that country’s postwar epidemic of
amphetamine abuse. lt was estimated that perhaps 2 million Japanese
were involved in amphetamine abuse, with about a quarter of those
using amphetamines intravenously. Harsh penalties were imposed: 3
to 6 months for possession of amphetamines, 1 to 3 years for drug
sales, and 5 years for illicitly producing amphetamines. After the
program was initiated, arrests for amphetamine offenses dropped from
56,000 to 271 in 4 years (1954 to 1958), and the epidemic was
effectively over. McGlothlin (1980) suggests that the Japanese
situation points out the success of a country’s restrictive policy in a
situation involving intensive public education, a homogenous popula-
tion, and a culture with a tradition of regard for authority. Simi-
larly, Bejerot (1983) points to broad political agreement on the
wisdom of the Japanese drug policy.
In China’s anti-opium campaign (Lowinger 1977), efforts were made to
link that campaign to other popular reforms, notably land reform and
the growing of much needed food crops. In addition, the opium
importer was characterized as an enemy of the people, i.e., of the
State. The importing of opium was described as an imperialist
approach to destroying the Chinese nation. Massive educational
programs were organized involving 1-hour-a-day discussions which
linked political and health topics and concluded that those topics
were of national consequence. Specifically, on June 3, 1951, Anti-
Opium Day was proclaimed in Canton, and over 10,000 persons
assembled in a mass meeting. In conjunction with the suppression of
opium growing, compulsory registration of opium addicts began, as did
the treatment of opium addicts in urban areas. In rural areas, the
treatment was reportedly self-imposed detoxification. Harsh penalties
were reserved for individuals identified as major dealers; much lighter
penalties were assessed for lower level members of opium manufac-
turing and distribution gangs.
The Chinese action is usually described as demonstrating the adoption
of a popular restrictive drug abuse program as part of a well orches-
trated uprising against opium use, where that opium use was charac-
terized as a pernicious problem serving foreign interests. In this
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assessment, the drug abuse policy was part of a larger political action
that demanded both individual and national commitment. As in Japan,
the goals were achieved in a remarkably short period of time, largely
between 1951 and 1953, and in a country with a 300-year history of
opium smoking and a population of 20 million opium smokers at the
campaign’s inception.
McGlothlin (1980) provides the most rigorous analysis of the impact
of a restrictive national policy directed against drug abuse.
McGlothlin also points to the characterization of threat posed by
drug abuse to the larger society—in this instance to the city-state of
Singapore. A heroin epidemic affecting that country’s youth was used
to marshal public support for Singapore’s antidrug program.
Singapore’s newly found prosperity was dependent on maintaining a
fully employed workforce. The heroin epidemic among young men
made drastic governmental action both acceptable and necessary. In
about a 3-year period (1974 to 1977), it was estimated that 3 percent
of Singapore’s young male population had become involved in smoking
heroin. Further, it was expected that those figures would continue
to grow rapidly. In 1977, the Singapore government established an
enforcement policy relying heavily on the commitment of opiate users
to the city-state’s newly created Drug Rehabilitation Centers.
The Singapore effort included an existing law that provided for a 6-
month commitment, without trial, for individuals with urines positive
for any illicit drugs. With the advent of a heroin-smoking epidemic,
the law was amended to permit the death penalty for major drug
traffickers, to create a registry of heroin users, and to open six
rehabilitation centers. Most important to the Singapore effort was
Operation Ferret, which was initiated in 1977. That effort involved
the arrest of large numbers of suspected heroin users. Urine
specimens were obtained, and arrestees who tested positive were
forcibly referred to rehabilitation centers.
McGlothlin (1980) reports that nearly 20,000 people were arrested and
directed to give urine specimens during the first 9 months of
Operation Ferret. He also indicates that 40 percent were found
positive for drugs, overwhelmingly heroin, and those found to be
positive were sent to rehabilitation centers for 6-month periods. The
goals for this dramatic action were to slow the spread of heroin
smoking through the youthful population and to modify the behavior
of persons already invested in heroin smoking.
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The treatment approach, as described by McGlothlin, consisted of cold
turkey withdrawal efforts to instill discipline in terms of work be-
havior, as well as an exercise and a personal care regimen: education
regarding the individual’s responsibilities to society and about the
evils of drug use; schooling and job training as warranted: and
religious and personal counseling. In addition, a 2-year period of
compulsory supervision after discharge from the rehabilitation center
was required. That supervision involved urine testing and visits to
home and work, as well as some limited counseling (up to 10 minutes
each visit).
McGlothlin concludes that using the adopted measures achieved the
objective of arresting the Singapore epidemic. The number of
commitments to rehabilitation centers dropped from 700 cases a
month in 1977 to under 200 a month in 1979, while new users were
being added to the registry at a much lower rate than had been the
case earlier. Relapse, l-year posttreatment, as measured by returns
to treatment and/or convictions, was found to be 37 percent.
McGlothlin reasons that the success of the Singapore program was
due to three factors. First, the program could be sold to the public,
and was in fact heavily marketed, as an effort to protect and
guarantee the country’s economic prosperity. The heroin epidemic
among youth threatened to remove from the workforce the very
persons on whom Singapore’s continued prosperity depended. Second,
Singapore’s size made police activity and surveillance both feasible
and effective. As a city-state, there was permitted a greater
cooperation of enforcement agencies than might be possible in a
larger geographic area. Finally, the government in power had more
than 15 years of popular administration by the time a drug crisis was
recognized and, in McGlothin’s words, had established “one of the
most closely regulated societies in South East Asia” (McGlothlin 1980
p. 12).
While McGlothlin takes care to relate the utility of civil commitment
measures to the political climate and geography of the area affected,
one may take some issue with the degree of success reportedly
achieved in Singapore, at least insofar as that success is interpreted
from the decrease in cases referred to treatment. The diminution in
cases referred to rehabilitation centers, even assuming the same
aggressive zeal attached to Operation Ferret 2 years after its
initiation, must be understood in terms of the high level of success
likely with a new operation involving, in significant part, a
“creaming” of naive addicts. Certainly, any new operation of this
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type can be presumed to enjoy a greater degree of success in its
beginning stages than it will even a short time later. Thus, it is
impossible to know to what extent the reduced rate of treatment
referral reflects reduced use of heroin, as opposed to an increased
capacity to use heroin covertly. Similarly, a relapse rate of 37
percent, while again suggesting success of the commitment/surveil-
lance program, must be interpreted with some caution, since the only
outcome data available to McGlothlin were returns to treatment or
convictions. While the close supervision of rehabilitation center
releasees argues for the accuracy of those figures, McGlothlin himself
raises the specter of a switching to other drugs not tested (as of
1979) in supervisees’ urine specimens. One can again posit that
heroin users also became more expert at hiding their drug use from
the authorities.
Nonetheless, while arguing about the degree of success, it seems clear
that civil commitment and related enforcement practices in Singapore
achieved the desired goal of containing the heroin crisis. That is,
the procedures achieved the societal objective of permitting
Singapore’s continued economic growth and prosperity. Again, civil
commitment was justified as necessary to the well-functioning of the
society. A health issue could be seen as carrying a threat sufficient
to demand social-control behaviors.
THE SPECIAL CASE OF AIDS
In that context, it is interesting to consider Connell’s address to the
Annual Meeting of the Society for the Study of Addiction, in London,
in November 1985 (Connell 1986). Connell notes the opportunities
available to manage and treat addiction problems in the United
Kingdom, but raises, as a potential and dramatic threat to British
efforts, the likely emergence of AIDS in the United Kingdom.
Connell himself makes no mention of civil commitment or of any
policy initiative in relation to AIDS. It is, for Connell, simply an
issue about which his colleagues should be aware. Nonetheless, we
can raise the question as to whether AIDS has the potential to
encourage civil commitment practices directed toward intravenous
drug users in at least some parts of the world. Given that AIDS is a
lethal disease spread, in significant part, through the sharing of
needles by intravenous drug users, there would certainly appear to be
potential for marshaling public support in response to a clear and
dramatic health risk. Moreover, it can be argued that the risk of
AIDS will not stay long and, indeed, is not staying exclusively in
traditionally pariah populations, e.g., gays and drug users. Again, at
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least in the United States, AIDS has edged its way into the hetero-
sexual population, and, to the extent it has, the origins of the
disease have been largely traceable to the sexual activity of addicts.
Similarly, the intravenous drug user has been viewed as largely
responsible for cases of pediatric AIDS. There are, of course, many
constraints on national policy and behavior in relationship to any
threat, including that posed by AIDS. Certainly one such constraint
is that the health risk is not viewed as of sufficient moment to
society or, if one will, to the heterosexual society, to warrant social-
control measures. lf that threat increases, given the availability of
commitment procedures specific to a population many feel they
already have reason to disparage, civil commitment may become a
policy for serious consideration.
CONDITIONS NECESSARY TO IMPLEMENT CIVIL COMMITMENT
In summary, the conditions that follow have been described as
necessary to implement civil commitment procedures.
First, and perhaps foremost, there needs to be the appearance of
major risk to the larger society by virtue of a subgroup’s inappro-
priate behavior.
There needs to be the capacity to marshal significant public
support for (or, at worst, neutralize public opposition to)
containing those behaviors.
There must be a capacity and/or a technology to identify and to
isolate the subgroup with the offending behaviors.
The offending subgroup must be without sufficient political support
or capability to mount a competing political pressure on its own
behalf.
Mechanisms must be available to process, detain, and confine
individuals whose behaviors can be seen to be inappropriate and
threatening.
Finally, there should be a belief in the community’s ability to
develop initiatives that will humanely change individuals’ behavior
for their own and for society’s well-being.
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The Costs of Crime and the Benefits
of Drug Abuse Treatment: A Cost-
Benefit Analysis Using TOPS Data
Henrick J. Harwood, Robert L. Hubbard,
James J. Collins, and J. Valley Rachal
INTRODUCTION
The toll of drug abuse on society is high, both in social and
economic terms. Despite increases in Federal and State budgets, the
public resources for addressing the problems of drug abuse are still
limited. To reduce the high cost of drug abuse, available resources
must be allocated for cost-effective public efforts. Allocation of
resources requires careful consideration of the probable costs and
benefits of alternative public efforts to address the problems. One of
the principal efforts to reduce the social cost of drug abuse, particu-
larly the costs attributed to crime, is drug abuse treatment. This
paper uses data from the Treatment Outcome Prospective Study
(TOPS) to assess the benefits of crime reduction attributable to drug
abuse treatment (Hubbard et al. 1984b).
ECONOMIC lMPACT OF DRUG ABUSE
Until recently, the major perceived economic cost of drug abuse was
the criminal activity ostensibly motivated by the high cost of
addiction to heroin and other expensive drugs. The extensive and
still growing literature on the drug/crime link (Gandossy et al. 1980;
Ball et al. 1980; Chaiken and Chaiken 1982; Collins et al. 1985;
Gropper 1984; Johnston et al. 1985) has spawned a literature on the
economic costs to society of drug-related crime (Harwood et al. 1984;
Cruze et al. 1981; Rufener et al. 1977; Goldman 1978; Lemkau et al.
1974; Arthur D. Little Company 1974).
The most recent economic-cost study (Harwood et al. 1984) found
that Crime-related costs of $18.343 billion were a major part of the
estimated $47 billion total cost to society of drug abuse (table 1).
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Most of the crime-related costs ($10.2 billion) were attributable to
the loss of criminals’ potential legitimate productive activity and to
the cost of incarceration. Federal drug traffic control efforts totaled
$537 million, and other criminal justice system (CJS) expenditures
were $4.5 billion. Victim losses from property damage, lost produc-
tivity, and homicide were $1.8 billion, and private protection services
were $1.3 billion.
TABLE 1. Economic costs of drug abuse—1980
Costs of Drug Abuse Value
(dollars in millions)
Crime-Related Costs
Federal Drug Interdiction $537
Other Drug-Trafficking CJS 2,178
Other Drug-Related Crime CJS 2,276
Private Protection Services 1,297
Private Legal Services 48
Property Damage 111
Victim (Lost Productivity) 919
Homicide (Lost Productivity) 786
Incarceration of Criminals 1,466
Crime Career 8.725
Subtotal 18,343
Other Costs
Drug Abuse Treatment 1,200
Other Health Support Services 243
Drug Overdose Deaths 1,194
Reduced Workforce Productivity 25,716
Lost Employment 2 3 8
Subtotal 28,591
Total 46,936
SOURCE: Harwood et al. 1984.
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Most of the non-crime-related costs were from reduced productivity
in the workforce ($25.7 billion). Other large costs were $1.2 billion
for drug abuse treatment and $243 million for other health
expenditures including education, prevention, and research.
PERSPECTlVES ON SOCIAL COST
The methodology used to estimate the social cost requires the use of
an accepted economic framework. Alternative perspectives on the
role of other factors (expenditures on illegal drugs, the value of
stolen property, and nonpecuniary effects of crime) need to be
carefully considered.
Expenditures on illegal drugs and the value of property stolen by
drug abusers are not included in the $47 billion calculation. Esti-
mates of the retail value of illegal drugs consumed in 1979 range
from $21 billion to $65 billion (U.S. Department of the Treasury,
Internal Revenue Service 1983). The 1980 National Victimization
Survey (U.S. Department of Justice, Bureau of Justice Statistics 1984)
estimated that $7.3 billion was stolen from all individuals in 1980.
The study by Harwood et al. (1984) estimated that $1.5 billion of the
$7.3 billion could be attributed to thefts by drug addicts. These
values are excluded from the total crime cost estimate to avoid
double counting.
The issue of double counting drug expenditures and the income used
to purchase the drugs must be handled carefully. These two compo-
nents are opposite perspectives on the same transaction, and the two
values are equal. Therefore, they should not be added together. Each
of the drug abuse cost studies cited above avoided the double
counting problem by using only the income side of the drug market
ledger in making total cost estimates. However, the problem of
double counting also arises when calculating the value of stolen
property. When property is stolen, it is, in effect, involuntarily
transferred from a law-abiding citizen to a criminal. While there is a
loss to the victim, the criminal gains. Therefore, there is no net loss
to society. Both the value of stolen property and how much is lost
in legitimate productivity can also be estimated. These two compo-
nents, however, are not necessarily equal in value and should not be
added together.
It is also widely recognized that crime exacts a greater toll from
society than is typically measured in monetary terms. The lives of
victims, their families, friends, and neighbors are all disrupted by
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fear, shock, pain, and suffering. Articles stolen may have value to
the victims far beyond the “market price” of a replacement or the
value of the stolen Rem on the street. Although quite real, these
dimensions of crime are excluded from consideration in this study (as
they are in virtually all studies on the economics of crime) because
dollar amounts for their values cannot be estimated.
OBJECTIVES OF THE CURRENT STUDY
The major objective of this study is to estimate the economic
benefits of drug abuse treatment in reducing criminal activity of drug
abusers during and after treatment. The study also examines whether
clients referred to treatment from the CJS demonstrate reduced crime
costs during the year following treatment discharge.
This chapter describes the methodology used to calculate the costs
and benefits in the established cost-of-illness economic framework.
Next, these methodologies are used to calculate costs in the periods
before, during, and after treatment for clients participating in TOPS.
Specifically, the costs of drug abuse treatment are compared with the
savings of lower crime rates. The primary comparison is between the
average cost of providing a day of treatment and the reduction in
crime-related costs during the year following discharge from treat-
ment. In addition to these basic descriptive tabulations comparing
criminal activity costs before, during, and after treatment, the
posttreatment economic benefits have been estimated using multi-
variate regression analysis.
METHODOLOGY
The following sections describe: (1) the data base used to calculate
the crime-related costs and benefits; (2) the methodologies used for
the calculations; and (3) the potential effects of the quality of the
self-report data.
Data Base
TOPS is a longitudinal survey with data on over 11,000 drug abusers
admitted to 41 different treatment programs in 10 different cities
across the nation. TOPS has been described in detail in Hubbard et
al. (1984b). The programs included the major treatment modalities
(outpatient methadone, residential, and outpatient drug free).
Information from clients and program records was obtained to
indicate whether a client was referred to treatment from the criminal
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justice system. Records were also checked to determine how long
clients stayed in treatment.
All participating clients were interviewed at admission to treatment
and during the period of time they received treatment services from
the participating TOPS program. Samples of clients were selected for
followup interviews at 3 months, 12 months, or 24 months following
discharge from treatment. Another sample was reinterviewed 3 to 5
years following admission to treatment. Most of the analyses
reported here are based on the 12-month followup sample of clients,
although some analysis has been done on the 24-month and 3- to 5-
year samples.
The TOPS data base is used for this analysis because it includes
detailed information about clients’ criminal activity and involvement
with the CJS. Self-reports were obtained of aggravated assault,
robbery, burglary, theft, auto theft, forgery/embezzlement, fencing,
gambling, pimping/prostitution, and drug sales or manufacturing. The
data covered the 12 months preceding the admission, each 3-month
period during treatment, and the specified periods after treatment
termination. The respondents were asked whether they were involved
in the illegal activity in each time period and, if so, how many times
they did the act. Other important information from the interview
was the number of arrests (by type of offense) and days spent in jail
or prison in each period.
In addition, respondents were asked about their income from “illegal
or possibly illegal sources, such as hustling or dealing,” and the
amount received. Other questions concerned income from a legitimate
job or business, various public assistance programs, family or friends,
and expenditures on illicit drugs.
Calculations for Components of Social cost of Drug-Related Crime
This study used the cost framework and methodology developed by
Harwood et al. (1984). In that methodology, the cost components are
the tangible consequences of drug abuse that can be assigned dollar
values. Values were estimated for three explicit kinds of drug-
related crime costs: victim costs, CJS costs, and crime career/
productivity costs.
Victim Costs: the value of medical services, property destruction,
and lost work and household productivity.
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CJS Costs: the cost of police protection services, prosecution,
adjudication, public defense, and corrections services.
Crime Career/Productivity Losses: the value of legitimate
productivity lost because individuals pursued income through
predatory or consensual crime.
Each of these types of crime-related impacts or costs involves a loss
of resources to the detriment of society’s economic well-being.
Victim costs from crime include the expense of medical treatment,
the value of personal property damaged or destroyed in the crime,
victim loss of productivity at work or in the home because of injury
or simple inconvenience, and the value of the stolen property.
Crime career/productivity costs include the loss of legitimate
productivity when criminals never enter the economy or when they
leave it for illegal pursuits such as burglary, theft, drug trafficking,
prostitution, or gambling. Such costs also include incarceration costs
for drug-related crimes and the loss of opportunity to participate in
the legitimate economy.
This study has calculated the value of these costs for the year before
admission, the period in treatment, and the appropriate followup year
for each drug abuser admitted to treatment. These values were
estimated by assignlng average values (costs) to each criminal act the
client reported in the interview. Estimates of victim costs per crime
(by type of crime) are baaed on the 1979 National Victimization
Survey (U.S. Department of Justice, Bureau of Justice Statistics 1983).
These average values for medical costs, property damage, loss of
productive time, and value of property stolen are in table 2.
CJS costs per crime were calculated for police services, adjudication,
and incarceration. Police costs per act were based on an average
police cost per arrest in 1979 and adjusted by the probability that a
type of crime will result in an arrest. In 1979, total police expend-
itures In the United States were $17 billion (U.S. Department of
Justice, Bureau of Justice Statistics 1981). This value, divided by the
10 million arrests in 1979 (U.S. Department of Justice, Federal Bureau
of investigation 1981), indicates average police expenditures of $1,700
per arrest.
Although only a fraction of offenses result in arrests, police incur
costs for every offense they are required to investigate. Therefore,
the police investigation costs are averaged across the number of
214
TABLE 2. Costs to victims per offense
Type of Offense Type of Cost
(dollars per victimization)
Property Property
Employment Stolen
Aggravated Assault $210 $80 $150 $0
Robbery 50 20 220 300
Burglary 0 30 140 690
Theft 0 10 110 130
Auto Theft 0 100 160 2,670
SOURCE: U.S. Department of Justice, Bureau of Justice Statistics 1984.
offenses per arrests. For example, the Uniform Crime Reports (UCR)
reported 500,000 arrests for aggravated assault in 1979, while there
were an estimated 4 million assaults according to the National Crime
Survey. Therefore, eight assaults occurred for every arrest for
assault; average police investigation costs were $212 per aggravated
assault (or $1,700 per arrest divided by eight offenses). The results
of these calculations for each offense type are presented in table 3.
Crime career/productivity costs are estimated for each drug abuser by
calculating the difference between the person’s actual self-reported
legitimate earnings and an expected or national average for persons
of the same age and sex estimated by the Bureau of Labor Statistics.
Virtually all drug abusers in this sample had actual earnings below
average, both before and after treatment. The proportional deficit in
expected productivity was also applied to expected fringe benefits and
household productivity.
All values in the following analysis are adjusted for inflation to 1979
dollars, the year of the first TOPS admission cohort.
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TABLE 3. Police investigation costs
Offense Value
(dollars per
self-reported crime)
Aggravated Assault $290
Robbery 240
Burglary 140
Theft 80
Auto Theft 320
Forgery 110
Fencing 60
Gambling 0.10
Prostitution 0.20
Drug Trafficking 0.20
SOURCE: U.S. Department of Justice, Bureau of Justice Statistics 1984.
Methods of Summarizing Costs
The benefits of treatment can be weighed against the sums of various
cost components rather than a single cost component. Two summary
measures are described below.
(1) Costs to Society: the value of net losses of goods and services
to all of society, including victim losses, CJS costs, and crime
career/productivity losses.
(2) Costs to Law-Abiding Citizens: the sum of victim losses plus
CJS costs, plus the value of theft.
The cost to society includes costs to victims, CJS costs, and crime
career/productivity costs. The value of stolen property is not
included in the cost to society because the loss by law-abiding
citizens is offset by the gain to law-breaking individuals.
The cost to law-abiding citizens includes victim losses, the value of
property stolen, and CJS costs. Crime career/productivity costs are
excluded from this measure because foregone legitimate earnings are
not a loss to law-abiding citizens, but rather a loss to law-breaking
216
citizens and their families. While the concept of the cost to law-
abiding citizens has appeal, a more complex calculation could include
factors such as income subsidies received by drug abusers or their
families, taxes, fines, or restitution paid by drug abusers. Because of
the complexity of attributing these costs to criminal activity, these
values have been excluded from this analysis.
Quality of TOPS Self-Reports of Illegal Activity
The quality of the data on criminal activity needs to be carefully
considered in the following analyses. Some clients appeared to
exaggerate their level of criminal activity. Others refused to respond
to the questions. lt was found that a small number of respondents
claimed to have committed 500 or more predatory offenses in a year.
Criminal activity counts of this magnitude were judged to be unreal-
istically high, although most of the individuals did appear to be
heavily involved in crime. Accordingly, annual activity values for
predatory crimes that were greater than 365 were reduced to 365
(one act per day).
The rate of missing data for the pretreatment illegal activity ques-
tions was three to four times as high as the rate on the posttreat-
ment questions. One hundred and eighty-four of the 2,420 clients in
the l-year followup sample refused to answer the entire section on
criminal acts for the pretreatment period, compared to only 67 for
the posttreatment period. Nonresponse to selected items of the
criminal activity section was much higher, although the 3 to 1 ratio
of pretreatment to posttreatment nonresponse was maintained (table
4). Item nonresponse averaged 15 percent for the pretreatment
period (ranging from 10 to 20 percent), and about 4.5 percent for the
posttreatment period (ranging from 3 to 6 percent).
Several alternative approaches to handling nonresponse were
considered. One was to simply exclude any case with missing data.
This approach was rejected because too many cases would have been
lost. Several different procedures for estimating the level of criminal
activity of clients with missing data were also considered. The
results of these imputations are presented in table 5. The low
imputation for a criminal activity item assumes that nonrespondents
were as active on average as those with a valid response (either zero
or greater than zero). The high imputation assumes that nonrespond-
ents were as active as respondents who admitted to any offenses on
that item. The middle imputation is an average of the low and high
imputations. Work by Chaiken and Chaiken (1982) suggests that
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TABLE 4. Criminal activity in the year before and after treatment
(2,420 clients)
Before Treatment After Treatment
Total Total
Offense Refusals Admissions Acts Refusals Admissions Acts
Assault 283 216 678 78 168 659
Robbery 310 178 2,124 83 120 740
Burglary 320 296 3,096 88 227 3,554
Theft 387 486 13,544 111 325 9,302
Auto Theft 300 98 505 79 91 1,165
Forgery 315 230 3,977 93 136 2,902
Fencing 346 302 8,098 98 218 5,880
Gambling 377 255 23,244 119 215 14,116
Prostitution 329 159 16,935 100 123 15,776
Drugs 537 547 84,315 146 406 54,715
All Items 184 NA NA 67 NA NA
Any of Above NA 1,161 156,576 NA 917 108,809
TABLE 5. Effect of alternative nonresponse imputations for
self-reported criminal activity on selected estimates in
the year after treatment (2,420 clients)
Number of
lllegal Acts
Pre Post
Victim Investigation Value of
Costs Costs Theft
(acts and dollars per person per year)
P r e Post Pre Post Pre Post
Level of Imputation
None 65 45 $1,321 $1,045 $1.382 $1,109 $2,431 $2,890
Low 80 47 1,546 1,089 1,618 1,155 2.819 3,002
Mid 114 55 2,061 1,200 2,229 1,289 3,995 3,333
High 145 67 2,723 1,540 3,034 1,700 5,640 4,832
nonrespondents to criminal activity questions are more likely to have
committed those acts and at a higher rate than those who admit
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criminal activity. The nonresponse problem suggests that pretreat-
ment costs are likely to be greater underestimates than the post-
treatment costs and that costs calculated with crime counts will be
underestimates.
The approach for handling nonresponse, adopted for all calculations in
this report, is to set any missing criminal activity value equal to zero.
This yields conservative estimates of the amount and concomitant
costs of criminal activity committed by our sample. The magnitude of
the nonresponse suggests that values calculated with these data will
underestimate costs, and that pretreatment values are likely to be
greater underestimates than the posttreatment values.
RESULTS AND DlSCUSSlON
Virtually all economic measures show that crime is lower after treat-
ment than before. However, the magnitude of the reduction differs
considerably, depending on the economic measure. Although
the overall effects of drug abuse treatment are important from a
programmatic and public policy perspective, the cost benefits of each
modality and CJS involvement need to be compared.
The definitions of each cost component used in the analysis are
shown in table 6.
Overall Economic Impacts
The initial analyses presented below describe the cost benefits for
clients entering outpatient methadone, residential, and outpatient
drug-free programs. In the year before treatment admission, crime-
related economic costs to society were an average of $15,262 per
client and fell to $14,089 in the year after treatment discharge (table
7). This is a reduction of economic impact of only $1 ,173 per client,
or about 8 percent. Costs to law-abiding citizens fell from $9,190
per client to $7,379 (about 20 percent).
According to self-reported criminal activity, costs to crime victims
fell by about 30 percent (from $1,802 to $1,236), and costs to the CJS
fell by about 24 percent (from $3,926 to $3,049). Partially offsetting
these reductions was a decrease in productivity from $9,534 to $9,804
(about 3 percent). The productivity loss, or crime career costs,
increased slightly even though legal earnings increased from $3,437 to
$3,858. The apparent contradiction arises because drug abusers’
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earnings did not increase as rapidly as would be expected for non-
abusers of the same age. Drug abusers report little improvement in
legal earnings—indicating continued low employment levels.
The 20 percent reduction in costs to law-abiding citizens is composed
of the reductions in costs to victims and the CJS and in the value of
theft from $3,462 to $3,094.
TABLE 6. Definition of terms
Cost Components
Drug Expenditures: the self-reported net amount spent on the
purchase of drugs for one’s own consumption.
Victim Costs: the value of medical services, property destruction,
and lost work and household productivity.
CJS Costs: the cost of police protection services, prosecution,
adjudication, public defense, and corrections services.
Value of Theft: the estimated value of property or money stolen by
the drug abuser.
Illegal Income: the self-reported net dollar amount realized by
criminally active individuals from predatory or consensual crime.
Legal Earnings: the amount earned in legitimate employment.
Crime Career/Productivity Losses: the value of legitimate produc-
tivity lost because individuals pursue income through predatory or
consensual crime.
Summary Estimates
Costs to Law-Abiding Citizens: the sum of victim losses plus CJS
costs, plus the value of theft.
Costs to Society: the value of net losses of goods and services to all
of society, including victim losses, CJS costs, and crime
career/productivity losses.
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The reduction in self-reported illegal income of drug abusers from
$6,937 per year to $2,546 per year is in strong contrast to the
modest improvements estimated above. Furthermore, it was found
that before admission drug abusers spent $6,854 per year (about $19
per day) on drugs (table 7) and in the year after treatment $2,687 (or
about $8 per day). The close correspondence between drug expendi-
tures and illegal income cannot be ignored. They were virtually
TABLE 7. Economic impacts of drug abusers 1 year before treatment
and 1 year after discharge (2,420 clients)
Before After
Treatment Treatment
(dollars (dollars
per person) per person)
Cost Components
Drug Expenditures
Victim
CJS
Value of Theft
Illegal Income
Legal Earnings
Crime Career/Productivity
Losses
Summary Estimates
Costs to Law-Abiding Citizens 9,190 7,379
Costs to Society 15,262 14,089
$6,854 $2,687
1,802 1,236
3,926 3,049
3,462 3,094
6,937 2,546
3,437 3,858
9.534 9,804
identical in each period and declined by similar values and propor-
tions. Similar high correlations between drug use and criminal
activity were also reported by Ball et al. (1980), Collins et al. (1985),
and Johnson et al. (1985).
The inconsistency of our findings on self-reported counts of criminal
acts and on self-reported dollar values needs to be examined. The
values based on criminal act counts reflect only modest reductions in
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costs between pretreatment and posttreatment, while the self-reported
dollar values indicate major reductions. We considered three reasons
for the apparent inconsistency. First, pretreatment costs may have
been underestimated because of the high nonresponse rate in the
pretreatment period. Second, the illegal income estimate includes
“receipts” from all kinds of illegal activity, not simply predatory
crime. Drug abusers may have reduced involvement in consensual
crime proportionately more than in predatory crime. Finally, drug
abusers may have engaged in less lucrative crimes during the followup
period by stealing smaller amounts or making smaller drug deals in an
attempt to reduce their risk of arrest and incarceration. Resolution
of these issues would require more detailed data in both treatment
outcome studies and ethnographic observations.
Effects of CJS Involvement
Clients referred to drug abuse treatment by the CJS (CJS referrals)
are different than other criminally active but self-referred clients.
One major difference is that the CJS refers clients primarily to
residential and outpatient drug-free treatment. The results of this
section are based solely on clients entering TOPS residential and
outpatient drug-free treatment. The CJS referrals generally cost
society and law-abiding citizens more than the self-referrals in both
the pre- and posttreatment periods. This was largely because CJS
referrals admitted significantly more crimes (and the corresponding
victim, CJS, and theft costs) than the self-referrals.
Clients treated in residential facilities had appreciable reductions in
crime-related economic costs from the year before admission to the
year after discharge. This is true both for individuals referred from
the CJS and for self-referrals. The CJS referrals imposed costs on
law-abiding citizens of $17,392 per year in the 12 months before
admission to the TOPS treatment episode and $10,963 in the year
after discharge, a 35 percent reduction (table 8). In contrast, the
self-referrals had pretreatment costs of $11,123, which fell to $4,641
after discharge, a 60 percent reduction. Although the CJS referrals
reduced their costs by about as much as the self-referrals, the
proportional decrease was smaller due to their greater costs before
intake. The same pattern holds true for changes in costs to society.
In contrast to residential treatment, outpatient drug-free treatment
seems to have relatively small cost-reduction benefits. The CJS
referrals had costs to law-abiding citizens of $4,595 before treatment
and $4,108 after treatment, a reduction of about 11 percent (table 9).
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The costs for self-referrals actually rose from $4,227 per year before
treatment to $5,343 after treatment. The reductions in costs to
society for both CJS referrals and self-referrals were modest (4
percent and 10 percent, respectively).
The types of individuals entering residential treatment are quite
different from those entering outpatient drug-free treatment. The
residential clients have much higher criminal costs both before and
after treatment than the outpatient drug-free clients. Although the
costs for residential clients improved substantially between the pre-
and posttreatment years, in the year after treatment the residential
TABLE 8. Average economic impacts of drug abusers in the year
before treatment end the year after discharge from
residential treatment by source of referral (2,420
clients)
CJS Criminally Active
Referrals Self-Referred
(dollars per person) (dollars per person)
Before After Before After
Treatment Treatment Treatment Treatment
Cost Components
Drug Expenditures $5,398 $2,666 $7,965 $2,852
V ic t im 1 , 2 3,045 1,795 2,968 928
CJS1,2 7,137 4,778 3,550 2,093
Theft1 7,210 4,392 4,605 1,620
Illegal Income 6,799 3,747 9,932 2,444
Legal Earnings 2,601 2,940 3,056 3,054
Crime Career2 10,239 10,758 9,852 10,672
Summary Estimates
Costs to Law Abiders 17,392 10,983 11,123 4,841
Costs to Society 20,421 17,329 16,370 13,693
1The sum of these items equals the costs to law abiders.
2The sum of these items equals the costs to society.
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CJS referrals still had significantly higher costs to law-abiding
citizens than the outpatient drug-free CJS referrals had. Self-
referrals in residential treatment had somewhat lower posttreatment
costs than outpatient drug-free self-referrals.
TABLE 9. Average economic impacts of drug abusers in the year
before treatment and the year after discharge from
outpatient drug-free treatment by source of referral
(2,420 clients)
CJS Criminally Active
Referrals Self-Referred
[dollars per person) (dollars per person)
Before After Before After
Treatment Treatment Treatment Treatment
Cost Components
Drug Expenditures
Victim1,2
$1,911 $1,592
647 608
CJS1,2 2,621 2,239
Theft1 1,327 1,261
Illegal Income 2,743 2,140
Legal Earnings 4,543 5,311
Crime Career2 7,484 7,467
Summary Estimates
Costs to Law Abiders 4,595 4,108 4,227 5,343
Costs to Society 10,752 10,314 8,693 7,764
$3,853 $2,429
1,266 1,006
1,498 1,551
1,463 2,786
3,411 1,406
3,849 5,223
5,929 5,227
1The sum of these items equals the costs to law abiders.
2The sum of these items equals the costs to society.
Cost-Benefit Ratios of Treatment
Residential treatment is more expensive than outpatient drug-free
treatment and yields greater reductions in costs from the pre- to
posttreatment periods. According to special tabulations from the 1979
National Drug and Alcohol Treatment Utilization Survey (NDATUS),
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residential treatment costs three times as much as outpatient drug-
free treatment: $18.50 per day compared to $6.00 per day. In TOPS,
the average residential treatment stay was 159 days, for a total
episode cost of $2941.50. The average outpatient drug-free episode
was 101 days, for an average cost of $606 per episode.
The average residential treatment episode cost $3,000 and yielded a
reduction of $6,000 in the costs to law-abiding citizens for both CJS
and self-referrals. Outpatient drug-free treatment cost $600 and
yielded a $500 reduction for CJS referrals and a $900 increase for
self-referrals. Residential treatment produced benefits to society of
about $3,000 per client for both CJS and self-referrals with treatment
costs of about $3,000. Outpatient drug-free treatment produced
benefits of $450 for CJS referrals and $900 for self-referrals with
treatment costs of $600.
The ratio of benefits, i.e., reduction in costs, to the expense of
providing the treatment is strong for residential treatment. The ratio
is somewhat weaker (even unfavorable for self-referrals, using the
costs to law-abiding citizens measure) for outpatient drug-free
treatment. Note, however, that residential clients are significantly
more criminally active on average than outpatient drug-free clients.
It is not reasonable to judge the relative efficacy of the two treat-
ment modalities without a much more thorough and sophisticated
analysis. At this time, it may be sufficient to state that there are
notable economic benefits from drug abuse treatment and that these
benefits generally compare favorably with the cost of treatment in
the respective modalities. A positive cost-benefit ratio was obtained
in residential treatment and a breakeven was obtained for outpatient
drug-free treatment by the first year after treatment.
Modeling the Posttreatment Economic Benefits
Regression analyses were used to examine the correlates of crime
costs for outpatient methadone, residential, and outpatient drug-free
modalities for the 12 months after treatment. These analyses were
also used to estimate posttreatment benefits. In addition to
estimating the economic benefits from increased length of stay, the
models also examined the effects of previous treatment episodes,
pretreatment involvement in crime, and CJS involvement at entry into
treatment. In addition, sociodemographic (sex, age, race, and
education) and pretreatment drug use variables were included in the
models.
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Notable findings from these regression analyses were as follows.
Previous treatment involvement was not significantly associated
with crime costs to society in the year after residential or
outpatient drug-free treatment. More previous treatment before
outpatient drug-free treatment was associated with &favorable
crime costs to law-abiding citizens, i.e., higher costs in the year
after treatment.
High pretreatment crime costs were associated with less favorable
(higher) crime costs to law-abiding citizens per day of treatment
in the year after outpatient methadone treatment.
CJS-involved residential clients had less favorable (higher)
posttreatment crime costs than residential clients not legally
referred or involved. Crime cost benefits were substantial for
legally referred or involved clients, but such clients had to stay in
treatment longer than clients not legally involved to accumulate
the same crime cost savings.
The most consistent correlate of favorable crime cost outcomes
was time spent in treatment; longer stays are associated with
lower posttreatment crime costs.
The above results are not definitive comparisons of the effectiveness
for the three treatment modalities because separate models were
estimated for each modality. The findings of this research need to
be replicated elsewhere before these recommendations can be made
with confidence.
However, the same variables were included in each model, and the
following suggestions are based on the results.
The referral of those with extensive previous treatment experience
to outpatient drug-free treatment should be carefully assessed.
The referral of clients heavily involved in criminal activity to
outpatient methadone treatment should be carefully evaluated.
Because length of time in treatment is associated with favorable
outcomes, clients should be encouraged to continue in treatment
for additional months, not weeks.
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SUMMARY OF ECONOMIC RETURNS IN THREE TREATMENT
MODALITIES
There are positive economic returns to society from drug abuse
treatment. Similar conclusions are reached using two measures of
these benefits: costs to society (table 10) and costs to law-abiding
citizens (table 11). Benefits are estimated for the time clients are in
drug treatment and for the 12-month period following their dis-
charge from the TOPS episode.
TABLE 10. Summary of costs and benefits of drug abuse
treatment: benefits in reduced costs to
society
Treatment Modality
(costs and benefits in dollars)
Outpatient Outpatient
Residential  Methadone Drug Free
Estimated Costs and Benefits for Each Day of Treatment
Average Cost of Treatment
per Day $18.50 $6.00 $6.00
Average Benefit per Day
While in Treatment 15.77 5.54 7.63
Average Benefit per Day
Year After Treatment 21.40 (9.95)* 18.06
Estimated Costs and Benefits for a Treatment Episode of Average
Duration
Average Length of Stay (Days) 159 267 101
Total Cost of Treatment $2,942 $1,602 $606
Total Benefits in Treatment 2,507 1,479 771
Total Benefits After
Treatment 3,403 (2,657)* 1,824
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TABLE 10. (Continued)
Treatment Modality
(costs and benefits in dollars)
Outpatient Outpatient
Residential  Methadone Drug Free
Total Benefits in Treatment
and Year After Treatment 5,926 1,479 2,595
Ratio of Benefits to
costs 2.01 0.92 4.28
*Not statistically significant and, therefore, not included In benefits.
Intreatment benefits are estimated as the difference between an
individual’s costs during treatment and those costs before or after
treatment, as hypothesized costs (to society and law-abiding citizens)
during treatment were notably lower than either before or after
treatment. Posttreatment benefits are estimated from a multivariate
regression analysis estimating the returns from increased length of
stay. In general, the returns to increased length of stay in treat-
ment are positive and significant both statistically and clinically. For
a complete discussion of these analyses see Harwood et al. (1987).
Residential
Residential treatment appears to have the greatest economic return of
the three modalities examined in this study. Using the reduction in
cost to law-abiding citizens, the return of an additional day’s
treatment is estimated at $37.62, somewhat higher than the return to
society of $21.40 per day. Clients admitted to residential treatment
imposed costs on law-abiding citizens of $43.17 per day before
treatment. This was only $0.65 per day while in treatment. Alterna-
tively, the cost to society was $53.18 per day before treatment and
$33.13 during treatment. By either measure, the economic benefit of
the intreatment period was substantial, at $42.52 per day or $20.05
per day, depending on the measure chosen to estimate benefits. A
more conservative way of estimating treatment benefits is to compare
the intreatment value with costs per day following treatment. This
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TABLE 11. Summary of costs and benefits of drug abuse treatment:
benefits in reduced costs to law-abiding citizens
Treatment Modality
(costs and benefits in dollars)
Outpatient Outpatient
Residential  Methadone Drug Free
Estimated Costs and Benefits for Each Day of Treatment
Average Cost of Treatment
per Day $18.50 $6.00 $6.00
Average Benefit per Day
While in Treatment 33.44 13.30 7.65
Average Benefit per Day
Year After Treatment 37.62 10.96 (16.40)*
Estimated Costs and Benefits for a Treatment Episode of Average
Duration
Average Length of Stay (Days) 159 267 101
Total Cost of Treatment $2,942 $1,602 $606
Total Benefits in Treatment 5,317 3,551 773
Total Benefits After Treatment 5,982 2,926 (1,656)*
Total Benefits in Treatment
and Year After Treatment 11,299 6,477 773
Ratio of Benefits to Costs 3.84 4.04 1.28
*Not statistically significant and, therefore, not included in benefits.
conservative approach would indicate benefits of $24.36 per day for
law-abiding citizens or $11.38 per day for all of society.
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A middle estimate of intreatment benefits, using all intreatment
analyses, is derived by averaging the high estimate and the conserva-
tive estimate. The middle estimates of intreatment benefits are
$15.77 in savings to society and $33.44 in savings to law-abiding
citizens.
After summing benefits from the intreatment and 12-month posttreat-
ment periods, the return was $71.06 per day in residential treatment,
using the costs to law-abiding citizens, or $37.17 per day, using the
costs to society. The price paid to achieve these returns was about
$18.50 per day of treatment in publicly funded residential treatment
facilities in 1979 to 1981 (Allison et al. 1985).
The costs and benefits from a treatment episode in a residential
facility are readily summarized (tables 10 and 11). A stay of 159
days (the average for this sample) would incur treatment costs of
$2,942. Savings in costs to society would be $2,507 during treatment,
and another $3,403 in the year following treatment discharge. Total
benefits to society would be $5,926, for a ratio of benefits to costs
of 2.01. Savings in costs to law-abiding citizens would be $5,317
during treatment and another $5,982 in the year following discharge.
Total benefits would be $11,299, or 3.64 times the cost of the
treatment episode.
Outpatient Methadone
The economic returns to outpatient methadone treatment are also
positive, although more modest than to residential treatment. The
average reduction in cost to law-abiding citizens was $24.26 per day
of treatment ($10.96 per day during the followup year, plus $13.30 per
day while being treated). The return to society was $7.29 per day
while in treatment, but there were no statistically significant benefits
to society in the followup year.
The cost of methadone treatment is estimated to be $6 per client
day, based on data the TOPS programs provided NDATUS (Allison et
al. 1985). These values indicate that society virtually saves its total
costs for methadone treatment on the day that it is delivered, and
that longer lasting effects are an economic bonus. There were
statistically significant benefits to law-abiding citizens in the
followup year, although benefits were negligible or even negative for
treatment of the most criminally active clients.
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The average episode of outpatient methadone treatment for this
sample lasted 267 days. Benefits to society for this episode were
almost equal to the cost of treatment ($1,479 and $1,602 respec-
tively), and benefits to law-abiding citizens were four times as great
as treatment costs ($6,477 and $1,602, respectively). The ratio of
benefits to the cost of treatment was 0.92 for the costs-to-society
measure and 4.04 for the costs-to-law-abiding-citizens measure.
Outpatient Drug Free
The costs of outpatient drug-free treatment (about $6 per client day)
compare very favorably with the benefits estimated in this study.
Benefits to law-abiding citizens were $7.65 per day of treatment (all
from intreatment benefits); posttreatment benefits were sizeable,
although not statistically significant. Benefits to society were even
larger, at $25.69 per day of treatment ($7.63 per day while in
treatment and $18.06 per day during the followup year).
An average treatment episode for outpatient drug-free services was
101 days for this sample. The cost of treatment for an average stay
was about $606, while the benefits were $2,595 and $773 in costs to
society and law-abiding citizens, respectively. The ratios of economic
benefits to the cost of treatment are 4.28 for costs to society and
1.28 for costs to law-abiding citizens.
CONCLUSION
There are three critical questions that these estimates of benefits
raise. The first concerns the expected duration of the treatment
effect, the second concerns the relative efficacy of the three
treatment modalities, and the third concerns the economic value of
simply enrolling in treatment regardless of length of treatment.
The benefits totaled at this point include only the intreatment period
and the first year after treatment discharge. While no multivariate
estimates have been made, there is reason to believe that treatment
effects may last more than 1 year. Some clients are completely
rehabilitated through drug treatment, leaving their drug habits and
criminal careers behind. Even if it is contended that drug abusers
eventually “mature out” of their lifestyle without treatment, the
treatment effects estimated in this study indicate that clients who
stay in treatment for longer periods are more likely to mature out
than those with only short treatment episodes. Consequently, the
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intreatment and 1-year followup values estimated in this study are
only a partial accounting of benefits.
While this study has estimated economic returns for three different
drug abuse treatment modalities, the issue of the relative efficacy for
these modalities to treat specific individuals has not been addressed.
In other words, issues of “treatment matching” or self-selectivity bias
are not included here. Although greater returns are estimated from
residential treatment than from methadone or outpatient drug-free
treatment in this quasi-experimental study design, there has been no
random assignment of clients to modalities or to length of stay. lt is
not possible to conclude that methadone and outpatient drug-free
clients assigned to residential programs would get the same benefits
as those observed for residential clients in this study.
Finally, these multivariate estimates of benefits do not indicate the
value to society of drug abusers voluntarily deciding to find help for
their addiction problem and to seek treatment. There may be crime-
reduction benefits to society from this voluntary decision to change
the “addict lifestyle,” regardless of how long drug abusers stay in
treatment. However, the TOPS database can only indirectly address
this issue, because no untreated drug abusers are included in the
TOPS database. One comparison group may be those who enrolled in
treatment and then left very quickly.
Despite the limitations cited above, it appears that there are real
returns to society and law-abiding citizens from greater length of
stay for CJS referrals. The benefits occur even though CJS referrals
are more criminally active than self-referrals in the followup year.
Unfortunately, there is no comparison group of drug abusers sent to
prison or put on probation without referral to drug treatment.
The findings from this study indicate that there are significant
economic benefits associated with drug abuse treatment. Generally,
these benefits seem to be at least as great as the expense of each
modality. There also appear to be greater crime-reduction benefits
accruing to treatment in residential facilities than in methadone or
outpatient drug-free programs. Longer term outcomes must be
assessed to determine the duration of these different benefits.
232
REFERENCES
Allison, M.; Hubbard, R.L; and Rachal, J.V. Treatment Process in
Methadone, Residential, and Outpatient Drug-Free Programs.
National Institute on Drug Abuse Treatment Research Monograph
Series. DHHS Pub. No. (ADM) 85-1388. Rockville, MD: the
Institute, 1985. 89 pp.
Arthur D. Little Company. Social Cost of Drug Abuse. Report for
the Special Action Office for Drug Abuse Prevention of the
Executive Office of the President. Cambridge, MA: Arthur D.
Little Company, 1974. 55 pp.
Ball, J.C.; Rosen, L; Flueck, J.A.; and Nurco, D.N. The criminality
of heroin addicts when addicted and when off opiates. In:
Inciardi, J.A., ed. Crime/Drug Nexus. Beverly Hills, CA: Sage,
1980. pp. 39-65.
Chaiken, J., and Chaiken, M. Varieties of Criminal Behavior. Santa
Monica, CA: Rand, 1982. 321 pp.
Collins, J.J.; Hubbard, R.L; and Rachel, J.V. Expensive drug use and
illegal income: A test of explanatory hypotheses. Criminology: An
Interdisciplinary Journal 23(4):743-764.
Cruze, A.M.; Harwood, H.J.; Kristiansen, P.L; Collins, J.J.; and Jones,
D.C. Economic Costs of Alcohol and Drug Abuse and Mental
Illness-1977. Research Triangle Park, NC: Research Triangle
Institute, 1981. 302 pp.
Gandossy, R.P.; Williams, J.R.; Cohen, J.; and Harwood, H.J. Drugs
end Crime. A Survey and Analysis of the Literature. Washington,
DC: U.S. Department of Justice, National Institute of Justice, 1980.
173 pp.
Goldman, F. The SociaI Costs of Drug Abuse. Draft. New York:
Columbia University, 1978. 105 pp.
Gropper, B.A. Probing the links between drugs and crime. NIJ
Reports/SNI 188:4-8, 1984.
Harwood, H.J.; Collins, J.J.; Hubbard, R.L; Marsden, M.E.; and Rachal,
J.V. The Costs of Crime and Benefits of Drug Abuse Treatment.
(RTl/3413/00-01FR.) Research Triangle Park, NC: Research
Triangle Institute, 1987. 48 pp.
Hat-wood, H.J.; Napolitano, D.M.; Kristiansen, P.L; and Collins, J.J.
Economic Costs to Society of Alcohol and Drug Abuse and Mental
Illness: 1980. (RTl/2734/00-01FR.) Research Triangle Park, NC:
Research Triangle Institute, 1984. 234 pp.
Hubbard, R.L.; Marsden, M.E.; and Allison, M. Reliability and Validity
of TOPS Data. (RTl/1901/01-15S.) Research Triangle Park, NC:
Research Triangle Institute, 1984a. 50 pp.
233
Hubbard, R.L; Rachal, J.V.; Craddock, S.G.; and Cavanaugh, E.R.
Treatment Outcome Prospective Study (TOPS): Client
characteristics and behaviors before, during, and after treatment.
In: Tims, F.M., and Ludford, J.P., eds. Drug Abuse Treatment
Evaluation: Strategies, Progress, and Prospects. National lnstitute
on Drug Abuse Research Monograph 51. DHHS Publication No.
(ADM) 84-1329. Washington, DC: Supt. of Docs., U.S. Govt. Print.
Off., 1984b. pp. 42-68.
Johnson, B.; Goldstein, P.; Preble, E.; Schmeidler, J.; Lipton, D.;
Spunt, B.; and Miller, A. Taking Care of Business: The Economics
of Crime by Heroin Abusers. Lexington, MA: Lexington Books,
1965. 275 pp.
Lemkau, P.; Amsel, Z.; Sanders, B.; Amsel, J.; and Seif, T. Social and
Economic Costs of Drug Abuse. Baltimore, MD: Johns Hopkins
University, 1974. 85 pp.
Rufener, B.L; Rachal, J.V.; and Cruze, A.M. Management Effective-
ness Measures for NIDA Drug Abuse Treatment Programs, Vol. II:
Costs to Society of Drug Abuse. Research Triangle Park, NC:
Research Triangle Institute, 1977. 84 pp.
U.S. Department of Justice, Bureau of Justice Statistics. Justice
Expenditures and Employment in the U.S., 1979. Washington, DC:
the Bureau, 1983a. 265 pp.
U.S. Department of Justice, Bureau of Justice Statistics. Sourcebook
of Criminal Justice Statistics. Washington, DC: the Bureau, 1983b.
693 pp.
U.S. Department of Justice, Bureau of Justice Statistics. The
Economic Cost of Crime to Victims. Washington, DC: the Bureau,
1984. 8 pp.
U.S. Department of Justice, Federal Bureau of Investigation. Crime in
the United States, 1980: Uniform Crime Reports. Washington, DC:
the Bureau, 1981. 308 pp.
U.S. Department of the Treasury, Internal Revenue Service. Income
Tax Compliance Research. Washington, DC: the Service, 1983.
173 pp.
AUTHORS
Henrick J. Harwood, B.A.
Robert L. Hubbard, Ph.D
James J. Collins, Ph.D
J. Valley Rachal, M.S.
234
Research Triangle Institute
Box 12194
Research Triangle Park, NC 27709
235
Compulsory Treatment: A Review
of Findings
Carl G. Leukefeld and Frank M. Tims
INTRODUCTlON
The current drug abuse treatment system has its roots in a number of
initiatives closely related to the criminal justice system (Maddux 1967;
Maddux 1978). Specialized treatment (Rasor 1978) for addicts in the
United States began with two Public Health Service hospitals which
opened at Lexington, KY, in 1935 and at Fort Worth, TX, in 1938.
These hospitals treated incarcerated Federal prisoners but voluntary
patients were also accepted. However, most voluntary patients did
not remain for the entire treatment program. In fact, treatment
before passage of Public Law 89-793, 1966, the Narcotic Addict
Rehabilitation Act (NARA), did not provide for community aftercare,
and followup studies reported an extremely high relapse rate (Vaillant
1966). Vaillant (1966) also concluded that the most significant
variable in determining abstinence in the confirmed user was the
availability of compulsory parole supervision.
Using State civil commitment programs (e.g., compulsory court-
ordered treatment as an alternative to incarceration) from California
and New York as models, and the logic from available followup
studies (Maddux, this volume), NARA was enacted at the Federal level
in 1966. This legislation established a close linkage between the
health-care system and the criminal justice system and provided civil
commitment to keep addicts in treatment beyond withdrawal. NARA
also included community-based followup care after detoxification,
initially provided at the Lexington and Fort Worth hospitals, Later,
NARA inpatient treatment facilities were established in several major
cities. NARA also set the stage for community treatment of narcotic
addicts and, subsequently, drug abusers by providing initial funding
and developing a group of treatment experts in drug abuse.
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A second major effort in the drug abuse criminal justice area was the
Treatment Alternatives to Street Crime (TASC), which was established
in 1972 by the Special Action Office for Drug Abuse Prevention
(SAODAP) and was modeled, in part, on the court referral program
developed in Washington, DC. TASC is essentially a diversion
program for drug abusers. The program identifies clients, refers them
to treatment, and monitors their adjustment. It serves as an
“outreach” or “case-finding” function for treatment agencies
(Cook et al., this volume).
With the above brief history, the purpose of this volume is to review
existing research related to civil commitment and mandatory treat-
ment that might be applied to reduce the spread of the AIDS virus.
With that purpose, a specific consensus statement was developed by
the participant authors and is included here as written by those who
attended the meeting. The consensus suggests that, based on the
research that indicates that treatment is effective in reducing
intravenous drug abuse and that the length of time in treatment is
positively related to treatment success, the criminal justice system is
important for identification and retention of drug abusers in treat-
ment.
OVERVIEW OF THE FINDINGS
Using data from a 1974 to 1976 evaluation of the California Civil
Addict Program, the efficacy of mandatory treatment and civil
commitment was presented by Anglin (this volume). This evaluation
of nearly 1,000 addicts who came into the California Civil Addict
Program examined the joint effect of civil commitment and methadone
maintenance. That cohort was reinterviewed 25 years after admission
to the Civil Addict Program.
Using a time series approach, with the dependent variable the percent
of time spent using narcotics daily, data from 8 years prior to
admission (including an “out of control” period of usually 2 years
before admission to treatment) and 11 to 13 years following admission
showed significant changes. These changes show that civil commit-
ment has the effect of suppressing daily drug use and criminal
involvement. Other outcome variables showed similar but moderate
effects corresponding to decreasing drug use and criminal involve-
ment. However, the more prosocial the behavioral outcome, the less
dramatic the effect. For example, while significant effects on
employment were seen, they were not as dramatic as reductions in
antisocial behavior. While most of the changes reported were
237
moderate, Anglin maintains that a “long tail” of parole should be used
to monitor addicts against relapse to addiction. According to this
data, supervision without drug testing produced nearly the same
results as no supervision, while outpatient supervision and supervision
with testing showed major reductions in narcotics use. Therefore,
supervised aftercare with objective monitoring is the most important
component of civil commitment.
When Anglin examines the cohort in another way, civil commitment
reduced daily drug use for three groups—active drug users (showing
considerable addiction in the year prior to the interview), inactive
drug users (showing minimal addiction in the year prior to the
interview), and addicts on methadone maintenance at interview. From
these results, it can be concluded that civil commitment is an
effective approach for several behavioral types of addicts. However,
of the three programs reviewed (the California Civil Addict Program,
the New York State Civil Commitment Program, and NARA), only the
California program proved to be effective in modifying behaviors. It
was suggested that the New York State and NARA programs may not
have been as effective because they were administered through
agencies other than the criminal justice system.
Reviewing followup studies from the Lexington and Fort Worth Public
Health Service Hospitals, Maddux suggests that treatment with legal
coercion, when combined with compulsory community followup,
produced better outcomes but not vastly different from outcomes for
voluntary patients. Drawing on his experience at the Public Health
Service hospitals, Maddux also suggests that most opioid users enter
treatment with some type of coercion. NARA provided for supervised
aftercare following hospitalization at the Lexington and Fort Worth
Hospitals. That experience suggests that civil commitment will hold
about one-third of narcotic addicts in treatment. It appears that this
high attrition may have been related to the intensive psychosocial
approach. In addition, disruptive and noncompliant patients were
found not suitable for treatment and were quickly released. Further,
limited long-term followup research exists that examines coercion and
long-term abstinence. Therefore, civil commitment is useful for
bringing narcotic addicts into treatment, but it is not treatment and
cannot take the place of treatment.
TREATMENT OUTCOME STUDIES
The Treatment Outcome Prospective Study (TOPS) included 12,000
clients in 10 cities; 5 cities also had TASC programs. lt must be
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noted that in a 3-year study, from 1979 to 1981, only 17 clients were
referred to methadone maintenance programs by the criminal justice
system. Those clients who were more likely to be referred to treat-
ment by the criminal justice system included: males, younger clients
(21 to 25 years old), and those with no prior treatment. While some
of the TOPS data were not consistent with the California Civil
Addict data, the general conclusions are the same. Although there
are cautions, the bottom line from TOPS is that criminal justice
referral was effective for many addicts at an early stage in their
careers.
In outpatient methadone treatment, less than 3 percent of the TOPS
clients (by self-description) were criminal justice system referrals,
which contrasts with over 30 percent of the residential and out-
patient drug-free clients. Among those clients who self-reported
legal status, about 20 percent had some form of involvement with the
criminal justice system, although they did not indicate treatment
referral by that system. These data are very different from the
southern California data which Anglin presented. Further, in some
jurisdictions the criminal justice system will not refer clients to
methadone maintenance programs because such treatment is viewed
only as a continuation of drug use.
TOPS data indicate that young users, ages 21 to 25, were nearly
twice as likely to be referred by the criminal justice system than by
any other source of referral. Or to put it another way, an active
heroin user in treatment is half as likely to have been referred by
the criminal justice system. The trend shows a preference for
individuals with less severe drug problems to be referred to out-
patient drug-free treatment.
TOPS data confirm previous studies that found that criminal justice
system-referred clients often stayed in treatment longer, implying
stronger motivation. For example, regression coefficients indicate a
non-TASC/criminal justice system client would stay in treatment
approximately 28 days longer than a client with no criminal justice
involvement. Further, a TASC client would remain in treatment
nearly twice as long. However, this difference between TASC and
criminal justice referrals did not hold for residential treatment
clients. Another finding was a lower level of service for criminal
justice system referrals in outpatient programs. Looking at an array
of six different types of services, clients with no legal involvement
tended to receive more services in outpatient drug-free treatment.
Again, this differential did not appear in residential treatment. A
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possible explanation noted was that clients with no legal involvement
tended to have more psychological problems and aggression than
criminal justice system-referred clients and, therefore, may be in
more need of comprehensive treatment services.
Using a sample of 405 male addicts from the Drug Abuse Reporting
Program (DARP), Simpson examines the influence of pretreatment
legal status for addicts in their 12-year treatment followup study.
Legal status was defined as probation, parole, or awaiting trial. The
405 subjects were divided, 204 with legal status and 201 with no legal
status. For this study, legal status was compared to reasons for
leaving treatment and to behavioral performance after leaving
treatment. With few exceptions, there were no significant relation-
ships between legal status and these selected variables. More
specifically, and for each treatment modality (including methadone
maintenance, therapeutic community (TC), outpatient drug free, and
detoxification), the length of time in treatment, reasons for dis-
charge, and posttreatment outcomes were similar for addicts with
legal status and for those with no legal status. However, it should
be noted that over 80 percent of the addicts involved in this analysis
had one or more prior arrests, and over half had spent time in jail
or in prison.
These findings for DARP suggest that legal status at treatment entry
is not related to treatment success. Nevertheless, there is evidence
from DARP and other treatment evaluation studies that treatment is
effective in improving behavioral outcomes. Longitudinal analysis of
opioid use patterns over time (Simpson and Marsh 1986) reveal that
25 percent of their sample never returned to daily opiate use during
the 12-year followup. In addition, and by year 12, 63 percent of that
total sample had not used opiates daily for at least 3 years.
Likewise, data from this 12-year followup indicates that, while they
were in a treatment program, 50 percent of the sample stopped using
opiates. Further, addicts who entered treatment were more often
influenced by legal pressures and family concerns. Finally, further
examination of the pre-DARP legal status variable reveals that addicts
who were admitted to DARP with legal involvement were more likely
to report in year 12 that probation, parole, and legal problems had
previously been important incentives for entering treatment.
EFFICACY STUDIES
After describing the TASC Program, Cook et al. depicts TASC as a
bridge between the criminal justice system and drug abuse treatment
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programs. In other words, TASC identifies, assesses, refers, and
monitors appropriate drug- and/or alcohol-dependent, nonviolent
offenders. Thus, treatment serves as an alternate or supplement to
the criminal justice system. Although there is a lack of compre-
hensive data, several evaluations of TASC (Collins and Allison 1963;
Lazar 1976) found that the TASC linkage provided an alternative to
incarceration that is less costly, and TASC clients remained in
treatment longer. Currently, more than 100 sites in 16 States have
TASC programs. Perhaps, most important to the success of TASC is
the case-management aspect which “tracks” drug abusers through
their drug careers.
Joseph draws upon his experiences and research to present a histor-
ical review of selected New York City programs which were developed
to combat opiate addiction. After defining probation (community
supervision in lieu of incarceration) as well as parole (community
supervision after incarceration), he presents research findings from an
evaluation study of five probation clinics operated by the New York
Office of Probation during the early 1970s. Four of these clinics
operated directly within probation offices. Although 53 percent of
the 1,000 persons treated from 1970 to 1973 were unemployed, only
10.4 percent of the first 900 admissions were rearrested.
Results from a study of the New York City Addiction Services
Agency’s Diversion Program revealed a 50 percent retention rate for
those patients admitted to methadone maintenance treatment for 12
months in 1973 and also a 60 percent retention in methadone
maintenance treatment during 1974. These findings also hold for both
TCs and ambulatory drug-free programs. After presenting additional
data, Joseph concludes by urging that methadone maintenance
treatment can have a number of cost-effective benefits when the New
York experience and data are examined.
lnciardi suggests “what not to do” in the area of civil commitment by
using his personal experiences in New York with the Narcotics
Addiction Control Commission (NACC). Data from a 1956 New York
study show that, while under supervision by specially trained parole
officers, 45 percent of the parolees refrained from drug use (Diskind
and Kronsky 1964). A later study reported 66 percent of the parolees
had avoided drug use (Diskind 1967). lnciardi suggests that this data
may be misleading, since not all cases were randomly assigned to
parole supervision. Instead, selective case assignment was used for
those most likely to succeed. Measures of failure were rearrest
and/or return to drug use. However, either drug use frequently went
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unreported by parole officers, or parolees learned ways to beat drug
detection. Finally, due to racial tension in New York during the
1960s many middle-class, white parole officers were out of touch with
the areas where the rates of crime and addiction were the highest—
the minority neighborhoods.
However, two aspects of the project demonstrated considerable
clinical efficacy. First, a special arrangement was made between the
parole project and Daytop Village, and from 1965 to 1967 a total of
43 parolees were accepted into Daytop Village for treatment.
Although no followup data are available, 16 of the 43 parolees had
graduated from Daytop Village by June 1966. The second aspect of
the project was a rudimentary approach to multimodality program-
ming. One option of the parole officer was to refer relapsed cases
to available, although limited, local programs for treatment.
The New York State Narcotics Control Act of 1966 established the
NACC. The resulting civil commitment program, which can probably
be described as the largest and most costly in history, allowed
addicts to be committed to treatment for 3 to 5 years. Eligibles
included those arrested for drug-related crimes, those whose family
members petitioned the courts, and volunteers. The treatment
process included a period of incarceration followed by community
aftercare.
New York purchased facilities from the State Department of Correc-
tions; such facilities provided an environment not conducive to
therapeutic treatment. lnciardi concludes by suggesting that if the
New York civil commitment experience is used, policymakers should
have learned that implementation is important, monitoring must be
carefully carried out, and compulsory treatment should utilize existing
treatment programs rather than creating a whole new separate
system.
Since drug abusers who are using drugs heavily report six times more
criminal activity, Wish reports that reducing drug abuse also reduces
crime. Therefore, a critical issue is identifying drug-abusing
offenders and deciding what to do with those identified. Drug
testing for all offenders is important to identify drug users. In
addition, testing offenders can help predict community drug-use
trends. Wish describes four techniques for identifying drug-using
offenders: offender self-report, criminal justice records, urine
testing, and radioimmunoassay of hair.
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Results from a 1984 study in Manhattan of 6,406 male arrestees who
were being held in central booking awaiting arraignment reveal that
95 percent agreed to participate in the confidential research interview
and 84 percent provided a voluntary urine specimen for analysis. The
most common drug found was cocaine, followed by opiates (21 per-
cent), PCP (12 percent), and methadone (6 percent). Overall, 56
percent were positive for one or more of these drugs and 23 percent
were positive for two or more drugs. The self-reported estimates of
drug use in the last 24 to 46 hours were about half of what was
detected by the urine tests. Female offenders were more likely to
test positive for drug use and more likely to self-report serious drug
abuse than males. Of the women who were charged with prostitution,
75 percent tested positive for one or more drugs, with intravenous
cocaine use in this group at approximately 45 percent. After arrest
most prostitutes are on the streets again within several hours.
Referral rates to TCs from the criminal justice system have steadily
declined from 50 percent in the mid-1960s to 16 percent in 1985,
which indicates that these linkages have been weakened. Using 1974
self-report data, in which success was defined by absence of drug use
and arrest as well as having a job or going to school, De Leon
reports a success rate of 38 percent. Data from 1971 and 1974
cohorts show that successful outcomes increase with length of time in
treatment. Likewise, data from 1970 and 1971 indicate that the
length of time in treatment reduces arrest rates for dropouts,
although outcomes are slightly better for volunteers than for legal
referrals. In addition, as time in treatment increases, the proportion
of legal referrals increases. Most TC dropouts occur within the first
120 days, with a peak during the first 15 days.
Recovery from drug abuse is an interactional phenomenon involving
the interplay of client factors with nontreatment factors, such as
social climate, as well as treatment itself. Interaction of these
domains needs to be considered in order to understand recovery.
Client factors include two critical areas—external pressure and
internal pressure. Legal referrals belong in the external pressure
category. A stable recovery cannot be maintained by external (legal)
pressure only; motivation and commitment must come from internal
pressure. The role of external pressure from this point of view is to
influence a person to enter treatment.
Subgroups, including legally referred, legally involved, volunteers with
past legal involvement, and volunteers with no legal involvement,
should be the focus of future research. lt is one thing to
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operationally deliver pressure as an action—an individual enters
treatment. lt is another thing to perceive the pressure in the sense
that it is dangerous not to go to treatment and it is dangerous to
leave treatment, which may be one of the biggest sources of vari-
ance. In addition, legally referred clients may actually be pushed
into treatment, but their perception of legal consequences accounts
for dropouts among the legally referred clients. These sources of
variance need to be better understood to examine civil commitment.
Ball presents information on an ongoing 3-year study of methadone
maintenance and drug-free outpatient treatment programs in New
York, Philadelphia, and Baltimore. This study examines client charac-
teristics related to treatment success and failure, characteristics of
the seven different programs, and the types of services received by
clients. Both client outcome and patient services are examined.
Clearly, not all methadone programs are the same.
Ball also notes that methadone maintenance is an ambivalent treat-
ment modality, since most programs do not even have names. There
is still a lot of controversy about methadone maintenance. Many
program staff do not tell their friends that they are working in a
methadone program. Because methadone maintenance programs typi-
cally consist of three-fourths male clients and one-fourth female
clients, the study focuses on males only. The mean number of incar-
ceration years was 4. Roughly 95 percent of clients in the study had
prior drug abuse treatment, and three-fourths of those clients had
prior methadone maintenance treatment. Since arrests are a poor
indicator of actual criminal involvement, “crime days” was used to
define the number of days per week on which a client was involved
in criminal activity. Specifically, crime days per week during the last
addiction period before treatment were approximately 80 percent, or 6
days per week of criminal involvement, indicating a high-crime
population. Results show that, after 1 year in methadone mainte-
nance treatment, 77 percent of clients did not use heroin. By
comparison, cocaine use shows a major reduction, but some amount of
use persists even after 5 years in treatment. Marijuana use also
continues, and alcohol use to the point of intoxication remains
nearly consistent.
COSTS AND POTENTIAL BENEFITS
Brown examines the costs and benefits of civil commitment from an
international perspective but cautions that no hard data exist in this
area. The objective of civil commitment is twofold: containment of
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objectionable persons, and changing those persons’ objectionable
behavior. These international differences are largely a matter of
degree; different countries have very different ways of implementing
civil commitment. There may or may not be an adjudication process.
Effectiveness is measured by the reduction of community disruption,
and costs can be measured as the toll on civil liberties. In demo-
cratic countries, a massive campaign against drug abuse requires clear
evidence of public support. For a major intervention program to be
successful, especially with reliance on compulsory treatment, the
problem must be isolated and enlarged—or, in certain circumstances,
even created.
Of the 43 countries studied by Porter et al. (1986), 27 had civil
commitment practices. Implementation of civil commitment procedures
differs markedly according to whether it comes under mental health
legislation or under separate legislation specific to drug abuse. lf
covered under legislation specific to drug abuse, the rationale for
civil commitment may be limited to evidence of dependence/addiction
and the need for treatment. Three different types of review author-
ities can determine whether commitment is appropriate: (1) the court
system; (2) existing or specially created government agencies; or (3) a
medical agency.
Reporting for the World Health Organization, Porter et al. (1986)
made the following recommendations regarding civil commitment: (1)
persons who need a short-term emergency commitment for incapacita-
tion due to drug dependence should be immediately released from
detention on completion of treatment, that is, completion of detoxi-
fication; (2) compulsory civil commitment for other than emergency
care is justified only when an effective treatment program as well as
adequate and humane facilities are available; (3) the period of
confinement should be limited and a person’s involuntary status
subject to periodic review; and (4) the person concerned should be
afforded substantive and procedural rights during the commitment
proceedings. Brown concludes by raising the question of whether
AIDS has the potential to muster popular support for civil commit-
ment of drug addicts in the United States. He cites constraints on
national policy in a democracy and notes that the health risk is not
now viewed as a sufficient threat to the heterosexual population.
Harwood identifies resource availability as the major constraint on
public efforts, with the present spotlight on both costs and benefits.
Before presenting specific study results, Harwood states that his
study’s objective was to estimate the economic benefits of drug abuse
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treatment in reducing intreatment and posttreatment criminal activity
of drug abusers, as well as examining reduced-crime costs 1 year
after treatment. A 1984 economic-cost study by Harwood estimated
the cost of drug abuse at $47 billion in 1980, with crime-related costs
representing about $18.3 billion.
Using sample data from TOPS at 12 months, as well as 24 and
48 months, the major conclusion reached was that virtually all
economic measures show that crime is lower after treatment than
before treatment. Clearly, this finding varies by the measurement
used. In addition, when TOPS criminal justice referrals are compared
to self-referrals receiving treatment, a significant reduction of
primary drug use is seen among criminal justice system referrals in
residential treatment. However, alcohol remains a problem for all
groups studied, with drinking reported to be heavier or at the same
level as before treatment. This finding corresponds with other
studies showing positive cost-benefit effects of treatment, especially
residential treatment, which has a high cost-benefit ratio.
CONSENSUS STATEMENT REGARDING COMPULSORY
TREATMENT
With the above research findings as background, the following
consensus recommendations related to compulsory treatment for drug
abuse were developed. Except as noted below, there was little
controversy concerning these statements. The consensus statements
developed by the meeting participants are:
lt is recommended that the term “compulsory treatment” be used
rather than “civil commitment” to capture a wider range of
possible interventions, since civil commitment is only one type of
compulsory treatment. Further, it is essential that candidates for
compulsory treatment receive appropriate legal protections.
While there was considerable discussion, it was tentatively agreed
that the type of persons targeted for compulsory treatment should
be chronic drug abusers and, more specifically, the drug-abusing
offender who would benefit most from treatment. Since it will
not be possible to treat everyone who is identified or tests
positive for drugs, it will be necessary to examine drug abuse
careers and, initially, choose those intravenous drug abusers who
pose the greatest threat to themselves and the community.
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Treatment has proven effective in reducing drug abuse and, most
specifically, in reducing intravenous drug abuse. Nonetheless, drug
dependence is chronic, and repeated interventions will probably be
needed for most clients.
Research has shown that the length of time in treatment is
related to treatment success and that long-term client aftercare
and monitoring is an essential part of treatment. In addition,
research has indicated that compulsory treatment in the form of
civil commitment increases treatment retention for intravenous
drug abusers.
Urine testing is an important tool for identifying and monitoring
drug use for both the criminal justice system and treatment
programs.
The efficacy of methadone treatment needs to be more clearly
presented to personnel in the criminal justice system, since there
seems to be a bias against methadone as a treatment approach.
The TC has a unique role for clients receiving long-term manda-
tory treatment and should remain an attractive treatment alterna-
tive for the judicial system.
Discussion of compulsory treatment must include the impact of
such a policy on the Nation’s treatment network. Treatment slots
must be readily available, and the treatment offered should include
the range of existing treatment modalities—methadone treatment,
TC, and drug-free outpatient treatments. Compulsory treatment
should not displace the treatment capacity available for other
clients.
The criminal justice system is important for client identification
and retention. A strong link needs to be developed at all levels
between treatment programs and the criminal justice system. The
interface involves education, development of common goals, and
inclusion of criminal justice as treatment items in data systems.
Compulsory treatment cannot be considered a panacea for dealing
with the AIDS problem among intravenous drug abusers. Consid-
eration also must be given to other alternatives for curbing the
spread of AIDS infection. However, if one of the goals of a
compulsory treatment program is to reduce the spread of AIDS
infection, there needs to be a greater focus on prostitution. This
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recommendation is based upon research that shows that a high
proportion of those arrested for prostitution are intravenous drug
abusers.
ADVANTAGES AND DISADVANTAGES
The following advantages of compulsory treatment and, more specifi-
cally, civil commitment emerged. lt is summarized as an approach
that:
helps get drug abusers into treatment;
appears to keep drug abusers in treatment longer if managed by
the treatment system;
makes treatment available before a crime has been committed;
is separate from postoffense criminal justice system processing;
provides clear due-process procedures: and
has clear treatment goals to contain the addict rather than only
providing punishment.
On the other side of the coin, several disadvantages of compulsory
treatment/civil commitment were evident. It can be summarized as
an approach that:
incorporates delays in processing;
would overwhelm treatment facilities unless more funding, facil-
ities, and staff are available;
many addicts may be unwilling to use or found to be unsuitable
for;
at first Mush appears too costly, however, this is tempered when
compared to court and incarceration costs; and
is too cumbersome administratively.
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RECOMMENDATIONS FOR FUTURE RESEARCH
The panel also recommended that research should be encouraged to
develop and extend knowledge related to compulsory treatment in the
following areas:
Treatment outcome studies should assess the impact of treatment
interventions on criminal activity and should also collect baseline
criminal data.
Treatment outcome studies should incorporate standardized
protocols to allow for clear understanding for replication.
Replication studies should be initiated to reexamine the efficacy of
intensive supervision and urine surveillance in reducing drug use
for probationers and parolees.
Diagnostic criteria should be further refined to identify clients
who could benefit from compulsory treatment and to match clients
to specific treatment approaches.
Linkage models to strengthen the relationship between the criminal
justice system and the treatment system should be further
examined.
Descriptive study, including criteria and use of State civil
commitment laws for drug abusers, should be undertaken.
Cost-benefit studies should be updated and should include criminal
justice variables.
Epidemiological studies that focus on drug abuse should incor-
porate criminal justice data.
Secondary data analysis of existing data sets should focus on
criminal justice questions.
Finally, it should be emphasized that compulsory treatment might be
only one of the many approaches to reducing the spread of AIDS
among intravenous drug users and the general population, and that
approaches like TASC may be useful in directing intravenous drug
users to treatment.
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